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SECTION ONE
The colposcopic study of the cervix  
at,  and around, the menopause. The 
evaluation of the colposcope as an 
aid to standardisation of stigmata of 
hormone defic iency. The incidence and 
importance of the atypical 
transformation zone in the 
postmenopausal woman, and the 
l im ita t ions  of available  screening 
methods.
SECTION TWO
The microbiological environment of 
the cervix in CIN, human papilloma 
virus in fections , and health. The 
varia t ion  in iso lation of organisms 
with advancing age. The re lationship  
of previous infection with certain  
organisms, in patients developing 
cervical cancer and matched controls. 
The concept of two forms of cervical 
cancer.
SECTION THREE
Structural study of the factors  
re lated  to the apparent 
movement of the squamo-columnar 
junction . Biochemical investigation  
of the structure of the cervix at 
d if fe re n t  ages, and the influence of 
exogenous oestrogens. Histological 
study of varying collagen presence, 
with advancing age.
INTRODUCTION AND ACKNOWLEDGEMENTS
The concept of th is  thes is , emerged when I was working as a 
re g is tra r  in Gynaecology and Obstetrics, at the Western 
In firm ary , and Queen Mothers Hospital, Glasgow. I had a 
concurrant commitment to colposcopy, gynaecological oncology,
and menopausal c l in ic s  . A colposcopic study of postmenopausal
women, who attended the menopausal c l in ic ,  was devised. The aim 
was to ascertain both the prevalence of the atypical 
transformation zone in the older woman, and the e f fe c t  of 
hormone replacement therapy, on the colposcopic appearances of 
the cervix.
This study, however, raised fu rther  questions, and i t  was 
apparent that fu r th e r  work would have to be done. The surprise  
f in d in g , of occult pre-invasive disease in an older population, 
has prompted questions, both on aetiology in the older p a t ien t ,  
and on the screening aids ava ilab le  at present, for detection of 
neoplasia. General in terest in a specific  agent, as the 
in i t ia t o r  of cervical neoplasia, has never been greater, and the 
evidence is becoming very strong in the younger woman. The older  
woman, on the other hand, appeared to be so remote from the
sexually transmissible agents, that I considered there may
possibly be more than pathway fo r cervical cancer to develop. 
Age may be a co-factor, rather than a sexually transmissable 
agent. Working in a gynaecological oncology c l in ic ,  afforded an 
ideal opportunity to study putative aetio log ica l agents, at a 
wide range of ages, in patients with cervical carcinoma.
Subsequent studies were devised, to attempt to answer the
questions raised by the colposcopic study on postmenopausal 
women. What were the differences in the cervix colposcopically  
in these older women, and what was the relevance to neoplasia? 
What were the microbiological d ifferences, in the genital t ra c t  
of older women, compared to the younger woman? In p a r t ic u la r ,  
was there any evidence of considerable prevalence of human 
papillomavirus, and what relevance did th is  have to neoplasia? 
Did the older woman with cervical cancer have the same genital 
pathogenic precursors as younger women, and has there been a 
change in prevalence of these possible precursors to neoplasia? 
Lastly , are there structural changes in the cerv ix , with
advancing age, which are responsible fo r the problem of f a i lu r e  
of diagnosis in the postmenopausal woman?
Such questions do not have easy answers, but there were 
in teresting  findings in each phase of th is  work. As the work
lends i t s e l f  into division into three parts , so the thesis is 
dealt with in three sections, each with two main studies. An
introductory chapter, gives a h is to r ica l overview of the
background to each phase, and each study is described and
discussed. A short summary of each phase is given a f te r  the 
papers.
All the studies were devised by myself, but the study on
genital microbiological f lo ra  of patients at the colposcopy
c l in ic ,  was devised jo in t ly  with Dr. Stephen Walkinshaw. 
Considerable help was given to me in the execution of the
studies, and these are acknowledged fo rthw ith . All work, 
(1983-4), and authorship, (1985-7), was carried out when I was 
working within the National Health Service. No grant was
employed fo r th is  work, and where laboratory services have been 
used,this was by v ir tu e  of the kindness of individual c l in ic ian s  
and s c ie n t is ts ,  to whom I am gra te fu l.
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cytology.
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In firm ary, and Dr. Clive Bouch, Consultant Pathologist, 
Leicester Royal Infirm ary, for reviewing and advising on the 
histopathology. Histology was independently reviewed by Dr. 
Malcolm Anderson, Consultant in Gynaecological Pathology, 
Samaritan Hospital fo r Women, London, and I am most gratefu l to 
him for his help. I carried out a l l  cytological review, for  
endocervical ce lls  in a ll  specimens, before and during therapy.
CHAPTER 4
This study was jo in t ly  devised as indicated above. Drs.
Stephen Walkinshaw and James Cordiner, recruited about 50% of 
the patients from the study group, and 13% of control patien ts ,  
and I recruited the remainder. The cytology and pathology was 
performed by the depts. of Cytology and Pathology, Western 
In firm ary , Glasgow. The HSV iso lation  was performed by Dr. Joan 
Macnab and s t a f f ,  at the In s t i tu te  of Virology, Glasgow. The 
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SUMMARY
This thesis,has attempted to ind icate , that the cervix a f te r  
the menopause,is a considerably d i f fe re n t  organ from that of the 
younger woman. A paradox now exists with carcinoma of the
cerv ix , namely high incidences of pre-invasive disease in the 
younger woman, and low incidence of carcinoma, which contrasts 
with the s ituation  in the older pa t ien t ,  who has high incidence 
of invasive disease, and low incidences of pre-invasive disease. 
This has led to the suspicion of two d i f fe re n t  aetio log ies . The 
older patient may not progress through a detectable pre-invasive  
phase, as low rates of carcinoma in s itu  in the older woman 
would suggest (209). Thus, age i t s e l f ,  may be a co-variable  in 
the genesis of disease (92 ,93 ) .  This questions whether the 
agents that are putative causes for cervical cancer, in the
younger woman, are also aetio logica l factors in the older woman.
The work in chapter two, defined the colposcopic appearances 
of f i f t y  p e r i-  and postmenopausal women,who had symptoms of the 
c lim ac te r ic ,  and were to be prescribed hormone replacement 
therapy (HRT). Colposcopic and cytologic variables were compared 
and related to serum analyses of oestrad io l. A scoring system 
was devised, to enable the e ffe c t  of HRT to be quantitated. HRT 
improved the colposcopic appearance of the cerv ix , and enabled
the SCJ to be seen, when previously i t  was not v is ib le .
Other work,carried out on the same p a tien ts , indicated that  
twelve of the f i f t y  patients (24%),had a colposcopic abnormality  
or atypical transformation zone. Of greater alarm, was that four 
of these eleven patients,had h is to lo g ic a lly  proven CIN, without
any cytological abnormality, despite repeated smearing. Doubt
has been cast on the a b i l i t y  of these CIN lesions, in the
postmenopausal patient , to  e x fo l ia te  abnormal c e l ls ,  at least in 
the early  grades of CIN found in th is  study. This has not been 
encouraging to the concept that cytology may be discontinued at 
the age of 60 years, i f  i t  has been negative up to that age
(21).
The second section of the work of th is  thes is , considered the 
factors that have been proposed as causal to carcinoma of the 
cerv ix . A population of women with carcinoma of the cerv ix , were 
matched with a population of women of l ik e  age, p a r i ty ,  and 
socio-economic group, who had no previous evidence of cervical 
neoplasia. Three putative agents, which lend evidence of past 
in fection were studied. No conclusive evidence could be found, 
to implicate any agent or combinations of agents. A trend,  
however, appeared with C. trachomatis and tumour 
d i f fe r e n t ia t io n ,  and i t  is possible that th is agent, or
combinations involving th is  agent, are implicated in more 
aggressive tumours.
Data on socio-economic grouping,proved crucial to the study. 
S ero pos itiv ity  appears in tim ate ly  related to S.E. group, and
indicates the severe l im ita t io n s  of studies which do not have
this information. Perhaps the greatest value of th is work, l ie s  
in the i l lu s t r a t io n  of sero p o s it iv ity  with age. The patien t  
under the age of th i r ty f iv e  years, with carcinoma of the cerv ix ,  
had much higher rates of se ro p o s it iv ity  to a l l  three agents, but 
especia lly  to C. trachomatis and CMV, than the control p a t ien t .  
The older patient who had had carcinoma of the cerv ix , had
almost identical s e ro p o s it iv ity  rates to the control patients .  
This is fu rther  evidence that carcinoma in the older p a t ien t ,  
may be of d i f fe re n t  origins to the carcinoma in the younger 
pa tien t .  One problem with these data, is the dominance of 
carcinoma among the older woman, thus burying any s ig n if ic a n t  
differences evident only in the younger woman, who have 
developed carcinoma.
The next section of the work, was to id e n t ify  agents 
associated with CIN, and to compare these to a population of 
normal women, and healthy postmenopausal women. HPV was 
confirmed as an agent commonly associated with CIN, but no other 
agent was more commonly associated, than in the control group. 
The id e n t if ic a t io n  of a group with abnormal cytology and 
negative colposcopy, who had s ig n if ic a n t ly  greater 
microbiological iso la tio n , gave support to cervical culture  
before re fe rra l  to colposcopy, i f  such a service was l im ited .  
The postmenopausal women had higher isolations of vaginal 
pathogens, and an inexplicably high iso la tion  rate  of group B 
Streptococci. Surpris ingly HRT did not reduce th is  reservoir of 
vaginal pathogens.
Having data available  on both iso la tion  and serology fo r  the 
same patients , allowed closer examination of trends in 
Chlamydial infection with age. The conclusion from th is  
evidence, is e ither that C. trachomatis is not detectable by the 
microimmunof1uoresence technique in advancing age, or th is  
organism is considerably more prevalent now, than in the past. 
This may s t i l l  be a co-factor to HPV or smoking, in the genesis 
of carcinoma,in the younger woman with the aggressive tumour.
The f in a l  section of the work, has attempted to provide some 
explanation, for the d i f f i c u l t y  in v isua lisa tion  of the squamo- 
columnar junction (SCJ), that often accompanies age. Decreased 
cervical water, at the area around the SCJ was found. 
Hydroxyproline estimation suggests, that collagen is present in 
greater density, near the SCJ, in the older woman. The collagen 
content in the cervical stromal core, however, appears s im ila r  
at a l l  ages. A h isto log ica l study, confirms increasing collagen 
density near the SCJ, with advancing age. HRT may increase 
cervical water, which may render the SCJ v is ib le ,  by allowing  
greater eversion of the endocervix. This study found no e f fe c t  
on collagen by HRT.
I t  has been the aim of th is  work, to show the cervix in the 
older woman is d i f fe re n t  from that in the younger woman. The 
differences are in appearance, s tructure , microbiology, and 
prior vaginal pathogens. The differences may a ffec t  the a b i l i t y  
to detect cervical neoplasia, and question whether cervical 
cancer in such older women, is t ru ly  the same disease as that in 
women of childbearing years.
CHAPTER 1
HISTORICAL REVIEW
A) SECTION 1 - CARCINOMA OF THE CERVIX IN THE
POSTMENOPAUSAL PATIENT- A CAUSE 
FOR CONCERN?
B) SECTION 2 - FEATURES ASSOCIATED WITH AND POSSIBLY- CAUSAL
TO CARCINOMA OF THE CERVIX
C) SECTION 3 - VARIATION IN THE STRUCTURE OF THE
HUMAN CERVIX WITH ACS
CARCINOMA OF THE CERVIX IN THE POSTMENOPAUSAL PATIENT- 
A CAUSE FOR CONCERN?
"With the exception of stopping the population 
from smoking, cervical cytological screening 
offers the only major proved public health 
measure fo r s ig n if ic a n t ly  reducing the burden 
of cancer today."
ICRF CO-ORDINATING COMMITTEE 
ON CERVICAL SCREENING 
(Br. Med. J. 1984;289:894-5)
Cytological screening of the cerv ix , has been practiced fo r  
almost twenty f iv e  years in Europe and America, and although 
i n i t i a l  promise of the eradication of cervical squamous 
carcinoma has not occurred, there has been an appreciable 
decrease in the incidences and the death rates from the disease 
( 1 ,2 ,3 , ) .
Those who have benefited to the greatest extent, are the 
women in the 35-54 year age group; the very patients , in whom 
the maximum e f fo r t  has been expended to prevent the disease. 
Unfortunately, the women outwith th is  age range have not fared  
as well (4 ) .
The increase in number of cervical smears, taken in England 
and Wales between 1965 and 1980, rose from 700,000 to 2 ,900,000,  
and yet there was only an overall f a l l  in the death ra te  of 16% 
(5 ) .  Much of the explanation for th is ,  l ies  in the women
younger, and older than the 35-54 year group.
Concern is now being expressed, at the alarming increase in 
the incidence of carcinoma of the cerv ix , in the patient under 
35 years of age. B r it ish  data indicate a three fo ld  increase in 
the death rate  for these women from 1965-1980 (5 ) .  The to ta l
numbers of cases in th is  young group is however, small, and 
greatly  outweighed by the large improvement fo r the middle aged 
p a t ie n t .  I t  is a matter of speculation, what the incidence of
carcinoma might have been, without screening in these younger
patients .
There is now some evidence, to suggest cervical screening may 
not be so e f fe c t iv e  at preventing the deaths, in these young 
women. I t  is suggested that the tran s it io n  time from normal 
squamous tissue to frank invasion, may be shorter than the
recommended smear interval of 5, or even 2 years ( 6 ,7 ) .  I t  is 
possible that these tumours do not go through a prolonged 
pre-invasive phase, that is commoner in the older woman. The
cervical cytology h is to r ies ,  of these young women who develop 
invasive carcinoma, frequently  reveal negative cytology in the 
recent past (8 ,9 ,1 0 ,1 1 ) .  Series of such patients are usually  
very small; one however, reported 45 patients with invasive  
carcinoma under the age of 35 years. Almost a l l  these patients  
had poorly d if fe re n t ia te d  lesions, and 26% had pelvic  node 
involvement. Eighteen of these patients had negative cytology
within the 6 years p rior to diagnosis of carcinoma. The 
prognosis in th is  group was poor, and only 2 of the 9 patients  
with anaplastic tumours, were a live  (8 ) .
A s im ilar German study, reported 15 of 87 patients with
invasive carcinoma,as having a negative smear and negative 
gynaecological examination, within one year of diagnosis. These 
patients had the highest incidence of pelvic node metastases 
( 10).
Figures from cancer re g is tra t io n s , on the other hand, suggest 
an improved f iv e  year surv iva l, for women under t h i r t y  f iv e  
years. These data are based on cancer reg is tra tions  of a l l  
stages, and include many with microinvasive carcinoma. The most 
recent figures ava ilab le , indicate 5 year survival from cases 
diagnosed in 1978 (1 2 ) .  The situation  for the younger woman is ,  
however, dynamic; The number of cases of carcinoma of the 
cerv ix , registered in 1976, in women aged 25-34 years, was 348. 
Four years la te r ,  th is  number had increased to 492. There was 
also a 25% increase in the number of cases in women aged 35-44 
years over th is  period, but women of other ages had s im ilar  
rates in both years. There is also an extremely marked f a l l  in 
the three year su rv iva l,  of very young women under 25 years. I t  
is apparent that the poor prognosis, recognised by individual  
gynaecologists, is now being re flec ted  in the re g is try  f ig u res .
The rap id ly  progressive pattern of the disease in the young, 
has led to speculation that th is  may be a d i f fe re n t  form of 
tumour, but Anderson believes that these represent the malignant 
end of a continuous spectrum of neoplasia (13 ) .
The concept, that there may be more than one form of invasive  
squamous carcinoma, with a d if fe re n t  malignant p o te n t ia l ,  is not 
new; Ashley reintroduced the hypothesis in 1966 (1 4 ,1 5 ) .  He
based his postulation on the bimodality of the death rate  curve 
of the disease . A la te r  report from Scandinavia, agreed in
p rin c ip le  with th is  theory (1 6 ) ,  but others have not held the 
same view (17 ).
The precedent for considering more than one type of squamous 
tumour, depending on age, l ies  with tumours arising from other 
s ite s .  Brain, eye, kidney, ovary and uterus, among others, are 
l ik e ly  to harbour d i f fe re n t  tumours in the young, than in the 
old (16 ) .  Ashley's hypothesis, suggested tumour in old women, 
did not progress through the usual premalignant stages. Can the 
same thinking be applied to the tumours in the very young?
Anderson has suggested that some of these tumours on the 
cerv ix , may have arisen in the native squamous epithelium rather  
than in the transformation zone; the origin of carcinoma 
according to dogma (18).
Whatever the true progenitor ce ll  or ce lls  of carcinoma in 
the young, thought must be given to the p o s s ib i l i ty ,  that there  
has been a change in the natural h istory  of cervical carcinoma. 
The increasing appreciation of the importance, of human 
papillomavirus in carcinogenesis, may r e f le c t  a true increase in 
the prevalence of th is  agent. I ts  greatest e f fe c t  may have yet 
to be manifested.
One fu rth e r  explanation for th is  alarming increase in disease 
in the young, is the cohort e f fe c t  (19 ,20 );  th is  is well known 
to be associated with high rates of carcinoma in the generations 
sexually active in times of social deprivation. There is some 
evidence, that women under 35 years in the mid nineteen 
seventies, w i l l  continue to have a high incidence of disease, 
but those born in la te r  decades may have lower rates.
Although m o rta lity  trends in the young are worrying (1 2 ) ,  the
numbers are very small when compared to the s ituation  in the 
patient over 55 years. Here, there appears to have been a 
reduced impact of cervical screening ( 1 ,4 ) .  The effectiveness of 
screening in the 35-54 year age groups, has ensured that the 
mean age at diagnosis has r isen, with women over 60 years now 
having the highest death rates from the disease (2 ) .
There are several reasons why the death rate  is higher in the 
older p a tien t;  Cervical screening is often not performed in the 
postmenopausal woman, in the b e l ie f  that i t  is no longer 
necessary. This has the e f fe c t  of delaying diagnosis un ti l  the 
disease is symptomatic. The re-convened Canadian Task Force on 
cervical screening, reaffirmed that screening was not necessary 
a fte r  the age of 60 years, i f  i t  had been repeatedly negative  
until  that age (21 ) .  This is not synonymous with screening not 
being necessary in th is  age group; Macgregor and Teper, in 
presenting results from th e ir  screening campaign, concede that  
better results could be obtained, by the screening of more women 
over 55 years (1 ) .
Lack of screening a c t iv i t y ,  is also due to a reduction in the 
b e l ie f  in the te s t ,  in the older pa tien t;  Often the en tire  
transformation zone cannot be smeared, as the squamo-columnar 
junction is in the endocervical canal, and any material 
obtained, may be too scanty for valuable comment. Fa ilu re  to 
obtain appropriate c e l lu la r  m ater ia l,  renders a smear 
inadequate. Some laboratories report the lack of endocervical 
c e l ls ,  as an indication of l im ita t io n  of the smear (7 ,2 2 ) .  
Husain gives an excellent account of the d i f f i c u l t i e s  
encountered by the cy to log is t, in assessing whether a smear is
worthy of being classed as negative (23 ).  Scandinavian data
however, f u l l y  supports the value of the cervical smear, in the 
older patient.
The screening records of the Scandinavian countries, are to 
be envied; by means of population reg is te rs , stable populations, 
and e f f ic ie n t  central computerisation of resu lts ,  f igures are
obtained which are not ava ilab le  in other countries. Programmes 
were often aimed at a l l  women up to 70 years of age, and one 
report suggested, that over 80% of women between 60 and 70 years 
of age, were screened (24 ).  For cytological screening to be
e f fe c t iv e ,  the frequency of invasive disease, should f a l l  as 
much in the older screened pa tien t ,  as the younger woman. 
Although the incidence f e l l  dram atically , even in such a well 
screened population, there was s t i l l  a frequency of 30 cases of 
cervical cancer per 100,000 women. Such frequencies are
a ttr ibu ted  to carcinoma aris ing in the women who did not take
part in the screening programme.
Recently a Swedish report cited an incidence of 16 per
100,000 women between 60 and 69 years, in whom there was
evidence of at least one negative smear in the preceding 10
years (2 5 ) .This rate  was considerably higher, than rates fo r  
younger women who had been screened. This evidence ind icates,  
although cytological screening reduces incidences of cervical 
carcinoma, i t  may be less e f fe c t iv e  in the older p a t ien t .
Negative cervical cytology, shortly  preceding the development 
of invasive squamous carcinoma, is well documented (7 ,1 0 ,2 6 ,2 7 ) .  
Often the explanation is obvious; Smear review accounts for many 
cases where positive smears are fa ls e ly  interpreted (7 ,1 0 ) .
Others are explained by patient or c l in ic ia n ,  not acting on a 
positive  report (6 ) .  Many, however, cannot be explained and 
postulations about rap id ly  growing tumours, are made (6 ) .  There 
is another explanation for th is  s i tu a t io n ,  which may be 
applicable to the postmenopausal patient with low oestrogen
stimulus; Often in established cases of cancer, malignant ce lls  
are not ex fo l ia ted . In the older patient with dysplasia, 
possibly pre-invasive dysplastic ce lls  are also not shed, and
the smear may be reported as negative, in the presence of
dysplasia. The insistance on seeing endocervical c e l ls ,  to ca ll  
a smear adequate, is a council of perfection , not often
atta inab le  in the postmenopausal woman (22 ).
Early work by Coppleson and Reid, suggests that a colposcopic 
examination, may increase diagnostic accuracy in cervical 
screening by 5%, in patients with lesions missed by cytology
alone (28 ) .
Older pa t ien ts , often present with more advanced disease, due 
to awaiting symptoms, rather than ava iling  themselves of 
screening (29 ) .  Routine cytology in the older p a t ie n t ,  may 
reveal an invasive lesion, which has been caught at an e a r l ie r  
stage, than i f  symptoms were awaited. Screening the older
patien t ,  may thus decrease the chance of invasion, but also
improve the death ra te ,  which at present is considerably worse 
in the postmenopausal patien t, than the younger woman (12 ) .  In 
terms of numbers, the major hurdle to be overcome by cervical 
screening, is now the reduction of cervical neoplasia in the 
older woman.
The foregoing discussion, has been based on the premise, that
cervical cancer is s im ila r ,  whether in young or old. To study 
the converse, namely that there is a d ifference in the tumour at 
d if fe re n t  ages, the aetio logica l fac tors , and th e ir  prevalence 
at d i f fe re n t  ages, need to be considered. The next section w il l  
discuss these agents.
FEATURES ASSOCIATED WITH AND POSSIBLY CAUSAL TO THE 
DEVELOPMENT CARCINOMA OF THE CERVIX UTERI.
No argument suggesting more than one type of squamous 
carcinoma of the cerv ix , would be tenable, without some 
investigation and discussion into the putative causal factors of 
the disease. In the past two decades, many agents have been
postulated as having a role in the aetiology of neoplasia of the 
cerv ix . Many of the studies implicating such agents, have drawn 
data from younger patients. Data on possible precursors in older 
women are more scarce.
Whether in fec tive  agents are responsible or not, squamous 
cell carcinoma of the cerv ix , stands out as an example of a 
behaviour re lated disease. Although the r a r i t y  of the disease in 
nuns had been known for over 100 years (3 0 ) ,  in te res t  in the
association with sexual behaviour, was stimulated by a report of
r a r i t y  in virgins (31). Reports that e x is t ,  suggest that r isk of 
the disease w il l  increase in proportion to the number of sexual 
partners (32 ) ,  and with e a r l ie r  age at f i r s t  coitus (33 ) .
This la t t e r  r isk  fa c to r ,  has led to the hypothesis, that i t  
is age of the pat ien t ,  that plays a factor in the genesis of 
cervical neoplasia. The exposure of immature epithelium to a 
mutagen, may render i t  unstable, and more l ik e ly  to become
neoplastic (34 ) .  A fu rther  view, suggests that an in fe c t iv e  
agent, with oncogenic p o ten tia l ,  is more l ik e ly  encountered with 
m ultip le  sexual partners. Evidence of transmission of a fac to r  
involved in neoplasia, be i t  in fec tive  or chemical, is found in
unfortunate cases of sequential wives of the same man, 
developing carcinoma of the cervix (35 ) .  Such observations on 
the "high risk male", and also those indicating that male
promiscuity w i l l  increase the r isk  to a monogymous partner (3 6 ) ,  
strengthen the case fo r a transmissable agent being an
aetio log ica l fa c to r .
The search fo r an in fec tive  causal fa c to r ,  while not 
apparently d i f f i c u l t ,  has been hampered by the numerous
associations between sexually transmissable agents and cervical 
carcinoma. A ll such agents, w i l l  be more prevalent in a
population with cervical carcinoma, than a control population. 
To suggest causation rather than association, has proved very
d i f f i c u l t .  Many workers in this f i e l d ,  now feel that human
papillomavirus (HPV) is a l ik e ly  c u lp r i t ,  but in the past other 
agents have also been seriously considered.
Treponema pallidum and Neisseria gonorrhoeae, are now
infrequently  found in association with carcinoma of the cerv ix .  
Trichomonas vag ina lis , is now ra re ly  investigated as a causal 
fa c to r ,  but as yet i t  cannot yet be f u l l y  vindicated (37 ) .
The f i r s t  agent to have serious and intensive study, was
herpes simplex virus (HSV). The observation of cytological  
changes, due to HSV, in greater prevalence among women with
cervical dysplasia (38 ) ,  heralded a new era in th is  search. 
Rawls et a l . ,  augmented the body of knowledge, by finding higher 
prevalence of antibodies to HSV I I  in cervical cancer patients  
than controls (39 ) ,  and other reports have continued to confirm 
th is  association (40 ,41 ) .  Virus specific  p a r t ic le s ,  have been 
id e n t if ie d  in cervical neoplastic lesions (42 ) ,  and mRNA
specif ic  to HSV, was found more often in cancer biopsies, than 
control biopsies (43 ) .  HSV I I ,  also exhibits two important 
ch aracter is t ics ; latency and transformation. I t  may remain 
la te n t  in the neural ganglia (4 4 ,4 5 ) ,  and i t  may transform 
mamalian c e l ls ,  when incubated by u l t r a v io le t  l ig h t  (46 ) .
There has, however, been a great paucity of work, confirming 
HSV DNA in cervical cancer cell lines (47 ) ,  but some work has 
advised vaccination against HSV, in an attempt to prevent 
cervical carcinoma. (48 ).  The in a b i l i t y  to conclusively prove 
HSV as a true causal fa c to r ,  has led to the suggestion that HSV 
may be a co-factor in cervical cancer causation, rather than the 
sole agent (49 ,50 ) .
Coincident with the rea l is a tio n  that HSV was not the sole 
agent in carcinogenesis, was the search for other factors . The 
cytomegalovirus (CMV) supplied an a t tra c t iv e  model fo r  
carcinogenesis. This agent is sexually transm issible, able to 
transform ce lls  in v i t ro  (5 1 ) ,  and has been isolated in an 
infectious form from cervical carcinoma (52 ) .  Serological 
studies draw co n fl ic t in g  conclusions; a study by F uc il lo  e t . a l . ,  
involving lim ited  numbers, found no d ifference between the 
s ero p o s it iv ity  in cervical cancer patients and matched controls  
(53 ) .  However, in another study around the same time, 
Vestergaard and colleagues did show s ig n if ic a n t ly  greater
sero p o s it iv ity  among cancer patients (54 ) .  Such confusion,
probably results from the natural prevalence of CMV antibodies 
in the normal population. Of young women under 16 years, only
40% w il l  have antibodies to CMV, but th is  percentage rises
s tead ily ,  such that 80% of women over 41 years, w i l l  have
evidence of previous infection (55 ) .
Age is thus c r i t ic a l  to any serological study involving CMV. 
Cytomegalovirus, being a herpesvirus, may yet play a part in
cervical carcinogenesis. The in te res t in th is  agent in 
immunosuppression, and the observations of high rates of both 
CIN and CMV infections in renal transplant pa tien ts , raises
suspicion; current work on th is  agent shows CMV DNA in tumour by 
re s tr ic t io n  analysis (J.W. Cordiner personal communication).
A ll agents, at present accorded serious consideration as
aetio log ica l fac to rs , are viruses, with the exception of 
Chlamydia trachomatis (56 ) .  Other genital bacteria , such as 
Mycoplasma hominis, and Ureaplasma urealyticum, have been 
studied, but no greater prevalences were found in cancer
patien ts , compared to controls (57 ) .  Chlamydia is a Gram
negative bacteria l organism, which is in t ra c e l lu la r  during 
rep lica tion  (58 ) .  I t  is responsible for blindness, with an 
estimated 500 m ill ion  cases of trachoma worldwide. C trachomatis 
is also a genital pathogen, causing Lympho Granuloma Venereum, 
"non specific" lower genital t ra c t  infection (5 9 ) ,  s a lp in g it is  
(60) and c e rv ic i t is  (61 ) .  The presence of the organism is
related to sexual behaviour (6 0 ) ,  and prevalence is high among 
promiscuous women, such as those with gonorrhea (62 ) .  The 
a ttrac tion  of th is  organism as a causal agent, l ies  in i ts  
infectious sexual transmission (6 3 ) ,  in t ra c e l lu la r  re p l ic a t io n ,  
and cervical reservoir of in fec tion . The organism has been 
isolated in up to 16% of patients in early  pregnancy (59 ) .
The main body of data implicating C. trachomatis, comes from
seroepidemiolical studies. Higher prevalences of antibodies to
C. trachomatis, have been found in patients with cervical 
dysplasia than controls (6 4 ,6 5 ,6 6 , ) .  There are however, several 
problems; C. trachomatis, being a sexually transmissable agent, 
is more l ik e ly  to be prevalent in the population also at r isk  of 
cervical neoplasia, namely the more sexually active woman. A 
second less obvious fa c to r ,  is whether the dysplasia associated 
with C. trachomatis, is t ru ly  neoplastic, or a form of 
inflammatory reaction. Hare et a l . ,  suggested that in fection  is 
associated with a f o l l ic u la r  c e rv ic i t is  (6 1 ) ,  and such intense 
reactions may mimic CIN. Carr reports that mild changes thought 
to be CIN, may be due to C.trachomatis, and could be reversed 
with te trac yc lin e  therapy (67 ) .  This explanation may hold fo r  
the reported cases of regression of CIN, a f te r  application of 
local te trac yc lin e  (68 ,69 ) .  Genotypic studies, can now give more 
information; aneuploid lesions are neoplastic, and therefore  
less l ik e ly  to regress. With these l im ita t io n s  in mind, the 
presence of current or past infection with C. trachomatis, may 
act as a marker indicating women at higher r isk fo r cervical 
neoplasia.
The foregoing sexually transmissable agents have been 
overshadowed, for the role of the sole putative causal agent of 
carcinoma of the cervix; HPV has now the largest body of 
evidence to support i ts  claim. No matter how strong the evidence 
incrim inating th is  organism, however, there w i l l  be the 
potential fo r the role of other agents as co-factors.
Of the in fec tive  models for causation of cervical cancer, HPV 
f u l f i l s  many c r i t e r ia .  The virus is sexually transmitted (7 0 ) .  
I t  has specific  genital strains (71 ) ,  which are g en etica lly
d i f fe r e n t ,  from material from warts from other s ite s .  Some of 
the subtypes of HPV have d if fe r in g  malignant p o te n t ia l .  In 
p a r t ic u la r ,  types 5 and 8 are found in epidermodysplasia 
verruciform is; a condition with a 30% chance of progression to 
malignancy (72 ) .  Some subtypes are associated with benign 
cervical in fection (7 3 ,7 4 ) ,  and others are associated with CIN 
(75 ,76 ,77 ) .
The cytological changes associated with HPV, were described 
by Ayre as long ago as 1949 (78 ).  But i t  was not un til  Meisels
and Fortin categorised these as being due to HPV, that in te res t
in the virus as an aetio log ica l fac to r ,  was stimulated (79 ) .  The 
association with CIN, has now been confirmed by many authors 
(72 ,80 ) .
HPV antigens have also been observed in CIN lesions. The 
frequency of observation, however, decreases with increasing 
severity  of the CIN (81 ,82 ) .  Serological evidence does not
answer the main questions surrounding the re lationship  between 
HPV in fe c tio n , and CIN. This is mainly due to the in a b i l i t y  to
culture HPV, and hence raise an antibody that is specific  enough
to indicate previous genital wart, rather than plantar or common 
wart in fection (72 ).
I t  has been mainly from genetic analysis, that the 
incriminating evidence has accumulated. In p a ra l le l  with the
decrease in the microscopic and immunohistochemical changes of 
HPV in fec tion , with increasing grades of CIN, there has been 
increasing evidence of aneuploid lesions. Those lesions which 
appear warty, are l ik e ly  to be d ip lo id ,  with a t ra n s it io n
through polyploidy in warty atyp ia , to aneuploidy in CIN (83 ) .
DNA-DNA hybridisation studies, have revealed an association 
between HPV and both CIN and cervical carcinoma. This is very 
suggestive of a causal ro le . Hybridisation studies, suggest 
there are two va r ie t ie s  of HPV, that display homology with the 
DNA of the atypical condyloma. These are named types 6 and 11 
(7 1 ) .  Although these may ra re ly  be associated with cervical 
carcinoma, usually they are associated with lesser degrees of 
neoplasia. A report by McCance and colleagues, suggested the HPV 
DNA in cases of CIN, was present in a free  form, and not 
integrated into the host DNA (84 ) .  A report in 1983, suggested 
that another HPV, type 16, was present in 61% of cervical
cancers, but in only a small percentage of CIN lesions (85 ) .  A
fu rth e r  subtype, type 18, has also been found in cervical
cancers. Type 16 and type 18 HPV DNA may be integrated into the
host genome, but there is also evidence that HPV DNA to type 16
and type 18, may be episomal in cases of CIN (86 ).
In addition to the evidence that the virus involves
neoplastic t issue, there is exc iting  work to suggest that HPV 
may in fect h is to lo g ic a lly  normal tissue. Macnab and colleagues, 
have found DNA sequences which hybridise to HPV 16, from
h is to lo g ic a l ly  normal tissue in patients with cervical cancer. 
The HPV 16 was also found, in h is to lo g ic a l ly  normal cervix from 
11% of normal women (87 ).  Like HSV (4 4 ,4 5 ) ,  th is  work indicates  
that HPV may remain la te n t ,  or at least hidden.
Thus, there appears to be a logical progression, from 
cervical condyloma without atyp ia , through warty change with 
CIN, to carcinoma in s itu . At th is  stage there is often no gross 
evidence of HPV in fec tio n , but the lesion may contain HPV 6 or
11 DNA episomally. The f in a l  progression, may be to invasive
carcinoma, with HPV 16 or 18 DNA integrated into the host DNA. 
Whether HPV 16 and 18, are the same virus as HPV 6 or 11, but
altered by the process of in tegra tion , is not yet known. With
the information ava ilab le  at present, i t  seems that HPV gives a
good model fo r  cervical carcinogenesis, but not a l l  women with 
genital HPV develop cervical neoplasia, and other factors must 
be important.
Recently, there has been in te res t in the role of c ig are tte  
smoking in cervical cancer (88 ) .  I t  appears that r isk  of 
neoplasia increases with heaviness of smoking, and duration of 
smoking (89 ).  Nicotine is now considered a co-factor in 
carcinogenesis, and both th is ,  and some of the other agents 
previously mentioned, may also act with HPV in a synergistic  
process which results in carcinoma. The strong evidence 
implicating HSV type 2, and the paucity of iso lation  of DNA 
homologous to HSV in cervical tumours (47 ) ,  has led to the 
postulation of HSV as a "h it  and run" agent ; HSV transforms the 
epithelium, but does not remain in the tissue (50 ) .  zur Hausen 
has proposed a synergistic process, in which a mutagen, whether 
i t  be HSV or n ico tine , or some other agent, transforms the 
epithelium and renders i t  susceptible to malignant change, when 
subsequently infected with HPV (49 ) .
This is as yet a hypothesis, but there are animal models 
supporting i t ;  in teraction between bovine papilloma virus type 
4, and a substance quercetin, in c a t t le  grazing on bracken fe rn ,  
induces in tes tin a l cancer (90 ) .  Also, chemical carcinogens are 
synerg is tic , in the conversion of Shope papilloma virus
papillomas into carcinoma, in rabbits (91 ) .
Cancer, by v ir tu e  of the increased prevalence in the old,  
must have age as a co-factor. I t  has been suggested that the 
in f le c t io n  with age, in the bimodality noted in the death rate  
from c e rv ic a l . cancer, by Ashley (1 4 ,1 5 ) ,  is re lated  to the 
process of ageing (9 2 ,9 3 ) .  Thus age i t s e l f ,  may be as important 
a co-factor as others previously mentioned. Where age f i t s  into  
the above hypothesis, is not yet c le a r .  Evidence of HPV 
in fection in the older woman is unusual, but the true prevalence 
of in fection  decade by decade is not known. I t  is commoner in 
the 20-30 year decade than the 30-40 year decade, but does i t
confer r isk  i f ,  a f te r  the acute in fe c tio n , the epithelium is
s t i l l  normal?
I f  cancer (or pre-cancer), of the cerv ix , is dependent on a 
cascade of events, how does th is  apply to the postmenopausal 
woman? She may not have had intercourse fo r many years, or 
contact with these risk agents since her youth, and yet she 
maintains a high incidence of the disease. Do these agents
remain dormant? HSV may remain la te n t in the dorsal root
ganglion of spinal nerves (4 5 ) ,  but th is  property in HPV has 
s t i l l  to be f u l l y  proven. Generally, older women smoke less, 
have fewer sexual pathogens, and yet a higher rate  of cervical 
cancer. Has cervical cancer, in the older p a t ien t ,  a d i f fe re n t  
or modified series of in i t ia to r s  and promotors?
The following introduction, approaches the problem of high
m o rta li ty  in the older woman, from a d i f fe re n t  standpoint; I f
the aetio logica l factors for carcinoma of the cerv ix , are the
same in the older p a t ien t ,  then the f a i lu r e  to reduce m o r ta l i ty ,
may be due to a structural change in the cerv ix . This may a l te r  
the e ff icac y  of the available  screening, and diagnostic aids, 
used in the detection of cervical carcinoma.
VARIATION IN THE STRUCTURE OF THE HUMAN CERVIX WITH AGE
I t  is only now, in the la t t e r  part of the twentieth century, 
that most women l iv e  the m ajority  of th e ir  l iv e s ,  without
functional reproductive organs. L ife  expectancy in the past, 
usually ensured most women died before reaching the menopause. 
The reproductive system, is the only bodily system that can 
cease functioning without death. Consequently, postmenopausally, 
the internal genital organs have no function , and are frequently  
the s i te  of pathology.
Changes in ovarian f o l l ic u la r  and endometrial a c t iv i t y ,  are 
paramount to a woman who becomes aware of the c lim acter ic .  There 
are, however, also changes in the cerv ix . The endocervical 
glands are under hormonal control, and during the menstrual
cycle do have a cyc lica l a c t iv i t y ,  with increase in the height 
of the columnar epithelium, under the influence of oestradiol 
(94 ) .  S im ila r ly ,  gross hyperplasia of the endocervical 
glands, may occur during pregnancy, resu lting  in an endocervical 
prolapse (95 ) .  This a c t iv i t y ,  is g reatly  reduced a f te r  the 
menopause, and mucoid discharge may disappear a ltogether. The 
epithelium of the cervix w il l  become th in ner, and a less 
adequate b a rr ie r  to in fec tion . Cervical bulk w i l l  diminish, 
resu lting  in the typical cervix of the postmenopausal woman,
sm all,dry and f r a g i le  (96).
The cervix u teri has been recognised as a separate e n t i ty  to 
the uterine corpus, since the f i r s t  century A.D. (97 ) .  I t  
consists of a vaginal and a supravaginal portion, and for the
purposes of study, can be considered to consist of stroma, an
epithelium and endocervical glands. I t  is in the epithelium that  
neoplasia arises, but stromal changes may be respo ns ib le  for  
the d i f f i c u l t y  in iden tify ing  these changes in the 
postmenopausal pa tien t.  The stroma consists predominately of 
fibrous t issue, with 10-15% smooth muscle (98 ).  The muscle
content is var iab le , depending on the s ite  in the cervix; 28% in 
the upper th ir d ,  18% in the middle th i r d ,  and 6% in the lower 
th ird  (99).
In the immediate subepithelia l layer ,  there is a c a p il la ry  
plexus, and th is  region has more vascular channels, than deeper 
in the cervical stroma. Lymphatic vessels and neural elements, 
are found in the subepithelia l layer. H istological analysis, 
confirms greater neural tissue in the cervical isthmus, but 
f ib res  can s t i l l  be seen in the d is ta l  cerv ix , where there is
lim ited  smooth muscle. These f ib res  are known to be lacking in
the older woman, and probably regress with age (100). There is
also evidence fo r e las tin  in the human cervix (101), but the 
main constituents of cervical stroma are collagen, ground 
substance, and water. These w il l  be discussed in greater depth 
1ater.
A major problem, in the older woman, is the fa i lu r e  to
v isualise  colposcopically, or cy to lo g ica lly  sample the en t ire
transformation zone . The vaginal portion of the cerv ix , is
covered mainly by squamous epithelium, and the tra n s it io n  to 
columnar epithelium, may e ither be abrupt or gradual (102). All 
epithelium that is metaplastic squamous in type, i . e .  not native  
squamous or native columnar, constitutes the transformation
zone, and may be the s i te  of neoplasia. The landmark of the 
squamo-columnar junction , is often not v is ib le  in the older 
woman (103), but the reasons for th is  are not eas ily  explained. 
The process of squamous metaplasia, physio logically  transforms 
a ll  vag ina lly  exposed columnar epithelium to squamous 
epithelium, due to the e f fe c t  of the increased a c id ity  of the 
vagina. The atrophy that accompanies the menopause, ensures th is  
junction recedes into the cervical canal. The influence of the 
cervical stroma on th is  re tra c t io n , is not well documented. 
C artie r  suggests that the stroma is more dense, with a reduced 
blood supply. He indicates the cervix is fibrosed rather than 
oedematous, when compared to the younger woman (104). Novak, 
i l lu s t ra te s  a diminution in volume of the cerv ix , as inducing 
the squamo-columnar junction to recede into the endocervix 
(105). I t  would thus appear, that the diminution in bulk of the 
cerv ix , due to stromal volume changes, may be p a r t ly  
responsible.
The size of the cervix is determined by stromal volume, but 
deep in the stroma of the menstruating woman, are endocervical 
glands (106). In times of high steroid levels such as pregnancy, 
these may hypertrophy, and add to cervical bulk (107).  
Consequently, being under hormonal influence, they w i l l  diminish 
a fte r  the menopause, and th is  w i l l  contribute to the decrease in 
cervical bulk.
The cervical stroma i t s e l f ,  is also under hormonal contro l.  
The cervix is more r ig id  in the lu tea l phase (108). There are 
short term changes induced by prostaglandins (109), and the 
cervical softening of la te  pregnancy (110,111 ,112), a l l  indicate
the cervical stroma is hormonally sens it ive . Oestrogen binding 
s ite s ,  have been found not only in cervical glands, but also in 
cervical stroma (113). However, the changes in the cervical 
stroma that accompany the hormonally depleted state a f te r  the 
menopause, are not well documented.
There is no doubt that there is an a lte ra tio n  in the volume
of the cervix in the postmenopausal woman, and th is  is due to a
change in the composition of the cerv ix . Most l ik e ly ,  there are 
decreases in cervical water content, ground substances, c e l lu la r  
elements, collagen, and smooth muscle.
Hughesdon (114) compiled meticulous records on the histology  
of the human cerv ix , under certa in  conditions, and at certa in
ages. He believed, l ik e  many previous authors, that the cervix
contained an outer layer of smooth muscle, which comprised about 
25% of the cervix. This was believed to have a physiological 
action, in the 'taking up1 of the cervix in pre-labour. This 
layer enveloped a much more dense structure , composed la rge ly  of 
collagen. Danforth (98,115) took a d i f fe re n t  view, believing  
smooth muscle to be an ineffectua l and unimportant s tructure , in 
comparison to collagen, as fa r  as cervical d i la ta t io n  was 
concerned. Hughesdon (114) however,believed that the d i f f i c u l t y  
in recognising smooth muscle amid a dense collagenous m atrix , in 
addition to tangential cutting , served to reduce the apparent 
muscle presence, as indicated by h isto log ica l examination. 
Ferroni (116) and others (117), in e a r l ie r  h isto log ical studies, 
describe an inner layer of muscle sweeping round under the 
portio , to jo in  the vagina.
I t  was believed that contraction of th is  submucous layer of
muscle, in the prim igravid, would 'take up' the cervix without 
d i la t in g  the internal os. In the m ultigravid p a t ien t ,  Hughesdon 
thought, as the muscle had been disrupted by previous labour, 
contraction of the upper cervical muscle, would cause d i la ta t io n  
before f u l l  effacement.
Danforth (118), did not agree with th is  hypothesis on
cervical effacement. He proposed that changes in collagen, and
ground substance, would produce effacement and d i la ta t io n .  He
had shown that collagen is broken down and excreted in 
pre-labour and labour. He also found an increase in cervical  
water content, and th is  fu r th e r  reduced the density of collagen. 
In addition to these changes, Danforth and Buckingham (119),
have id e n t if ie d  amino acids appearing in la te  pregnancy and
labour, thus suggesting, the formation of a new protein in the 
cervical stroma. The role of smooth muscle when the cervix is 
already changed by the diminution of collagen, is not known.
These obstetric  observations, have relevance to the apparent 
movement of the squamo-columnar junction . The cervical stroma is 
under hormonal control in labour, and the location of the 
junction may be re lated  to hormonal e ffects  on the stroma. In 
the primigravid patient undergoing colposcopy, the squamo- 
columnar junction is eas ily  v is ib le  at the external os. The
m ultigravid patien t,  on the other hand, may have a gaping
ectocervix but closed internal os. The e f fe c t  of squamous 
metaplasia on th is  exposed columnar epithelium, would tend to 
s ite  the junction high in the cervical canal, and when
postnatal, this would regress into the canal.
The fa i lu r e  to v isua lise  the en t ire  transformation zone, in
the older p a t ie n t ,  is c e r ta in ly  a problem for the colposcopist. 
Considerations of the reasons fo r  the ease of v i s i b i l i t y  in the 
younger pa t ien t ,  y ields clues to th is  occurrance. Pregnancy
c e r ta in ly  allows adequate exposure of the squamo-columnar 
junction , for the reasons stated above, but also because the 
strong progesterone influence, induces hyperplasia of the 
endocervical columnar c e l ls ,  which secrete mucus. This causes an 
e f fe c t iv e  endocervical prolapse, and easy v isua lisation  of the 
junction (120).
Cervical water may also be a fa c to r .  In hormonal environments 
low in ovarian steroids, with th e ir  water retention e f fe c t ,  a
low percentage of water, w i l l  make the cervix more r ig id  and
less l ia b le  to manipulation and eversion by a speculum.
Postmenopausally, the cervix may also have a f irm  
consistancy, due to a higher density of collagen. In pregnancy,
administration of oestradiol d ire c t ly  to the cerv ix , w i l l  induce 
cervical softening, in part at leas t ,  due to collagen resorption  
(121). The postmenopausal p a t ie n t ,  with oestrogen defic iency,
has a gradual demineralisation of the skeleton and increase in 
collagen breakdown, a process that is reversed by exogenous 
oestrogen (122,123). I t  is unknown whether th is  also occurs on 
the cerv ix , resu lting  in a cervix with a lessened to ta l collagen 
content. The e f fe c t ,  however, of oestrogen on the amount of
subcutaneous collagen in abdominal skin , indicates an increase
with therapy, (124). The cervical stroma has oestrogen receptors
(113), and the response of the cervical collagen to oestrogen is 
unknown in the postmenopausal woman.
The cervix may be more firm  postmenopausally, due to
decreased water content, decreased collagen breakdown, or a true  
replacement of collagen with fibrous tissue (107). Study of the 
collagen density and water content near the squamo-columnar 
junction , at a var ie ty  of ages, and under exogenous hormonal 
influence, may answer some of these points.
CHAPTER 2
THE VALUE OF CERVICAL COLPOSCOPIC ASSESSMENT IN THE MANAGEMENT 
OF GENITAL HORMONE DEFICIENCY
INTRODUCTION
The natural po int, from which to s ta r t  any investigation is 
observation. The problems associated with the cervix in the
postmenopausal woman, are no exception. Observation and 
description of cervix and cervical abnormalities at th is  age, 
w il l  lead to fu rthe r  avenues of exploration.
In countries with active cervical screening campaigns, the
peak incidence of cervical carcinoma, now occurs in the
postmenopausal years . Screening has reduced the incidence of 
the disease in younger women, but l i t t l e  impact has been made on 
the death rate  in older women ( 1 ,4 ) .  A fter  the menopause,
screening is less l ik e ly  to be performed, and in te rp re ta tion  of 
cytological findings becomes more d i f f i c u l t .  In add ition ,  
colposcopy has lim ited value, due to the fa i lu r e  to v isua lise  
the en tire  transformation zone (103).
Hormone deficiency is thought to be responsible fo r  the
altered colposcopic appearance of the cerv ix , a f te r  the 
menopause. Hormone replacement therapy (HRT), has been reported 
to rejuvenate the colposcopic appearance of the cerv ix , and
enable a more complete examination of the transformation zone 
(107,125). The degree of hormone defic iency, when assessed 
colposcopically, has h itherto  been subjective. Quantitation and 
standardisation of colposcopically v is ib le  stigmata of hormonal 
defic iency, would allow comparison before and a f te r  therapy. 
Such assessments would also act as aids in the management of the 
hormone de fic ien t  states.
This study, attempts to define the colposcopic findings in
p e r i -  and postmenopausal women; To confirm the colposcopically  
v is ib le  changes due to HRT, and to quantify these changes 
allowing a reproducible assessment of hormonal status. The value 
of such a system, w i l l  be compared to vaginal cytology and serum 
oestradiol leve ls .
METHODS AND PATIENTS
Women presenting to a menopausal c l in ic ,  with symptoms of the 
clim acteric ,  had an objective assessment of th e ir  hormonal 
status made by three methods. Lateral vaginal wall cytology, and 
serum oestradiol estimation, were performed as a routine aid to 
management, and these were compared to a colposcopic assessment 
of genital hormone status. Patients with a past h istory  of 
hysterectomy, or cervical neoplasia, were excluded. I n i t i a l l y ,  
f i f t y  women were examined colposcopically, and the appearances 
of the transformation zone are recorded in the next chapter. A 
var ie ty  of hormone replacement therapy (HRT), was commenced. 
Forty two women returned a f te r  at least 2 months HRT, and they 
were re-examined. This group of women, received a v a r ie ty  of
oestrogens, and a homogeneous group of 29 women was selected,
and subjected to fu r th e r  study. Full de ta ils  of a l l  50 women, 
are shown in Appendix 1.
There were 34 women who were commenced on conjugated equine 
oestrogens and norgestrel, and the patients were invited to 
return a f te r  at least two months therapy. At the return v i s i t ,  
colposcopic and cytologic examinations were repeated.
The serum oestrogen, was expressed as the oestradiol in
picomoles per l i t r e ,  and the vaginal smear was graded on a three  
point scale, corresponding to the three point maturation value
of s u p e r f ic ia l ,  intermediate, and parabasal ce lls  (126,127).
At colposcopic examination, four indicators of hormonal status 
were systematically scored.
The f i r s t  colposcopic assessment, was of the thickness of the 
epithelium by a subjective consideration of the prominence of 
the c a p il la ry  vascular pattern; 0 was scored i f  the epithelium  
was very th in ,  and 1 to 3 were scored depending on the thickness 
of the epithelium.
Secondly, the presence of subepithelia l haemorrhages was 
assessed on a three point scale; 0 for severe , 1 for present
and 2 fo r  absent. T h ird ly ,  the reaction to Lugol's iodine, was 
scored from 0 , indicating poor uptake,to 3 with good uptake. The 
las t  ind ica to r ,  cervical mucus, was assessed on a four point 
scale; 0 none, 1 s l ig h t ,  2 moderate and 3 copious.
To give each indicator equal weighting, these scores were 
converted to a denominator of 6, and thus a maximum colposcopic 
score of 24, was possible. A young woman would have a score 
approaching 24.
A f i f t h  colposcopic feature was the location of the 
squamo-columnar junction (SCJ). This was also recorded fo r the 
study patients . These data are v a l id ,  however, fo r  a l l  50 
patients , and are recorded in Appendix 1
The i n i t i a l  colposcopic score, the score during HRT and the 
change in score, were evaluated for each patient and correlated  
to duration of menopause. The colposcopic score was correlated  
to serum oestrad io l, and in some patients to gonadotrophin 
estimations. The colposcopic assessment was compared to vaginal 
cytology, as both an indicator of hormonal status, and a method
of monitoring response to HRT. The colposcopic score and the 
serum estradio l were re lated  to the v i s i b i l i t y  of the SCJ. 
RESULTS
F i f t y  patients of mean age 50.38 years (S .D .4 .5 1 ) ,  and mean 
postmenopausal time of 31 months (S .D .33 .87 ),  were examined 
colposcopically before therapy. The SCJ was only v is ib le  in 12 
patients (24%). Further data is ava ilab le  in Appendix 1, but as 
th is  group received several preparations, these results are not 
commented on. The conclusions are drawn from the following  
patients .
T h ir ty  four patients were enrolled in the study, and twenty 
nine patients returned a fte r  at least two months therapy, a l l  of 
whom were symptomatica!ly improved. The mean age of these 
patients was 49.66 yrs. (S.D. 5 .22) and the mean postmenopausal 
time was 34.41 months (S.D. 39 .1 ) .  Twenty three patients were 
postmenopausal, and six were perimenopausal, but a l l  had
s ig n if ic a n t  symptoms. Of the f iv e  patients who did not re turn ,  
four discontinued therapy as a preference, and m ultip le  myeloma 
was diagnosed in one pa t ien t .  The ages and postmenopausal times 
were not d i f fe re n t  from those who completed the study.
Analyses are confined to the twenty nine patients who were
assessed before, and during therapy.
COLPOSCOPIC SCORE
Twenty six patients , had a colposcopically v is ib le
improvement in the hormone status of the cerv ix , a f te r  the 
administration of HRT. The colposcopic features and the response 
to therapy are shown in table  1.
The mean i n i t i a l  score was 12.90 (S.D. 4 .64) and the mean
f in a l  score was 19.62 (S.D. 2 .5 2 ) .  This difference is
s ig n if ic a n t  (paired students t  t e s t - ( t=  8 .7 4 ;p<0.0 0 1 )) .  Some
patients , however, had a very small increase in score with the 
administration of HRT, while others had a much larger
improvement.
The i n i t i a l  colposcopic assessment correlated closely with
postmenopausal time. The d is tr ib u tio n  of postmenopausal time,
was not normal, with 12 patients within 1 year of menopause, and 
the rest up to 12 years postmenopausal. The corre la t ion  
c o e ff ic ie n t  of logarithm of postmenopausal time, to i n i t i a l  
score was s ig n if ican t  (r= - .5 1 5 ,  t = 3 .12; p<0.01). There was a 
deteriorating  colposcopic p icture of hormonal status, with the 
elapse of time from menopause.
Of the three patients who showed no colposcopic change, 
i n i t i a l  scores were high at 18, 22 and 22, two had serum
oestradiols before therapy, of 793 and 540 picomol/L, and a l l
three had some menstruation within three months p r io r  to 
therapy. All three had high colposcopic scores, ind icating  
endogenous oestrogen, but vaginal cytology was mainly
intermediates in a l l  three.
Three fu rthe r  pa tien ts , had a minimal change in score of 2, 
with therapy. I n i t i a l  scores were 20, 18 and 18, and two of 
these had oestradiols of 237 and 542 picomol/L. Two were
menstruating ir re g u la r ly ,  and one was 5 years postmenopausal.
These six patients are i l lu s t ra te d  in table  2.
Thus, of patients with a minimal colposcopic response to
therapy, a l l  had an oestrogenic i n i t i a l  colposcopic p ic tu re ,  
four had high oestrogen leve ls , and f iv e  had menstruated w ithin
three months previously. The colposcopic score, c le a r ly  
indicated those women who, despite being symptomatic, had not 
yet developed genital hormone deficiency.
Women who showed the greatest change in colposcopic score 
were, surpris ing ly , not the oldest women, but a group whose 
menopause was f a i r l y  recent. Of 5 patients with a change in 
score of 12 or more, 3 had a menopause within 6 months, and 2 
were 3 years postmenopausal. The six pa tien ts , whose menopause 
was more than 6 years previously, had low i n i t i a l  scores (mean 
10.67) but the change in score was less (mean 8) than younger 
women, with an i n i t i a l l y  hormone d e fic ie n t  p icture.
OESTROGEN AND GONADOTROPHIN LEVELS
Oestradiol(E2) estimations were ava ilab le  for 26 of the 29 
patien ts . Five patients had i n i t i a l  E2 levels of greater than 
150 picomoles per l i t r e .  The mean i n i t i a l  score in these 
patients was 19 (S.D. 1 .79 ) .  In the 21 patients with E2 levels  
less than 150 picomoles per l i t r e ,  the mean i n i t i a l  score was 
11.76 (S.D. 4 .07) (unpaired students t  t e s t ; t = 3 .73;p<0.0 1 ) .
Three of these 5 patients with E2 levels greater than 150 
picomoles per l i t r e ,  were s t i l l  menstruating i r re g u la r ly ,  but 
two were post menopausal. Colposcopy was able to id e n t i fy  those 
patients in whom the serum oestrogen was not yet in the 
postmenopausal range, and the two methods were in accord. These 
data are shown in table 3
The data on gonadotrophin status were not so f u l l ,  with only 
18 results being ava ilab le . Two patients had premenopausal 
values (E2 540 and 542pmol/L, both irreg u la r  menstruation) and 
th e ir  i n i t i a l  scores were 22 and 18. The patients with
perimenopausal gonadotrophin values, had s l ig h t ly  higher scores 
than those with postmenopausal values, but the difference was 
not s ig n if ic a n t .
VAGINAL CYTOLOGY
Using a three point maturation value, rendered the vaginal
cytology less sensit ive , when compared with the colposcopic
score. Nineteen patients had intermediates, and only seven had 
basals or parabasals. The mean colposcopic score for those with 
parabasals was 10.14 (S.D. 2.74) and for those with
intermediates 13.89 (S.D. 5 . 0 5 ) , ( t  te s t ,  t = l .79; n . s . ) .  There
was agreement in one of the three patients with oestrogenic 
cytology before therapy. She was having irreg u la r  menstruation,
E2 was 542 pmol/L and i n i t i a l  colposcopic score was 18. The
other two, had low colposcopic scores and low serum E2, and one 
was 12 years postmenopausal. The repeat assessments on therapy 
showed better agreement; 16 patients intermediate cytology, mean 
score 18.69 (S .D .2 .51 ) ,  and 13 patients superfic ia l cytology,
mean score 20.77 (S .D .2 .1 5 ) ,  ( t  te s t ,  t= 2 .28; p<0.05), ( ta b le
4 ) .  A more c r i t i c a l  assessment of cytology, may have made these 
differences more dramatic, and increased the accord.
VISIBILITY OF THE SQUAMO-COLUMNAR JUNCTION
Of the 29 patients analysed here, seven patients had a 
v is ib le  SCJ before therapy (Table 5 ) .  Their mean i n i t i a l  score 
was 17.14 (S.D. 2.64) The other 22 patients had a mean i n i t i a l
score of 11.55 (S.D. 4 .4 5 ) ,  s ig n i f ic a n t ly  lower than those in 
whom the SCJ was v is ib le  ( t=  3 .04;p<0.01). While taking HRT, the 
SCJ became v is ib le  in a fu rthe r  12 patien ts . S ig n if ic a n t ly  more 
squamo-columnarjunctions were seen a f te r  commencement of HRT ( /=
10 .04 ;chi sq .tes t;  p<0.01)
DISCUSSION
Oestrogen deficiency which occurs p e r i -  and postmenopausally, 
causes gross morphological and cytological changes. 
Colposcopically v is ib le  stigmata of hormone deficiency of the
cervical epithelium, have been documented (128,129), and vaginal 
cytology has been used fo r many years as an indicator fo r the
need for HRT (130).
Exogenous oestrogen, increases p ro l i fe ra t io n  of basal 
e p ith e l ia l  c e l ls ,  resu lting  in a th icker epithelium. C a rt ie r  has 
proposed that exogenous oestrogen w il l  increase the thickness of 
the cervical epithelium, within ten days, and th is  therapy may 
improve the diagnostic accuracy in the postmenopausal patient  
(131). This process, in vivo, is evident within 11 days (132 ) ,  
and c e r ta in ly  should be complete by the 2 months fo r which
therapy was used in th is  study. Such an e ffe c t  would improve
vaginal cytology, increase e p i th e l ia l  thickness, decrease
like lihood of haemorrhages, and improve the uptake of Lugols
iodine.
The cerv ix , however, is not a good source of ce lls  fo r
cytological assessment of hormonal status. Local trauma, 
in fec tions , and sexual intercourse a l l  act to reduce the value
of ex fo lia ted  cervical c e l ls ,  as indiators of end organ response
to oestrogen (133). Consequently, cytological assessments have 
la rge ly  been confined to the la te ra l  vaginal w a ll .  Perhaps, for
s im ilar reasons, colposcopic examination of the cervix has not
been widely used as an aid in the management of hormone 
defic iency. This study, however, confirms that hormone
replacement therapy, a lte rs  the colposcopic appearance of the 
cerv ix . The change in appearance is greatest in those who have 
the most marked stigmata of hormone defic iency, before therapy. 
A s ig n if ican t  inverse corre lation  was found between the post 
menopausal time and the colposcopic score.
There is a strong re la tionsh ip  between cytological estimation  
of hormonal defic iency, and low serum oestradiol (134). This 
study, indicates that the colposcopically v is ib le  changes due to 
hormone defic iency, are q u a n tif iab le ,  and comparable to serum 
hormonal estimations. This work also suggests, that those who 
menstruate, or have higher oestradiol leve ls , are l ik e ly  to have 
a higher colposcopic score. These data, augment the cytological 
evidence of the end organ response to HRT. Colposcopy also 
examines the end organ response. I t  may have a ro le  as a true  
indicator of hormone deficiency, and possibly of greater value 
than the protein bound serum oes trad io l,  especia lly  as a dynamic 
te s t ,  useful in assessing response to therapy. This is an area 
where serum estimations are less valuable, and re liance has been 
on vaginal cytology.
The observations on the squamo-columnar junction , have 
importance to the colposcopic and cytologic exclusion of 
pre-invasive and invasive neoplasia of the cerv ix . The SCJ is 
less frequently  seen in the postmenopausal pa t ien t ,  than the 
younger woman (103,135), and this renders colposcopic evaluation  
less valuable. Paterson e t . a l .  reviewed the e f fe c t  of HRT on the 
v i s i b i l i t y  of the SCJ, and found that the squamo-columnar 
junction became v is ib le  in three of six patients , with the 
administration of HRT (125). There has been a recent report,
involving the use of ethinyl oestradiol in women with abnormal 
smears, in whom the whole transformation zone was not v is ib le .  
I t  has shown that complete examination was possible in 16 of 25 
such women, a f te r  oestrogen (136). All of these pa t ien ts ,  
however, were under 50 years, and the m ajority were f a i r l y  
young, but there is no comment as to whether any were 
postmenopausal.
Other authors, have fa i le d  to f ind  cervical eversion in older 
women treated with oestrogen (137). HRT, however, can enable the 
en tire  transformation zone to be seen in the older woman, when 
previously th is  was not possible. M ild ly  atypical or atrophic  
cytology, in the older woman, may be managed by oestrogen 
therapy, both as a theraputic measure and to enable more serious 
disease to be excluded by colposcopy. More suspicious or
p o s it iv e ly  dyskaryotic cytology in the older p a t ien t ,  demands 
cone biopsy, i f  the en tire  transformation zone is not v is ib le .
Twenty four percent of patients in th is  study, in whom the 
SCJ was v is ib le  before therapy, had a higher colposcopic score 
than those with a colposcopically in v is ib le  SCJ. This f in d in g ,  
implies that re traction  of the SCJ into the endocervical canal, 
is a hormone dependent event, and is probably due to a
deficiency of endogenous oestrogen. Administration of HRT
appears to allow v isualisation  of the SCJ.
Some comment, on the ro le  of progestogens on th is  observation 
should now be made. While oestrogen allows greater eversion of 
the cerv ix , and has an e f fe c t  on the thickness of the
epithelium, natural progesterone and synthetic progestogens,
also play a part in allowing the SCJ to remain v is ib le .
Oestrogens stimulate the columnar ce lls  (138), but the degree of 
hyperplasia and hypersecretion of the columnar glands, depends 
on the progestogen influence (139). This e f fe c t  is s im ila r  to 
the endocervical prolapse seen in pregnancy, where columnar 
ce lls  and thus the SCJ, are pushed from above by hyperplasia, 
and thus are more eas ily  v is ib le .  This property of progestogens 
in oestrogen primed columnar epithelium, contributed to the ease 
of v i s i b i l i t y  of the SCJ in th is  study, and in one patient in 
p a r t ic u la r ,  was very apparent.
TABLES FROM CHAPTER 2
TABLE 1 COLPOSCOPIC SCORES
n=29 BEFORE HRT DURING HRT
0 1 2 3 0 1 2 3
PARAMETER
e p ith e l ia l
thickness 1 3 14 11 0 1 3 25
haemorrhages 6 6 17 1 1 27
iodine
reaction 6 11 11 1 0 7 17 5
mucus
production 13 7 7 2 0 7 9 13
TABLE 2
n=6 Patient characteris tics  of those with
minimal change in colposcopic score
age meno­ E2 i n i t i a l i n i t i a l f in a l
pause pmol/L cytology score score
48yrs 3mts 793 2 18 18
46yrs lmt 540 2 22 22
48yrs lmt <150 2 22 22
50yrs lmt 542 3 18 20
45yrs lmt <150 2 18 20
41yrs 60mts 237 2 20 22
change in 
score 
0 
0 
0 
2 
2 
2
TABLE 3
n=5 Patient characteris tics  of those with E2
levels greater than 150 picomoles per L
age meno­ E2 i n i t i a l  i n i t i a l f in a l change
pause pmol/L cytology score score score
48yrs 3mts 793 2 18 18 0
50yrs lmt 542 3 18 20 2
46yrs lmt 540 2 22 22 0
45yrs 12mts 409 2 17 22 5
41yrs 3mts 237 2 20 22 2
TABLE 4 
n=29
pre-treatment 
smear score
TABLES FROM CHAPTER 2
Colposcopic scores re lated to vaginal 
cytology
during treatment
n
7
19
3
mean colp 
score(SD) 
10.14(2 .74)  
13.89(5 .05)  
13 (3 .74 )
smear score
1
2
3
16
13
mean colp 
score(SD)
18 .6 9 (2 .5 1 )*  
20 .77 (2 .15 )*
*  t=2 .28; p<0.05 the students t  tes t
TABLE 5 
n=29 V i s i b i l i t y  of the squamo-columnar junction
v is ib le  before mean i n i t i a l
therapy score(SD)
, 7 V  17 .14 (2 .64 )*
eas ily  with Koggans forceps
V  ^ 6
v is ib le  during 
therapy
eas ily  with Koggans forceps 
5 /  "M 4
in v is ib le  before mean i n i t i a l
therapy
22
in v is ib le  during 
therapy 
10
score
11 .5 5 (4 .4 5 )*
*  t=3 .04; p<0.01 the students t  test
COLPOPHOTOGRAPHS OF STUDY PATIENTS 
I t  was intended that a l l  study patients had colpophotographs 
performed, both before and during HRT. In a l l ,  there were 162 
colpophotographs taken from the f i f t y  women, but th is  has been 
one of the less successful aspects of th is  work. Colposcopy in 
the postmenopausal woman is not usually easy, and a good view is 
not always obtained. The q u a lity  of the photographs, was less 
than desired, and ha lf  way through the study, the flash unit  
broke, and the remaining photographs had to be taken with 
availab le  l ig h t .  This considerably reduced th e ir  q u a li ty .
A series of slides has been assembled from the patients in 
th is  study, and they i l lu s t r a te  the points made in th is  Chapter. 
Annotation to the slides is given in Appendix 2.
CHAPTER 3
THE ATYPICAL TRANSFORMATION ZCNE AND UNEXPECTED CERVICAL 
INTRAEPITHELIAL NEOPLASIA, IN POSTMENOPAUSAL WOMEN WITH NEGATIVE
CERVICAL CYTOLOGY
INTRODUCTION
There is again concern,that m o rta li ty  from carcinoma of the 
cervix in the woman past childbearing years, is not f a l l i n g .  
(140). The experience from B rit ish  Columbia, indicates that  
although the incidence of cervical cancer is highest in women 
over f i f t y  years of age, such women are less and less l ik e ly  to
attend for screening as age advances (141). Among th is  older
population there is therefore , proportionally  a greater  
incidence of invasive cancer, in unscreened women.
In the older woman, the diagnosis of preinvasive neoplasia, 
is made less frequently as age advances, but the incidence of
invasive cancer rises (142). The explanation fo r th is  aparent
paradox may l i e  e ith er  in a fa i lu r e  to detect preinvasive  
lesions in the older woman, or indeed, carcinoma in the old is 
less l ik e ly  to be preceded by in tra e p ith e l ia l  neoplasia. The 
fa i lu r e  to detect existing preinvasive lesions, may be due to 
lack of screening, or a fa i lu r e  of the scereening test in th is  
age group.
Certain questions need to be addressed in th is  context:
F i r s t ly ,  is there a reservoir of cervical neoplasia in th is  
population, which is undetected by screening methods? Secondly 
is screening being performed? and T h ird ly ,  is there a 
preinvasive element to the neoplasia? The second and th ird  
questions, can be answered by reference to the work, of those 
who extensively screen a l l  ages, fo r  cervical neoplasia. The 
Scandinavian countries, have comprehensive screening programmes, 
which have shown a decrease in incidence of cervical cancer fo r
a l l  ages (2 ,2 4 ,2 5 ,2 7 ) .  This implies preinvasive neoplasia can be 
detected, and invasion prevented. This f i r s t  question may be 
p art ly  answered by these studies, but in order for th is  concept 
to be t o ta l ly  re fu ted , the incidence of cervical cancer, in the 
older screened woman, should be the same as that in the younger 
screened woman. This is not the case according to the work of 
Stenkvist et a l . ,  who found an incidence f iv e  times greater in 
women 60-69 years, who were sreened, compared to women 30-39 
years, who were screened (25).
There may therefore be a reduction in e ff icac y , of the 
cervical smear in the postmenopausal years. This may be due to 
the abnormal areas not being available  to the cervical spatula, 
i . e .  endocervical, or i t  may be due a biological f a i lu r e  of the 
neoplastic tissue to e x fo l ia te .  The following study w il l  attempt 
to address th is  subject.
Colposcopic study of the cervix in the p e r i -  and 
postmenopausal woman, w i l l  id e n t ify  the incidence of the 
atypical transformation zone (ATZ), at these ages. Cytological 
examination of the cerv ix , w il l  be correlated to the colposcopic 
findings,and the presence of endocervical ce lls  as an indicator  
of adequacy of the smear,will be assessed.
PATIENTS AND METHODS
Cervical cytology and colposcopic examination of the cerv ix ,  
were performed in the f i f t y  women mentioned in the previous 
chapter. These were 50 consecutive patients with in tact u te r i ,  
seeking aid for symptoms of the c lim acteric . No patient was 
known to have had a past history of cervical dysplasia, a
previous abnormal smear, or c l in ic a l ly  suspicious cerv ix , before 
examination. The only indication to perform colposcopy and 
cytology, was to document the incidence of v is ib le  abnormalities 
and the e f fe c t  of HRT.
Repeat colposcopy and cytology were also performed in fo r ty  
two p a t ie n ts ,a f te r  at least two months therapy. I f  a colposcopic 
abnormality was seen, then a punch biopsy was taken with 
Leech-Wil1iamson biopsy forceps for histopathological study. I f  
histology was neoplastic, the patient was managed according to 
the nature of the abnormality, i . e .  cone biopsy i f  the en tire  
transformation zone was not v is ib le ,  otherwise local ablation or 
fo llow  up. A ll cervical smears, before and during therapy, were 
studied for unequivocal sheets of endocervical c e l ls ;  a 
cytological indicator that the upper l im i t  of the transformation  
zone has been smeared.
RESULTS
The mean age of the f i f t y  patients was 50.38 yea rs (S .D .4 .51 ) 
and the mean postmenopausal time in terval was 31 months 
(S .D .33 .87). One hundred and one colposcopic examinations were 
performed on these patients, and cervical cytology was obtained 
at each examination.
a)CYT0L0GICAL FINDINGS
I n i t i a l  cytology was negative in a l l  pa tien ts . Cytology from 
one patient was documented as suspicious at review, colposcopy 
revealing a d iffuse aceto-white lesion. Biopsy confirmed a 
subclinical papilloma virus in fec tion , without CIN. None of the 
remaining 49 patients had abnormal cytology during the course of
the study.
Review of the smears for sheets of endocervical c e l ls ,  
revealed only two patients with d e f in ite  evidence of these 
c e l ls .  They were present in both patients before and during 
treatment, but HRT did not render endocervical ce lls  v is ib le  
when previously not seen, in the other patients .
b)C0LP0SC0PIC FINDINGS
Colposcopic examination of the cerv ix , in the remaining 49 
patients , disclosed 11 patients with an ATZ. Aceto-white 
epithelium (AWE),was the predominent feature in a l l  eleven 
patients , seven of whom did not display a vascular pattern. A 
mosaic pattern was seen in three patients and one had a punctate 
vascular pattern. In ten of these patien ts ,the  abnormality was 
noted at the f i r s t  examination. In the eleventh p a t ie n t ,  an 
inflamed cervix was noted at the f i r s t  v i s i t ,  and a McDonald
suture , in s itu  for 19 years was removed. Two months la te r  when
taking HRT, an aceto-white lesion was seen.
All aceto-white e p ith e l ia  were biopsied. In seven p a tien ts ,  
histology revealed a benign epithelium. In the remaining four 
patien ts , h isto log ical evidence of cervical in t ra e p ith e l ia l  
neoplasia (CIN) was found. This was thought to be CIN 1 in two
cases and CIN 2 in one case. In the fourth case, the patient did
not take HRT. The biopsy displayed e p ith e l ia l  atypia bordering 
on CIN 1.
The histopathology was reviewed by several local 
histopathologists, and a l l  agreed the e p ith e l ia  in these 
patien ts , were abnormal. Therefore, fo r independent confirmation
of th is  f in d in g , h isto log ical sections from these four patients  
were sent to Dr. Malcolm Anderson, Senior lecturer in 
Histopathology, Samaritan Hospital, London, fo r his opinion. He 
agreed that a l l  displayed changes due to CIN. In one case he
considered the CIN may even be grade 3, (see Appendix 3 ) .
Cytology from these four patients were reviewed by cytologists  
and cytopathologists for evidence of fa lse  reporting. A ll these 
smears were considered negative. A colposcopic diagram, and
photocopies of cytology and pathology reports from the four 
patien ts , are i l lu s t ra te d  in Appendix 3. Photomicrographs of 
histology and cytology are shown in the f igures.
A summary of the cy to log ica l,  colposcopic and histo log ica l  
f ind ings, in a ll  patients with an ATZ, is shown in table 6.
Three additional patients (nos.12,13 and 14) presented during 
the course of the study, and are included as they appear to 
confirm the findings of the study. Their evidence is ,  however, 
anecdotal. Patient no .12 had a c l in ic a l ly  benign cerv ix , but a 
colposcopic examination was performed, due to a complaint of
post-menopausal bleeding. An aceto-white lesion was noted and 
biopsy confirmed CIN 2. Concurrent cervical cytology was 
negative.
Patient no. 13 presented at the colposcopy c l in ic ,d u e  to the 
presence of cervical polyps. Cytology in the past was negative. 
Colposcopy confirmed the polyps, but in addition there was 
aceto-white epithelium on the cervix, and biopsy confirmed CIN 
1. Concurrant cytology was inflammatory but negative, with no 
dyskaryotic or atypical ce lls  noted. Cone biopsy confirmed CIN 
1.
Patient no. 1 4 ,had a c l in ic a l ly  benign cervix and negative 
cervical cytology, p rio r to Manchester re p a ir ,  fo r  utero-vaginal 
prolapse. Histopathological examination revealed CIN 1 on the 
cerv ix .
I t  is of in te re s t ,  that in addition to having CIN with 
negative cyto logy,a ll  seven patients in table 6 with CIN, had a 
comparatively early  menopause. The average age of these patients  
is 49.5 years and the average time since the menopause is 8.1  
years.
DISCUSSION
The disappointing s ituation  fo r the older woman with cervical 
neoplasia, results from a combination of fac to rs .  
Postmenopausal women, are less l ik e ly  to present fo r cervical 
screening, than women of childbearing age. There is less
enthusiasm, fo r  performing cervical smears in the e ld e r ly ,
whether due to the wish to spare embarrassment, or due to lack 
of fa i th  in screening. Gynaecologists see less of a place for  
colposcopy in the older women, as the transformation zone is 
frequently  not t o ta l ly  v is ib le  (103,125,135).
There is , however, a pressing need for action to reduce the 
incidence and m o rta li ty  of th is  preventable condition. Yule has 
shown,that although there is a substantial improvement in
m o rta li ty  in the 35-54 year age group, the m o rta li ty  has been 
s ta t ic  in women aged 55 years and over (4 ) .  This has occurred 
despite screening greater numbers of women. The explanation
usually given, is those needing screening, are those who do not 
attend, and this seems to be the case in the m ajority of England 
and Wales (142). In Scotland too, Elizabeth Macgregor has found, 
that ninety percent of women developing cervical cancer, have 
never had a smear (143). Sadly, experience from America and 
elsewhere is very s im ila r ,  (144,145). Scandinavian data, on the 
other hand, shows the reduction in m o rta lity  that good screening 
can bring to the older woman (24, 25). Day has found, from these 
Scandinavian data, that the incidence of invasive cervical
cancer, may be reduced by 80%, by screening every 2-5 years, but 
there is l i t t l e  advantage in screening more frequently (2 ) .
High penetration of screening programmes into the population, 
such as the 80 or 90 % found in the Scandinavian series (2 4 ,2 5 ) ,  
can be emulated in the United Kingdom, though usually on a much 
smaller scale. Standing and Mercer, achieved a remarkable 96%
uptake rate  among th e ir  a lb e it  small female population (146). To 
achieve th is  degree of penetration required home v is i ts  fo r  non 
attenders.
Frequently, i f  neoplasia of the cervix is diagnosed in the
older woman, i t  has already passed the pre-invasive stage. 
However even in such a case, there is a substantial benefit  in 
the e a r l ie r  diagnosis of the tumour in the older woman
(147,148). The fee ling  that the prognosis is worse in the
e lder ly  woman with cancer of the cerv ix , due to la te  
presentation and poorer general health, is reinforced by cancer 
reg is try  s ta t is t ic s  (12 ) .  The f iv e  year survival figures are 
c e r ta in ly  reduced, however, there is some work to show that i f  
cancer of the cervix, is diagnosed at an early  stage in the
older p a t ie n t ,  then the prognosis may be better,than that in the 
younger p a t ie n t ,  whether the treatment is surgery (147), or
radiotherapy (148).
There is no doubt, that the mainstay of cervical screening is 
cytology, and th is  is indubitably e f fe c t iv e .  Work ind icating  
that i t  may be less e f fe c t iv e  in the o ld , than the young (2 5 ) ,  
supports the findings of Coppleson and Reid (28). Some years
ago, they suggested that i f  colposcopy and cytology are used in
collaboration , then the diagnostic accuracy of cervical
screening, is g reatly  improved.
This present study, suggests that there are lesions in the 
cerv ix , in this age group, which have not been detected by 
cytology alone. Colposcopy is a very sensitive aid to the 
diagnosis of pre-invasive neoplasia of the cervix. I t  is less 
s p e c if ic ,  however, and an ATZ does not always indicate CIN. A 
recent series of sexually active patients,found an ATZ in 65% 
(149). Older patients are also known to exh ib it  an ATZ, and 
Coppleson and Reid found atypical epithelium in a series of
40-65 year old women (28 ) .  This present study, has documented
atypical features in 12 ,of 50 peri and postmenopausal women. 
Only one patient had evidence of HPV and although
postmenopausal, th is  patient was aged 37 years. This 
comparatively low incidence of HPV infection in menopausal
women,is probably due to the reduced sexual promiscuity in th is  
age group.
Twentyfour percent of postmenopausal patients with a 
colposcopic abnormality, would render th is  form of examination 
less suitable fo r screening,as i t  is both time consuming and
demands expertise. The presence of AWE in i t s e l f ,  has not the 
same importance, provided th is  is not due to CIN. The diagnosis 
of CIN, however, means the pathologist considers the epithelium  
may have neoplastic p o te n t ia l .  The colposcopic d is t inc tion  
between an ATZ due to CIN, and one not due to CIN, may be very 
d i f f i c u l t  in a postmenopausal woman, without recourse to 
cervical biopsy. Other workers, reviewing the role of colposcopy 
in postmenopausal women, found colposcopy to be unsatisfactory  
in 53% of such patients (150). The explanation fo r th is  f in d in g ,  
is the lack of v i s i b i l i t y  of the en t ire  transformation zone. The 
c l in ic a l  application of the use of oestrogen, to improve the 
v i s i b i l i t y  of the squamo-columnar junction , may be of value, and 
P ren d iv il le  and colleagues reduced th e ir  cone biopsy rate  by 
such a treatment (136). All th e ir  patients were under 50 years 
of age, and the use of oestrogen, fo r th is  purpose, in older 
women is not widespread.
The S c h il le r  te s t ,  useful in outlin ing  areas of abnormal
epithelium on the cerv ix , has less value in the older woman.
S c h il le r  positive (iodine negative) areas,are not uncommon in 
the postmenopausal woman's cervix (135), and atrophic changes 
with a very thin epithelium may render the ATZ rather d i f f i c u l t  
to recognise. The find ing , however, of four patients with
e p ith e l ia l  abnormalities with neoplastic p o te n t ia l ,  from an 
unselected population of 50 women with symptoms of hormone
defic iency, has raised concern. This concern is heightened, by 
the repeated fa i lu r e  of cytology to indicate these lesions.
T ra d it io n a l ly ,  cervical cytology is regarded as a successful 
method of screening. Macgregor reports a 2% fa lse  negative ra te ,
(151), although many other centres have higher rates. There are 
many reviews of cervical cytology in women who subsequently 
develop invasive cervical cancer. Some, such as the study by 
Martin are depressing,in that they show errors in the p a t ien t ,  
the physician, and the laboratory (6 ) .  Sadly, over 50% of 
cases,demonstrated physician erro r .  In add ition , fa i lu r e  of the 
patient to present for fu rthe r  treatment, lessened the 
effectiveness of cervical screening in his study. He therefore  
concluded, that cytologic screening was only 50% protective  
against cervical carcinoma. Sim ilar audit by B rit ish  reseachers 
in Nottingham, has also indicated adequate follow-up of abnormal 
cytology, in only 59% (152). In th is  study, despite exhaustive 
e f fo r ts ,  8% of patients could not be traced.
Adopting a d if fe re n t  l in e  of thought, other American 
reviewers, have vindicated the fa i lu r e  of cytology to detect 
cervical tumours, which presented soon a f te r  negative cytology, 
by the tumour not having a prolonged pre-invasive phase (3 ) .
Macgregor, however, advises caution, and the need for closer
study of the so called 'ra p id ly  advancing cases' before there is 
a change in screening policy (143). The importance and need for  
centralised cytological services, to improve the q u a lity  of
fo llow-up, has been stressed by others (153).
Once again, the most complete data on the cytological f a i lu r e  
to detect invasive cancer, come from Scandinavia. Bjerre and
Johansson found, that of 131 women developing carcinoma a f te r  
screening, 90 had abnormal cytology which did not have
appropriate treatment (24). Ryelander, reported a 60% laboratory
misdiagnosis, among patients who subsequently developed invasive 
neoplasia (7 ) .  In another work, she reported that 3 of the women 
who developed cancer a f te r  screening, had abnormal colposcopy, 
but the reassurance of normal cytology prevented fu rthe r  action 
(27 ).  Most works on th is  subject, do not mention the ages of the 
p atien ts , who develop the cancer a f te r  screening, but a recent 
B rit ish  study found that seven of f i f te e n  such women, were over 
f i f t y  years of age (26 ).
The cervical smear, is only as good as the people obtaining  
and reporting i t .  I t  is fu r th e r  lim ited in the older woman, as 
the relevant area may not be smeared, as the SCJ has receded 
into the endocervix.
One cause for the normal smear shortly before cervical 
neoplasia, has not had the same attention as these others. This 
is the concept that the cervical in tra e p ith e l ia l  neoplasia, may 
not be ac t ive ly  e x fo l ia t in g .  Husain terms th is  'b io log ica l  
e r r o r ' ,  when no other id e n t if ia b le  cause fo r negative cytology 
can be found in women with neoplastic lesions on the cervix  
(23 ) .  The diagnosis of th is has, however, been by exclusion and 
this concept can only be tested in women who are known to have 
CIN, and concurrent cytology is examined for ex fo lia ted  
dysplastic c e l ls .  This condition is almost c e r ta in ly  unusual in 
the woman of childbearing years, however, i t  may be less unusual 
in the older woman.
In th is  present study, four women who were hormone d e f ic ie n t ,  
had a h is to lo g ic a lly  proven in tra e p ith e l ia l  neoplasia or atypia,  
with repeatedly negative cytology. In t o t a l ,  nine normal smears 
were obtained from these four women. Sadly, the expected
e x fo lia t io n  of abnormal ce lls  by the administration of 
oestrogen, to three of these women, (See previous chapter),d id  
not occur. The p o s s ib i l i ty  that the lesions were endocervical, 
and thus not smeared, would be a cogent argument i f  colposcopy 
had not been performed. A ll lesions were ectocervical and 
colposcopically v is ib le ,  and were thus adequately scraped. Two 
of the four patients with CIN in the study, had cone biopsy as 
the SCJ was not adequately v is ib le ,  and the other two were 
followed up with review colposcopy.
The addition of three s im ilar  anecdotal cases, with CIN and
negative cytology, heightens concern about th is  find ing and may
indicate l im ita t ions  of cytology in th is  age group. The find ing  
of a comparatively early  menopause, in these women, may be
spurious. There is the p o s s ib i l i ty ,  however, that continued
sexual a c t iv i t y ,  such as most women in the early  f i f t h  decade 
may have, may make the epithelium unstable i f  there is an early  
menopause. A s im ilar argument has been used in the incrimination  
of mutagens,on the epithelium of very young women having sexual 
intercourse. Such exposure, may render an immature epithelium  
unstable (34 ).  This is speculation and fu rther  work on th is  
hypothesis would be necessary for any d e f in it iv e  comment to be 
made.
The review of the smears for endocervical c e l ls ,  proved 
disappointing. Gondos and co-workers,found that although 92.5% 
of women under 45 years had endocervical or metaplastic c e l ls ,  
th is  figure  f e l l  to under 64% in women over 45 years (22 ) .  The 
finding in th is  present study of only four percent,is  explained 
by the s t r ic t ,  and possibly too s t r ic t ,  c r i t e r ia  of sheets of
endocervical c e l ls .  Metaplastic ce lls  only indicate that the 
transformation zone is being smeared, endocervical ce lls  
indicate the SCJ is being smeared. Looking for endocervical 
c e l ls ,  y ields few positives in th is  age group. I f  a l l  smears in 
which they did not appear were c lass if ied  as inadequate, then 
cervical cytology by Ayres spatula would have to be seriously  
questioned. There are now newer forms of spatula, which are 
shaped to allow endocervical ce ll  sampling, and these may be
more appropriate to the older woman. Weid showed that an 
endocervical swab could y ie ld  more abnormal ce lls  than a 
cervical smear (154). C e rta in ly , i f  the SCJ is not eas ily  
v is ib le , in  the older woman having cervical cytology, 
consideration should be given to performing an endocervical 
sampling with a swab moistened with sa line .
With approximately 4000 cases of cervical cancer registered  
in the U.K. in 1980 (1 2 ) ,  extrapo la tion , gives a woman a 1% 
chance of developing cervical cancer, throughout her l i fe t im e .
C lear ly , the finding in th is  study, of eight percent of a
'normal' post-menopausal population, harbouring a mild cervical
abnormality, does not indicate that a l l  would progress to
invasion. I t  does, however, raise concern that there is an
undiagnosed reservoir of cervical abnormality which may have 
neoplastic po ten tia l.  In th e ir  paper on rates of progression of 
cervical dysplasia, Richart and Barron found that only 6 of 462 
women with very mild dysplasia, regressed by the f i r s t  follow-up  
(155). The median rate  of progression from mild dysplasia to
carcinoma in s itu  was 86 months. Such progression, from a mild 
abnormality to a lesion with serious invasive p o te n t ia l ,  would
be expected to be slow, and there would be the opportunity to 
detect the lesions at a la te r  cytological examination. The 
recently  re-convened Canadian Task Force on cervical cytology  
(2 1 ) ,  has reaffirmed that i f  regular cytology is negative un ti l  
the age of 60 years, then i t  may be discontinued. This study 
appears to indicate that such a policy w i l l  not allow these mild 
in t ra e p ith e l ia l  lesions to be detected at a la te r  date.
TABLE FROM CHAPTER THREE
TABLE 6
Patients with negative cervical cytology and an atypical
transformation zone
\TIENT AGE MENOPAUSE CYTOLOGY COLPOSCOPY HISTOLOGY
1 54YRS 4YRS NEGATIVEx3 AWE CIN 2/3
2 53YRS 4YRS NEGATIVEx3 AWE NORMAL EPITH
3 52YRS 3MTS NEGATIVEx2* AWE+MOSAIC METAPLASIA
4 51YRS 5YRS NEGATIVEx2 AWE CIN 1/ATYPIA
5** 50YRS 9YRS NEGATIVEx2* AWE+MOSAIC CIN 1
6 50YRS 10YRS NEGATIVEx3 AWE NORMAL EPITH
7 49YRS MENST NEGATIVEx3 AWE NORMAL EPITH
8 49YRS 3YRS NEGATIVEx2 AWE+PUNCT METAPLASIA
9 49YRS 9MTS NEGATIVEx3 AWE ACANTHOSIS
10 45YRS MENST NEGATIVEx2* AWE+MOSAIC INFLAM EPITH
11 37YRS 6YRS NEGATIVEx2* AWE CIN 1
12 50YRS 12YRS NEGATIVExl AWE+PUNCT CIN 2
13 53YRS 11YRS NEGATIVExl* AWE CIN 1
14 52YRS 10YRS NEGATIVExl CIN 1
*  Negative with inflamatory exudate on one occasion 
* *  AWE seen at second v is i t
YRS-YEARS MTS-MONTHS AWE-ACETO-WHITE EPITHELIUM 
CIN-CERVICAL INTRAEPITHELIAL NEOPLASIA PUNCT-PUNCTATION 
EPITH-EPITHELIUM INFLAM-INFLAMATORY MENST-STILL MENSTRUATING
SUMMARY TO SECTION 1
Research into descriptive studies of cervical colpcscopic 
appearance,is lim ited in the age group here studied. A common, 
and reasonable view, is that colposcopy has a l im ited place in 
such women. I f  cytology is abnormal, the fear of missing 
invasive carcinoma, when f e r t i l i t y  is not a concern, often 
ensures cone biopsy is the f i r s t  diagnostic procedure. C a r t ie r ,  
sees a use fo r  exogenous oestrogen in improving the colposcopic 
p ic tu re ,in  older women with abnormal cytology (131). As regards 
v i s i b i l i t y  of the SCJ, th is  study has confirmed his experience, 
and that of others (125,136), In the study group of 50 women, 
four had in t ra e p ith e l ia l  neoplasia diagnosed, and three of these 
had HRT for at least 2 months. One of the three women had CIN 
2 /3 ,  and although the SCJ was v is ib le ,  i t  was high in the 
endocervix, and she required cone biopsy. One other patient with 
atypia/CIN 1 in the study group,did not take HRT. The SCJ was, 
and remained inv is ib le ,and  - despite only having a very mild 
abnormality, she also required cone biopsy. The two others had 
CIN 1, and the SCJs were v is ib le  before HRT. They were, however, 
high in the endocervix, but administration of HRT, rendered them 
eas ily  v is ib le  and continued surveillance, rather than cone 
biopsy was possible.
In th is  c l in ic a l  t r i a l , t h e  presence of unsuspected CIN was 
discovered. The administration of HRT, prevented the need fo r  
cone biopsy in two pa tien ts ,in  whom i t  would otherwise have been 
necessary.
The other aspects of th is  investigation , indicate a use fo r .
colposcopy in the management of the hormone d e fic ie n t  woman. A
logical scoring system,and a standardised technique, allow a
reproducible quantita tive  appraisal of genital hormone status. 
This assessment, may be superior to a three point maturation 
value assessment by cytology, although comparison to more
sensitive and c r i t i c a l  cytological assessments, was not made. 
Agreement with serum estimations of oestradiol was frequent, but 
colposcopy had advantages over hormonal assays. Degrees of
hormone deficiency were diagnosed by colposcopy, but oestradiol 
estimations were of l i t t l e  value, i f  in the menopausal range, 
below 150 picomoles per l i t r e .  A d d it iona lly ,  colposcopy could be 
used to monitor response to therapy, and was an indicator of end 
organ response.
U t i l is a t io n  of the scoring system, and association with the 
v i s i b i l i t y  of the SCJ,suggests that re traction  of the junction  
into the endocervical canal, is a hormonally dependent event.
CHAPTER 4
THE MICROBIOLOGICAL FLORA OF PATIENTS WITH CERVICAL 
INTRAEPITHELIAL NEOPLASIA AND NORMAL WOMEN,AT DIFFERENT AGES
INTRODUCTION
There is l i t t l e  doubt that the human papilloma virus (HPV), 
is closely associated with CIN, and i t  may have an aetio log ica l  
ro le  in the genesis of cervical carcinoma (72 ,7 5 ,7 6 ,7 7 ,8 0 ) .  I f  
HPV is a cause of CIN, and CIN progresses to invasive cancer, 
then HPV has importance as a cause of cervical cancer. This, 
however, is perceived as the importance of cervical HPV. CIN is 
not a disease, being asymptomatic and unharmful, provided i t  
does not progress to invasion. A s l ig h t ly  d i f fe re n t  approach, is 
to perceive HPV as a genital t ra c t  pathogen, which occurs w ith ,  
and without CIN. Consideration can be given to what other
effects  i t  may have lo c a l ly ,  other than i ts  probable
carcinogenic action.
Research, attempting to prove causation of cervical cancer, 
is necessarily sophisticated. Associations, however, may s t i l l  
be observed between putative causal agents, and valuable comment 
can be made. HPV, frequently yields cytological evidence of i ts  
presence, in the pre-invasive stage, but h isto log ica l evidence
of the v irus , is ra re ly  found in invasive cancer. The c lassical
cytological changes, are due to death of the c e l ls ,  and these 
have no part in cervical carcinogenesis. The c e l ls ,  which have 
the potential to become malignant, are those which have th e ir  
DNA altered by HPV, without cell death, and these changes are 
not h is to lo g ic a l ly  v is ib le  when invasion occurs. Until HPV can 
be cultured, and a specific  antibody to each subtype can be 
raised for serological study (72 ) ,  cy to lo g ica l,  h isto log ica l and 
microbiological study, must be confined to patients with
pre-invasive disease, fo r  any associations with HPV to be made.
The influence of HPV, on age at diagnosis of CIN, may be
valuable. I f  CIN was occuring at an e a r l ie r  age, due to HPV,
then possibly the age of onset of invasive cancer would f a l l .  
The p ara lle l  increase in the number of cases of cervical HPV 
in fe c t io n , and the number of very young women developing 
cervical cancer, may be re la ted . A study re la t in g  HPV presence 
to both age at diagnosis of cervical abnormality, and other 
organisms predominant in the lower genital t ra c t ,  may be of 
value. HPV may be a marker not only fo r CIN, but also fo r  
changes in microbiological flora,which may also have importance.
A study was designed, involving a l l  patients presenting with 
abnormal cervical cytology, to a colposcopy c l in ic .  Evidence of 
v ira l  and bacteria l in fection was sought, and related to CIN. 
The influence of age on the recovery of these organisms, was
also corre la ted , and these findings were compared to a group of
normal women. A fu r th e r  group of women at the c lim acter ic ,  were 
also examined fo r  these organisms, both before and during the 
administration of HRT.
PATIENTS AND METHODS
Two hundred and eighty-seven (study) patients with abnormal 
cervical cytology, were referred to the colposcopy c l in ic  at the 
Western In firm ary , Glasgow, between June 1983 and June 1984. 
These patients were matched with 100 control patients , with 
normal cytology, and no past history of cervical neoplasia, 
vaginal in fec tion , or pelvic inflammatory disease. These 
patients were recruited from women seeking gynaecological 
treatment, for conditions other than the above. Patients and
controls were matched for age, p a r i ty ,  contraception and 
socio-economic status. An attempt was made to match fo r  smoking, 
but an excess in the study group was found, and this precluded 
matching. There was no attempt to match for sexual behaviour, 
both because th is  information was f e l t  to be unsound, and also 
any attempt to do th is  may dissuade patien ts , with abnormal 
smears, to return for treatment. A ll study patients had 
cytology, colposcopy and biopsy, fo r  confirmation of diagnosis. 
All controls had current negative cytology and 24% had negative 
colposcopy.
Id e n t if ic a t io n  of HPV, was by typical cytological and 
histo logical changes (156,157). Other putative aetio log ica l  
agents were sought by iso la tion  techniques, in p a r t ic u la r  herpes 
simplex virus (HSV) and C. trachomatis, to assess th e ir  
prevalence in the local population. Endocervical swabs were 
obtained for both these agents. Swabs fo r HSV were transported  
in BHK 21 (Baby Hamster Kidney) medium (Gibco(Europe)Ltd.) ,  and 
cultured in BHK cl3 ce lls  in transport medium, supplemented by 
10% v/v fe ta l  c a l f  serum (Gibco). The swab fo r C. trachomatis 
was collected into 2SP transport medium, and innoculated into  
monolayer culture of McCoys c e l ls ,  without p rio r freez ing . The 
innoculation method used, was that of Harper e t .a l . ( 1 5 8 ) ,  except 
that Lugol's iodine was used to stain the cu ltu re , three days 
a fte r  innoculation.
T r ip le  bacteriology swabs from endocervix, high vagina and 
urethra, were also obtained from a ll  patients , to determine the 
predominant aerobic and anaerobic organisms in the lower genital 
t ra c t .  These swabs were transported to the laboratory, in
S tu art 's  Medium (Oxoid), and plated onto blood agar (Aerobic and
anaerobic), s e n s it iv i ty  blood agar, Macconkey agar, Thayer and
Martin medium, and Robertsons meat broth f lu id  medium, with 
subculturing i f  necessary. Trichomonas vaginalis was id e n t if ie d  
on the cervical smear, but was not cultured.
No attempt was made to culture each organism present in the 
vagina. Such exhaustive descriptive studies, have been carried  
out previously (159,160). Only the predominant organism, found 
at cu lture , was correlated to the h isto log ica l group from which 
i t  was iso lated .
The same iso lation  techiques fo r C. trachomatis, HSV, and
aerobic and anaerobic bac teria , were also performed on a group
of twenty women patients with symptoms of the c l im acter ic .  These 
patients were taken from the population of women undergoing 
colposcopy, before and during HRT (Chapters 2 ,3 ) ,  and iso la tion  
was performed at both these times. The culture results from 
these patien ts , are compared to the control group of younger 
women for evidence of changes in bacteria l f lo r a ,  and presence 
of HPV.
RESULTS
Two hundred of the two hundred and eightyseven patients had 
CIN, eightyfour of which also had evidence of HPV. T h ir ty -s ix  
patients had HPV alone, and f i f ty -o n e  patients had a benign 
abnormality, without CIN or HPV. Patient de ta ils  are shown in 
tables 7 and 8. There were no s ig n if ican t differences between 
study and control groups for age, p a r i ty ,  or d is tr ib u tio n  of 
socio-economic group. There were s l ig h t ly  more oral 
contraceptive users, and s l ig h t ly  fewer b a rr ie r  contraceptive
users in the study group, compared to controls. Of 120 patients  
with HPV in fe c t io n , only 3 (2.5%) used barr ie r  contraception, 
compared to 15% of controls. This is ind irec t evidence, of the 
protective e f fe c t  of b a rr ie r  contraception, to HPV in fec tio n .
HPV and AGE
The influence of the find ing of HPV associated with CIN on 
age at diagnosis, is shown in table 9. For CIN 1 and CIN 3, the 
presence of HPV, reduced the age at diagnosis by two years, but 
in CIN 2, those with HPV were s l ig h t ly  older. The differences  
were not s ig n if ic a n t .
C.TRACHOMATIS and AGE
Fewer patients were infected with C. trachomatis than HPV in 
the study group, but an almost identical proportion of controls, 
were iso lation  pos it ive . When age was re lated to C. trachomatis 
in fec tion , the patients were s ig n if ic a n t ly  younger than those 
who were not in fected, irrespective  of which group was studied 
( tab le  10).
HSV AND AGE
Among the 287 study and 100 control pa tien ts , no evidence of 
HSV was found on culture.
OTHER ORGANISMS
The three common vaginal pathogens, yeasts, T.vaginal is ,  and 
Gardnerella vag ina lis ,  were found in s im ilar  proportions in 
study and control groups, but yeasts were apparently more 
prevalent in the control group. The group with HPV alone, had 
low rates fo r T. vag ina lis ,  and none had any yeasts.
I f  an organism other than these noted above was id e n t if ie d  as 
a s ig n if ican t  growth, th is  was correlated to the h isto log ica l
group. The f iv e  most commonly isolated organisms, were re lated  
to histo logy, and are shown with these other vaginal pathogens 
in table 11.
C learly  the group with a benign abnormality, which was mainly 
' c e r v i c i t i s ' ,  has a s ig n if ic a n t ly  greater iso lation of these 
organisms, than the control group. Coliforms and Staph, albus, 
were more frequently  found in the CIN alone, and HPV alone, 
groups but not in the CIN and HPV group.
POSTMENOPAUSAL PATIENTS
Twenty patients had microbiological iso lation  performed 
before the commencement of HRT. None had a specific  complaint of 
vaginal discharge, although vaginal dryness was common. Eleven 
of these patients had no growth, or any s ig n if ic a n t  growth at 
any s i te .  Three patients had C.albicans or yeasts, one patient  
each had T. vag ina lis ,  Gardnerella vag ina lis ,  enterococci, and 
group B Streptococci. Two patients had coliforms, and one had 
non haemolytic Streptococci (Table 12).
Sixteen patients returned a f te r  at least two months treatment 
with HRT. Four did not, three because they did not l ik e  HRT, and 
the fourth , the patient in whom enterococci was iso la ted , had a 
m ultip le  myeloma diagnosed, and did not receive therapy. During 
therapy, there appeared to be greater iso lation  of vaginal 
pathogens. Only seven out of sixteen had no growth, or no 
s ig n if ican t  growth. Four patients had a group B Streptococcus 
iso lated, one of which also had C. trachomatis. Two patients had 
yeasts, two had T. vaginalis and one had Gardnerella vag in a lis .  
Excluding the GBS, there were s t i l l  six of sixteen patients with 
vaginal pathogens.
DISCUSSION
I t  is c le a r ly  outwith the scope of a study of th is  s ize , to 
accurately determine a ll  the micro-organisms present in the 
lower genital t r a c t .  The large proportion of pa tien ts , with HPV 
associated with CIN, adds fu rth e r  weight to the large body of 
information im plicating th is  agent as an associated fac to r  in 
the aetiology of CIN (7 5 ,80 ,81 ) .  I t  does not make any causal 
ro le  fo r HPV any c lea re r .  Were each grade of CIN to be diagnosed 
at an e a r l ie r  age, i f  there is the presence of HPV, then several 
explanations are possible. F i r s t ly ,  the HPV may be hastening the 
progression of the CIN, resulting  in more advanced CIN at a 
younger age. Secondly, the HPV may be a marker fo r a more active  
sexual practice , which may render epithelium neoplastic, at an 
e a r l ie r  age. Las tly ,  i t  is possible that the presence of HPV may 
be the factor that renders the smear abnormal, rather than the 
dyskaryosis due to the CIN. Although the cytological features of 
HPV infection have been documented fo r many years (7 8 ) ,  the 
features of dyskaryosis are un like ly  to be missed, i f  a ttention  
has already been attracted by ko ilocytosis. No firm  conclusion 
as to whether the HPV hastens CIN, can be drawn from these data 
on age incidence, but there is a trend to be found.
Sim ilar th inking , can be applied to C. trachomatis, an 
organism known for its  sexual transmission. The same prevalence 
was found in study and control groups. Although groups were not 
matched for sexual behaviour, as i t  was f e l t  th is  l in e  of 
questioning may jeopardise the women with CIN returning fo r  
treatment, th is information suggests, that study and control 
groups had s im ilar  sexual practices. L i t t l e  comment, can be made
fo r  C. trachomatis, as a causal factor in CIN, from these 
iso la tion  studies. The work in the following chapter, w il l  
consider past in fec tion , in th is  ro le  more closely. This present 
study, however, shows that a su itab ly  controlled group of normal 
women, have almost identica l prevalence rates, to women with CIN 
fo r  the iso la tion  of C. trachomatis. Group fo r group, women with 
positive iso lation  fo r C. trachomatis, were younger than 
iso la tion  negative women, almost c e r ta in ly  a manifestation of 
increased sexual a c t iv i ty  in the younger, than older woman.
Although, perhaps the least sophisticated investigation  
performed, t r ip le  bacteriology swabs from endocervix, high 
vagina and urethra, gave very in teresting  resu lts . The organisms 
that can be isolated from the vagina are legion, even in perfect  
health (161,162). Bacteroides species alone, can be isolated  
from the vagina, in over 50% of healthy women (162). Descriptive  
studies, employing meticulous and exhaustive cu lturing  
techniques are necessary to describe a l l  vaginal 
micro-organisms. Such studies are usually of small numbers 
(160,163). Studies on microbiology of the vagina, may e ith er  
concentrate on detection of a l l  possible organisms, detection of 
a specific  organism to establish the prevalence, or an attempt 
at quantitation of the organism (164). The f i r s t  and th ird  of 
these objectives, were beyond the scope of th is  study, in view 
of the numbers, and thus the predominant growth on plating  was 
considered, and associated to the h isto log ica l groups.
The culture techniques used, would show the pathogenic 
organisms and other bacteria l growths, which may be s ig n if ic a n t .  
Larsen and Galask point out, that results  are l ik e ly  to be of
greater value i f  a l l  isolations within the study populations are 
performed in the same laboratory, rather than cu ll ing  
information from more than one source (164). A ll isolations in 
th is  study, fo r  specific  agents, were performed in the same 
laboratory, from matched patients . Thus, any differences in 
iso la tion  can be explained, by differences in the lower genital 
t ra c t  microbiological environment.
I t  was f e l t  that perhaps the presence of CIN or HPV, may 
a lte r  the predominant organisms, or balance of organisms, and 
that th is  may have been detected. CIN is found in association  
with numerous commensal and pathogenic organisms, and several 
studies have attempted to deta il  these. A large study of 
patients from Ind ia , found a markedly high in festa tion  rate  of 
T. vaginalis in dysplasia pa tien ts , compared to controls, but 
l i t t l e  other comment could be made regarding associations (165).  
This work, supported the views of others, that T. vaginalis may 
s t i l l  have a part to play in the genesis of neoplasia (37 ,166 ) .  
A s im ila r  study to the present one reported, but carried out in 
North America, sought evidence of HPV and C. trachomatis, in 
addition to other bacteria . This group found s im ilar  incidences 
of HPV and C. trachomatis as found here, but higher incidences 
of Gardnerella and HSV (167). A smaller, but more intensive  
investigation on patients with dysplasia, and invasive  
carcinoma, found l i t t l e  to comment on the a lte ra tio n  of f lo r a  in 
dysplasia, but found much lower incidences of Gram negative  
anaerobic b a c c i l l i ,  in patients with invasive carcinoma (168).
Other workers have reported on f lo r a ,  associated with 
invasive neoplasia. One series , reported that among 21 cases of
cervical cancer, there was an increased frequency of E. co li and 
Bacteroides species (169). Another series , however, found no 
increase in bacteria l growth among necrotic cancerous cervices 
(170). The data found in th is  study, are suggestive of a s h i f t  
in predominant bacteria  to the enterobacteria, and enterococci, 
among the CIN group. A s im ila r ly  high incidence of enterococci, 
was found by Thadepalli and co-workers, among patients with CIN 
(168). A conclusion from th is  work, and that of others, on the 
organisms isolated at the time of diagnosis of CIN or HPV, must 
be that there are no strong correlations of any one agent, to 
CIN. HPV appears to be a strong risk factor in i ts  own r ig h t ,
and possibly i ts  presence may in h ib it  other agents. The ro le  of
prior infections and the genesis of CIN, is discussed in the
next chapter.
The main value of bacterio logical screening of women with 
abnormal cervical cytology, may be i l lu s t ra te d  by the findings  
in the group with no subsequent evidence of CIN or HPV, a f te r  
colposcopy and biopsy. By routine lower genital t ra c t
microbiological screening, these patients were s ig n i f ic a n t ly  
more l ik e ly  to have a positive iso la te  than controls, fo r  the 
most commonly isolated groups of organisms. S ign ifican t cervical  
in fec tion , can cause abnormalities on cervical cytology, which 
may be misinterpreted as CIN (67 ) .  This may account fo r  reports 
for cases of CIN being controlled, by local application of 
an tib io t ics  to the cervix (68 ).  I f  a gynaecologist, or general 
p rac tit io n er  has lim ited access to colposcopic f a c i l i t i e s  and is 
faced with a m ild ly  abnormal smear, he may perform these 
rou tine ly  ava ilab le  microbiological tes ts , and t re a t  any growth.
Subsequent cervical cytology may prove normal and cone biopsy 
may be avoided.
No herpes simplex was isolated from the cerv ix , during the 
study. This is a prevalent organism in the United States, but i t  
does not appear so in the population from which these patients  
were recru ited . No positive iso la te  among 387 cases was 
unexpected. The iso lation  technique was validated during the 
course of the study, by women with known genital herpes being 
screened by the same technique, and proving pos it ive . The virus  
may remain la ten t in the sacral ganglia (4 5 )and be found on the 
cerv ix , only during acute in fec tions , but i t  seems l ik e ly  that  
herpes simplex is not a s ig n if ican t problem in th is  area.
Early work, on the change in microbiological f lo r a  that  
accompanies the menopause, concentrated on the decrease in the 
lac tobacillus  (171). Since then, there has been fu rther  work 
implicating other changes. Blum and Elian suggested, that the 
f lo r a  in postmenopausal women, was more akin to that found in 
children, or in pregnancy (1 7 2 ) .Osborne and colleagues, could 
f ind no s ig n if ican t  differences in culture ra te ,  between 
postmenopausal women receiving HRT and those who did not (173).  
Some have suggested, there may be an increased iso la tion  ra te  of 
anaerobic bacteria  in women not treated with HRT, and c e r ta in ly  
there w i l l  be a lower iso la tion  of the lac tobac il lus  (164).
The work of th is  present study, indicates that the group of 
women at the c l im ac te r ic ,  had a considerably higher rate  of 
iso lation  of vaginal pathogens, such as yeasts, T. vaginalis  or 
Gardnerella vag ina lis .  Five of twenty patients (25%) isolated  
one of these pathogens before treatment, and the s ituation  was
even worse during therapy, with six of sixteen patients having a 
pathogen iso la ted . The rate  of iso lation  of these organisms, is 
higher in comparison to the rates in younger women (Table 11). 
HRT does not appear to improve the s itu a t io n . C trachomatis, T. 
vag ina lis ,  and G. vaginalis a l l  have a positive correlation  to 
cervical mucopus (174), but th is  was not found in these
patients . The find ing of four of sixteen hormone d e fic ie n t  
patien ts , having a group B Streptococcus during HRT, was
surprising. The significance of th is  finding is not c lear .
The conclusion from these data, must be that the study
population observed in this older age group, have a reservoir of 
pathogens, at least as large as that in the younger woman. HRT 
may not improve the genital microbiological environment.
TABLES FROM CHAPTER 4 
TABLE 7 Patient deta ils
A) AGE AND PARITY
NUMBER MEAN AGE MEAN PARITY
n yrs.(SD) (SD)
CONTROLS 100 29.61(8 .05) 1 .93 (1 .59 )
CIN 116 29.81(6.43) 1 .71 (1 .56 )
CIN+HPV 84 28.82(6 .05) 1 .86 (1 .57 )
HPV 36 28.80(9 .18) 1 .08 (1 .61 )
BENIGN 51 30.69(9 .82) 1 .43 (1 .37 )
TOTAL STUDY 287 29.54(7 .41) 1 .63 (1 .55 )
B) CONTRACEPTIVE PRACTICE
STER/ O.C. IUCD BARRIER
n NO CONT PILL
CONTROLS 100 44(44%) 31(31%) 10(10%) 15(15%)
CIN 116 37(32%) 53(46%) 17(15%) 9(7%)
CIN+HPV 84 25(30%) 45(54%) 12(14%) 2(2%)
HPV 36 17(47%) 16(44%) 2(6%) 1(3%)
BENIGN 51 15(29%) 27(53%) 4(8%) 5(10%)
TOTAL STUDY 287 94(33%) 141(50%) 35(12%) 17(6%)
C) SMOKING PRACTICE
CPD
n 0 -10 -20 -30 >30 UNKNOWN
CONTROLS 100 41(41%) 9(9%) 22(22%) 2(2%) 2(2%) 24(24%
CIN 116 31(27%) 7(6%) 38(33%) 11(9%) 3(3%) 26(22%
CIN+HPV 84 19(23%) 12(14%) 26(31%) 6(7%) 1(1%) 20(24%
HPV 36 9(25%) 10(28%) 8(22%) 2(6%) 0(0) 7(19%
BENIGN 51 17(33%) 7(14%) 11(22%) 0(0) 0(0) 16(31%
TOTAL STUDY 287 76(26%) 36(13%) 83(29%) 19(7%) 4(1%) 69(24%
TABLES FROM CHAPTER 4
TABLE 8 Patient de ta ils  
SOCIO-ECONOMIC STATUS
S.E. GROUP» 1 2 3 4 5 6 UNKNOWN
CONTROLS 2(2%) 17(17%) 27(27%) 10(10%) 8(8%) 12(12%) 24(24%
CIN 3(3%) 19(16%) 32(28%) 20(17%) 7(6%) 14(12%) 21(18%
CIN+HPV 0(0) 14(17%) 21(25%) 9(11%) 3(4%) 18(21%) 19(22%
HPV 0(0) 4(11%) 8(22%) 10(28%) 1(3%) 6(17%) 7(19%
BENIGN 3(6%) 9(18%) 10(20%) 10(20%) 1(2%) 3(6%) 15(29%
TOTAL STUDY 6(2%) 46(16%) 71(25%) 49(17%)12(4%) 41(14%) 62(22%
TABLE 9 Age, CIN and HPV
GROUP n AGE(SD)yrs.
CIN 116 29.83(6.43)
CIN 1 26 29 .11(7 .40)
CIN 2 51 28.54(5.22)
CIN 3 39 31.97(6 .74)
GROUP n AGE(SD)yrs. 
CIN+HPV 84 28 .82(6 .05)
CIN1+HPV 18 27.06(6 .41)
CIN2+HPV 47 29.00(5 .91)
CIN3+HPV 19 30.05(5 .99)
TABLES FROM CHAPTER 4
TABLE 10 Age and C.trachomatis culture
GROUP +veCULTURE AGE(SD) -veCULTURE AGE(SD)
CONTROLS 10(10) 26.60(5 .18) 90(90) 30.02(8.23)
CIN 11(10) 23 .25(7 .96) 105(90) 30 .31(6 .50)
CIN+HPV 12(14) 25.83(4. 40) 72(86) 29.32(6 .16)
HPV 4(11) 26.50(14 .47) 32(89) 29.09(8 .61)
TABLE 11 Prevalence of positive cultures in each group
*MEN0P-
TOTAL AUSAL-
CONTROL CIN CIN+HPV HPV BENIGN STUDY bef dur
( * )  (%) (%) (%) { % ) (%)
enterococci 6(6) 14(12) 8(9) 1(3) 10(20) 33(11) 1 -
coliforms 2(2) 11(9) 5(6) 5(14) 8(16) 29(10) 2 -
Staph.albus 2(2) 10(9) 5(6) 3(8) 4 (8) 22(8) -
Gp. B Strep. 2(2) 2 (2) 2(2) 0 (0) 5(10) 9(3) 1 4
BacteroidesSp 1(1) 2(2) 3(4) 0 (0) 3(6) 8(3) -
C.trachomatis10(10)11(10) 12(14) 4(11) 6(12) 33(11) -  1
Yeasts 15(15)8(7) 5 (6) 0 (0) 6(12) 19(7) 3 2
T .vag ina lis  12(12)10(9) 4(5) 1(3) 7(14) 22(8) 1 2
G.vaginalis 2 (2) 4(3) 1(1) 1(3) 1(2) 7(2) 1 1
*  n=20 fo r  before(bef) HRT menopausal group and n=16 fo r  during 
(dur) HRT group
TABLES FROM CHAPTER 4
TABLE 12 Microbiology before and during HRT in perimenopausal 
and postmenopausal women
BEFORE HRT DURING HRT
Patient 1 HVS a ll  group B a l l  group B
Cx
II
Streptococcus Streptococcus
Patient 2 HVS no growth no sign i f  growth
Cx no growth no sign i f  growth
U no sign i f  growth no sign i f  growth
Patient 3 HVS C. albicans no sign i f  growth
Cx no growth no sign i f  growth
U coliforms no sign i f  growth
Patient 4 HVS a ll  non gp B Streptococcus
Cx haemolytic no sign i f  growth
U Streptococci no sign i f  growth
Patient 5 HVS no sign i f  growth Trichomonas but no
Cx no sign i f  growth s ig i f ic a n t  growth
U no sign i f  growth no sign i f  growth
Patient 6 HVS no sign i f  growth Trichomonas
Cx no growth no growth
U no sign i f  growth no sign i f  growth
Patient 7 HVS no sign i f  growth gp B Streptococcus
Cx no sign i f  growth gp B Streptococcus
U no sign i f  growth no growth
Patient 8 HVS Gardnerella mixed anaerobes
Cx Gardnerella C. trachomatis
U Gardnerella gp B streptococcus
Patient 9 HVS Streptococcus no sign i f  growth
Cx C. albicans no sign i f  growth
U no growth no growth
Patient 10 HVS Trichomonas but yeasts
Cx no sign i f  growth yeasts
U no sign i f  growth no growth
Patient 11 HVS no sign i f  growth Gardnerella
Cx no sign i f  growth Gardnerella
U no sign i f  growth Gardnerella
Patient 12 HVS yeasts yeasts
Cx yeasts yeasts
U yeasts yeasts
Patient 13 HVS no sign i f  growth no sign i f  growth
Cx no sign i f  growth no sign i f  growth
U no sign i f  growth no sign i f  growth
Patient 14 HVS coliforms no sign i f  growth
Cx coliforms no sign i f  growth
U coliforms no sign i f  growth
Patient 15 HVS no sign i f  growth no growth
Cx no sign i f  growth no growth
U no sign i f  growth no growth
Patient 16 HVS no sign i f  growth normal f lo ra
Cx no sign i f  growth normal f lo ra
U no sign i f  growth normal f lo r a
TABLE 12  c o n t .
TABLES FROM CHAPTER 4
Patient 17 HVS no sign i f  growth
Cx no sign i f  growth
U no sign i f  growth
Patient 18 HVS enterococci
Cx enterococci
U enterococci
Patient 19 HVS no growth
Cx no growth
U no growth
Patient 20 HVS no growth
Cx no sign i f  growth
U no sign i f  growth
NO RETURN 
NO RETURN 
NO RETURN 
NO RETURN
CHAPTER 5
AGE RELATED ANTIBODY STATUS OF PATIENTS WITH CERVICAL CANCER AND
MATCHED CONTROLS
INTRODUCTION
In the United Kingdom, cancer re g is try  figures indicate that  
carcinoma of the cervix is a disease, a ffecting  more 
postmenopausal, than premenopausal women (12 ) .  There are more 
cases, a ffecting  women over 65 years than women under 45 years. 
Despite these f igu res , the main thrust of cervical cancer 
protection schemes, has been to screen younger women, so they do 
not develop the disease la te r  in l i f e .  This pr inc ip le  is sound, 
provided that f i r s t l y ,  the disease has a long preinvasive phase, 
and secondly a l l  the population can be protected. The second, 
has not been achieved, and the length of the preinvasive phase, 
has been questioned by Ashley. He postulates that the disease 
may be d i f fe re n t  in the older woman (14 ,15 ) .  A reduction in the 
preinvasive phase, or a reduction in the e ff icac y  of screening 
methods in the older woman, imply the need for renewed vigour in 
screening as age advances, rather than a reduction.
Evidence is mounting, that much of the in t ra e p ith e l ia l
neoplasia in the younger woman, has an association with human
papilloma virus (HPV) (7 1 ,7 2 ,7 4 ,7 5 ,7 6 ,8 1 ,8 2 ,8 3 ,8 4 ) .  HPV is a 
sexually re lated  organism (7 0 ) ,  and thus is understandably more
common, in the younger woman. The question of how HPV may be 
involved in cervical neoplasia in these older women, many 
celibate  for years, has not yet been addressed. The property of 
latency, evident in herpes simplex virus in fec tions , is only now 
being questioned for HPV (87 ).  Does HPV a l te r  the genotype of 
squamous c e l ls ,  but the e f fe c t  remains dormant fo r many years, 
before leading to carcinoma in old age? Or does carcinoma in the
older woman have a d if fe re n t  series of in i t ia to r s ,  with age a 
co-factor in i ts  own right?
The following sero-epidemiological study investigates three  
putative causal agents for carcinoma of the cervix. Rates of 
s e ro -p o s it iv ity  in a study and control group are compared, and 
prevalence of the evidence of p rio r infection with these 
fac to rs , is re lated  to age. This attempts to id e n t i fy ,  whether 
the older woman with carcinoma of the cerv ix , has been exposed 
to the same sexual or other pathogens as the younger woman. HPV 
may not yet be investigated in th is  way, as culture and specific  
antibody production have not yet been possible (72 ) .
PATIENTS AND METHODS
One hundred patients with invasive carcinoma of the cervix  
(study), were matched with one hundred control patients  
(c o n tro l) ,  fo r  age, p a r i ty ,  and socio-economic status. A serum 
sample was obtained from a l l  patients , and analysed for antibody 
t i t r e s  to three genital pathogens which have been implicated in 
the causation of carcinoma of the cervix; Herpes simplex v irus ,  
cytomegalovirus and Chlamydia trachomatis.
Control patients had never had cervical neoplasia, or 
previous atypical Pap smear, and many were postmenopausal, 
seeking aid for symptoms of the c lim acteric .  The serum sample, 
was obtained from the study patien ts , before therapy in 27%, and 
a fte r  therapy, usually radiotherapy, in the remaining 73 
patien ts . The matching fo r age with control pa t ien ts , was based 
on the age at diagnosis of the carcinoma, and not age at 
sampling. I t  was f e l t  that genital in fection a f te r  therapy fo r  
carcinoma was u n like ly , and th is  matching c r i t e r i a ,  would avoid
a skew in the d is tr ib u tio n  toward the older woman.
Serology for Chlamydia trachomatis was performed by the 
standard micro-immunofloresence method,using as substrate McCoys 
c e l ls ,  which had been previously treated with cycloheximide, 
pre-in fected with C. trachomatis type i - c a l .  The reciprocal of 
the greatest serum d i lu t io n ,  showing typical inclusion body 
fluorescence, was recorded as the t i t r a t io n  endpoint. T i t ra t io n s  
were then read on a Le itz  microscope, f i t t e d  with Ploemopak 
i llum ination  for fluorescein isothiocyanate.
The antibody t i t r e s  to herpes simplex virus (HSV), and 
cytomegalovirus (CMV), were obtained by a standard complement 
f ix a t io n  technique.
The serological status of study and control p a tien ts , was 
compared for d ifference in infection ra tes , or synergism between 
agents possibly causing the cancer. The serological s tatus, was 
also linked to stage of disease, h isto log ica l d i f fe re n t ia t io n  of 
the tumour, and socio-economic status.
RESULTS
The mean age of the study patien ts , at the time of sampling, 
was 58.7 years (S .D .12 .31 ), and the mean age at diagnosis of 
cervical carcinoma was 53.4 (S .D .11 .85 ),  very s im ilar  to the 
mean age of the control patients. Age, p a r i ty  and socio-economic 
matching, are shown in table 13.
Serological t i t r e s ,  were available  fo r  a l l  study and control 
patients fo r HSV and CMV, however the results from f iv e  samples 
of the study group, and four samples of the control group, were 
not ava ilab le  for Chlamydia. These samples were broken, or lost  
in t ra n s i t  to the laboratory. The denominator for analyses
involving chlamydia t i t r e s ,  or combinations involving Chlamydia 
t i t r e s ,  is therefore 95 fo r  the study group, and 96 fo r  the 
control group, but i t  is 100 fo r controls and study for HSV and 
CMV. Stage of tumour was known in 96 study patien ts , and tumour 
d i f fe re n t ia t io n  was available  in 80 study patients ( tab le  14).
a) SEROLOGY
The number of pa tien ts , with evidence of previous in fe c t io n ,  
is shown for each agent, and combination of agents in control 
and study patients (tab le  15). There is no s ig n if ic a n t  
difference in the numbers with evidence of previous infection to 
HSV ,CMV or C. trachomatis, between study and control groups. An 
apparent difference between the groups for previous Chlamydia 
infection (8 c f .  17, chi sq. 3.83 N.S), did not reach
significance. S im ila r ly ,  differences in combinations of previous 
in fe c t io n , involving Chlamydia, were not s ig n if ic a n t .
Consideration of the absolute values for the t i t r e s  to each 
agent, did not reveal any differences between the study and the 
control groups ( tab le  16).
b) STAGE AND TUMOUR DIFFERENTIATION
The serological status, was linked to the above features of 
the disease in the study patients; Neither HSV or CMV 
antibodies, were found to be associated with more advanced 
disease, or poor tumour d i f fe re n t ia t io n .  The tumour type, was 
known in f i f te e n  of the seventeen patients , who had antibodies 
to C. trachomatis; nine of these patien ts ' tumours were poorly 
d if fe re n t ia te d .  Thus 24% of patients with poorly d i f fe re n t ia te d  
tumours, had antibodies to C. trachomatis, compared to 14% in 
patients with well or moderately d i f fe re n t ia te d  tumours ( n .s . ) .
Only 8% of the control group patients had these antibodies. 
There were seven patien ts , under the age of f i f t y  years, with 
poorly d if fe re n t ia te d  tumours, f iv e  of these had antibodies to 
C. trachomatis. There was no corre lation  between tumour stage 
and serological status for any agent (tab le  17).
c) SOCIO-ECONOMIC STATUS (SE) AND ANTIBODY PREVALENCE
The data for the control patients , indicate that the 
prevalence of antibody to HSV is usually between 65 and 75 % of 
S.E. groups. There is no increase in proportion affected with 
decreasing status, un ti l  group 5 which has a higher ra te .  The 
study group behave in the same manner.
The CMV status of the control patien ts , was s l ig h t ly  
d i f fe re n t ,  and there appeared to be an increasing prevalence of 
antibody, with decreasing status. In the control group, 37 of 48 
patients (77%), in S.E. groups 4,5 and 6, had antibodies to CMV, 
compared to only 26 of 48 patients (54%) in groups 1,2 and 3. 
This trend was was also evident in the study group. The numbers 
in the C.trachomatis group are so small, that meaningful comment 
cannot be made (Table 18).
d) SYNERGY
Synergy between agents such as these, has been suggested as a 
model fo r cervical squamous neoplasia (4 9 ) ,  but there has been 
no evidence from these data that synergy exists between these 
agents. There is no more prevalent se ro p o s it iv ity  fo r  
combinations of agents in the study group.
e) AGE AND ANTIBODY STATUS
A database of prevalence of se ro p o s it iv ity  rates at d i f fe re n t  
ages, was constructed among the control group. To expand the
numbers of premenopausal patien ts , data from the group of 
control pa tien ts , from the CIN study patients in the previous 
chapter, were added. These patients also had serology to HSV, 
CMV, and C. trachomatis evaluated. This gave a group of 
patients , of varied socio-economic status, a l l  of whom had no 
past h istory  of cervical neoplasia. I t  is considered va lid  to 
add th is  group to the control patients of the present study. 
This enables reasonable cohorts in each age range to be compared 
to the patients with carcinoma. There w i l l  be very few patients  
with carcinoma, in the young age group, and th e ir  infection  
p ro f i le  can now be compared to a larger group of normal women. 
This avoids bias against the findings in the young women, by the 
overwhelming number of older women. A one to one matching study 
w il l  not give useful information on the young woman who are few 
in number. This exercise w il l  allow population comparison, but 
w il l  not aid in the ascertainment of aetio logy. Data were 
availab le  for 200 patients on HSV,CMV status, and 194 patients  
on C. trachomatis status (tab le  19).
Study and control patients were analysed by proportion, 
having antibodies at each decade of reproductive and 
post-menopausal l i f e .  As stated, age at tumour diagnosis, ra ther  
than age at sampling, was chosen for the study patien ts , but 
f igures by both methods are shown; (tab le  20a study patients age 
at diagnosis, table 20b study patients age at sampling). Among 
the control patients , the percentage with positive serology to 
HSV, did not vary s ig n if ic a n t ly ,  from one decade to the next. 
Thus, i f  a patient was not seropositive by age 35, then new 
primary in fection was un like ly . The antibody p ro f i le  of CMV was
d i f fe re n t ;  The percentage s e ro p o s it iv ity  continued to increase 
with advancing age, indicating primary infection occuring 
throughout the reproductive years. The numbers with t i t r e s  to C. 
trachomatis are commented on in the next chapter.
Comparison of these f igures , ( tab le  19 to table 20a,20b), 
reveals that fo r  patients over the age of 45 years, each agent 
follows the same age/infection pattern. The s ituation  in the 
younger woman appears d i f fe re n t .  The very young p a t ie n t ,  
developing carcinoma, is more l ik e ly  to have antibodies to one, 
two, or a l l  three agents, than the young woman in the control 
group. The trend persisted in the 35-44 year age group, but was 
less marked. The large number of older patients with carcinoma, 
tends to obscure th is  observation. I t  appears the younger 
patient with carcinoma of the cerv ix , has a d if fe re n t  p rior  
infection p r o f i le ,  than control patients who were obtained from 
s im ilar  socio-economic circumstances.
DISCUSSION
A study of th is  nature, w il l  not id e n t ify  a causal agent, or 
agents, for cervical carcinoma. The control patients form a 
database, on which the l im ita t ions  of data from study pa t ien ts ,  
are evident. The three putative causal agents for cervical 
neoplasia, are viewed against variations in the normal p a t ie n t ,  
with age and socio-economic status. The data from control 
patien ts , indicates increasing s e ro p o s it iv ity  with age, and 
decreasing SE status; Both risk factors in the development of 
cervical carcinoma. I f  th is  is the natural progression of these 
infections in population terms, seroepidemiological t r i a ls  of 
th is  size w i l l  not produce an answer, as to whether these agents
are implicated in carcinogenesis.
Many previous, s im ilar  sero-epidemiological studies, into  
associations with cervical carcinoma, conclude that fu r th e r  more 
specific  research is required, to implicate any organism in 
carcinogenesis. The choice of which antibody test to use to 
indicate previous in fe c tio n , can greatly  influence prevalence 
estimates. Generally, microimmunofluorescence techniques w il l  
give considerably higher numbers with evidence of previous 
infection to C. trachomatis, than complement f ix a t io n  (C .F .)  
tests (64 ) .  In one study, 56% of patients had anti chlamydial 
C.F. antibodies, but 81% of the same patients , had pos itive
immunoflorescent t i t r e s  (65 ) .  I t  is most important, that  
comments and conclusions are confined to the group of patients  
under study, a l l  who have the same tests and are comparable.
Comparison of study and control groups, does reveal that  
previous infections with a l l  three agents, are more prevalent in 
the carcinoma group, but s ta t is t ic a l  s ignificance is not
reached. S im ila r ly ,  those with more than one previous in fe c t io n ,  
although more common in the study group, do not constitute  an 
id e n t i f ia b le  high r isk  group. Much of the d iffe rence , is due to 
the greater prevalence of C. trachomatis in the study group. The 
concept of synergy between two or more agents to i n i t i a t e  and 
promote carcinoma, is a t tra c t iv e  (49 ,50 ) .  There is l i t t l e  
evidence from th is  work, to suggest these agents act in th is
way. D e f in it iv e  comments on synergy between organisms, cannot be
made on data such as these. Patients who have had cervical  
cancer, also appear to have had exposure to more sexual 
pathogens, than other patients . No extremely high risk  group has
emerged. To exclude HPV from consideration of synergy, is to 
omit a powerful aetio log ica l contender. At present, there is no 
r e l ia b le  way of indicating prior HPV in fec tion , by serological 
means (72 ).  S im ilar work with cervical in tra e p ith e l ia l  
neoplasia, does not indicate evidence of synergism between HPV 
and any of these other agents (Walkinshaw, Roberts and Cordiner, 
unpublished observation).
The influence of socio-economic status, may be overlooked in 
studies such as th is .  When dealing with genital pathogens, 
social a ttitudes to sexual promiscuity, are very important in 
the rate of spread of the disease. Spread of Chlamydia, whether 
genital or e x tra g e n ita l ,  w i l l  be more rapid in conditions of 
poor hygiene, overcrowding and sexual promiscuity. While sexual 
behaviour may not equate with socio-economic status, the other 
aspects of re la t iv e  or absolute poverty, may considerably a ffe c t  
s ero p o s it iv ity  rates.
Socio-economic groups 2 through to 5, are well represented in 
the control data. Although a ll  se ro p o s it iv ity  is more common, in 
SE group 4, there are differences in the p ro f i le  of in fec tions .  
HSV se ro p o s it iv ity ,  appears less linked to SE status, than CMV. 
Among the control pa tien ts , seventyseven percent of SE 4 ,5 ,6  had 
antibodies to CMV, whereas only 54% SE 1 ,2 ,3 ,  had antibodies to 
CMV. Others, however, have found that CMV,is not correlated to 
social cl ass,and only HSV 2 is more prevalent in lower SE groups 
(54 ) .  Such large variations in the normal population, with change 
in SE group, render studies such as that by F u c il lo  e t . a l .  (53) 
which u t i l is e  case control matching, of greater value. This 
study confirmed an association between cervical carcinoma and
CMV. Other population studies, which may appear to confirm an 
association (5 4 ) ,  have less value unless they are very large.
Age is another extremely important var iab le , in the rate  of 
seroconversion to CMV. G r i f f i th s  and Baboonian, have shown a 
progressive increase in s e ro p o s it iv ity ,  during childbearing  
years. They found only 40% of a large population of women 
seropositive under 16 years, but th is  percentage increased to 
over 80% seropositive over 41 years (55 ) .  Others have confirmed 
th is  finding (54 ) .  Alexander has suggested th is  organism is 
sexually transmitted (175), but eighty percent of normal women, 
are un like ly  to be infected solely  by a venereal vector of 
transmission. These data confirm th is  re lationship  of CMV 
sero p o s it iv ity  to age, but as a womans sexual behaviour, is 
usually determined by her midtwenties, i t  is un like ly  that CMV 
is transmitted solely by venereal contact.
The re la tionsh ip  of increasing s e ro p o s it iv ity  to age, does 
not apply to HSV. Vestergaard e t . a l .  have shown higher 
proportions of cervical cancer pa tien ts , than controls have 
antibodies to HSV type 1 and type 2; With a more impressive 
re lationsh ip  to type 2 antibody (54 ) .  The study reported here, 
has involved complement f ix a t in g  antibody to HSV, and th is  is 
not type sp ec if ic .  Recent data, however, implicates both type 1 
and type 2 HSV in genital herpes (176), and perhaps i t  is now 
valid  to consider both as oncogenic. The m ajority  of people with 
HSV CF antibody, w il l  have produced, th is  due to oral herpes and 
have had no previous genital herpetic lesion. But to consider 
only type 2 HSV, w i l l  ignore the increasing group who have 
genital herpetic lesions due to HSV type 1.
I t  is because of the high prevalence of HSV antibodies, that  
these data are not helpful in id e n t if ic a t io n  of differences  
between controls, and carcinoma patients.
Chlamydia trachomatis, on the other hand, is an organism 
with a considerably lower seropositive prevalence. The micro- 
immunoflorescent te s t ,  however, is more specific  for the 
organism than the CF te s t .  Because of the lower prevalence, th is  
organism is more noticeable in the study group, than the control 
group and i t  appears that both alone, and in combinations with 
the other organisms, th is  agent is more frequently  encountered 
in the cervical cancer group. This f ind ing , i l lu s t ra te s  the 
d i f f i c u l t y  that studies such as th is  encounter. Although the 
agent is more frequently  found associated with cervical cancer, 
is th is  a causal ro le ,  or a casual association due to both 
conditions arising in the same high risk patient? A more f u l l  
discussion on the rates of iso lation  and s e ro p o s it iv i ty ,  is
given on these data in the next chapter.
Two in teresting  observations have arisen from this study. 
F i r s t ly ,  the presence of evidence of p rior infection with C. 
trachomatis, is more prevalent in patients with advanced and 
poorly d i f fe re n t ia te d  tumours. This is especia lly  true in the 
young woman who develops a poorly d if fe re n t ia te d  tumour.
Possibly C. trachomatis is a co-factor in tumours in the young 
woman, but is less important in the older woman. The large  
numbers of older women, however, have rendered th is  association  
less apparent. C. trachomatis in fe c tio n , re lated  to tumour 
d i f fe r e n t ia t io n ,  may be an indication that advanced disease
accompanies the increased sexual promiscuity, that chlamydial
in fection  implies. The a lte rn a tive  is that Chlamydia does modify 
the natural progress of the disease.
Secondly, the concept of d i f fe re n t  aetio log ica l factors in 
older women developing cervical carcinoma, finds support in th is  
work. In the control group, the prevalence of antibodies to a l l  
three agents, is greater in women over the age of 55 years, when 
compared to the study group. This contrasts with the younger 
woman, in whom the highest prevalences of p rior infection are 
found, in the study group. The older woman may have a less 
sexually re lated  disease.
TABLES FROM CHAPTER 5
TABLE 13
Patient de ta ils
n mean age at mean age at mean p a r i ty
sampling(SD) diagnosis(SD) (SD)
STUDY 100 5 8 .7yrs.
CONTROLS 100 53.5yrs.
n SE1 SE2 SE3
STUDY 100 2 12 23
CONTROLS 100 3 14 31
TABLE 14
Tumour stage and d iffe ren t! ’ a t i  
n=100
STAGE 1 44
STAGE 2 31
STAGE 3 17
STAGE 4 4
STAGE UNK.4
(12 .3 ) 5 3 .4 y rs . (11.85) 3 .44 (2 .40 )
16) 2 .93 (1 .
SE4 SE5 SE6 SEunknown
39 18 3 3
31 13 4 4
WELL DIFFERENTIATED 18 
MOD DIFFERENTIATED 24
POOR DIFFERENTIATED 38 
UNKNOWN 20
TABLES FROM CHAPTER 5
TABLE 15
Evidence ofprevious infection
n HSV+ CMV+ HSV+CMV+
STUDY 100 80 77 63
CONTROL 100 74 67 55
n Ch.+ Ch.+HSV+ Ch.+CMV+ Ch.+HSV+CMV+
STUDY 95 17 14 12 11
CONTROL 96 8 6 6 5
TABLE 16
Absolute values of t i t r e s  
n=100 fo r  HSV/CMV
n=95 fo r  Ch. study and n=96 fo r  Ch. controls
8 16 32 64 >64
HSV CMV Ch. HSV CMV Ch. HSV CMV Ch. HSV CMV Ch. HSV CMV C
STUDY 46 23 4 23 21 6 10 26 4 1 5 2 0 2 1
C0NTR0L25 27 2 35 24 4 13 11 2 1 4 0 0 1 0
TABLES FROM CHAPTER 5
TABLE 17
Antibody status re lated to stage and tumour d i f fe re n t ia t io n
n HSV+ CMV+ Ch.+ HSV+CMV+ HSV+CMV+Ch.+
WELL DIFF 18 11 11 4 6 2
MOD DIFF 24 24 20 2 20 2
POOR DIFF 38 29 29 9* 22 6
STAGE 1 44 37 33 7 28 5
STAGE 2 31 23 25 6 19 4
STAGE 3 17 13 15 3 11 3
STAGE 4 4 4 3 0 3 0
*  5/7 patients under 50 years with poorly d if fe re n t ia te d  tumours 
had antibodies to C. trachomatis
TABLE 18
Socio-economic status and antibody status
cont(c) study(s) HSV+ CMV+ Ch.+
n n (c) (s) (c) (s) (c) (s
SE 1 3 2 2 1 1 1 0 0
SE 2 14 12 10 9 8 6 1 2
SE 3 31 23 21 16 17 17 3 3
SE 4 31 39 25 33 25 33 2 9
SE 5 13 18 11 16 8 14 0 0
SE 6 4 3 2 2 4 3 1 1
SE unk .4 3 3 3 4 3 1 2
TABLES FROM CHAPTER 5
TABLE 19
Prevalence of antibody at d i f fe re n t  ages 
CONTROL GROUPS 
1 n=200
a g e (y rs .) HSV+(%) CMV+(%) HSV+CMV+(%)
<35 76 50(67) 20(26) 16(21)
35-44 24 15(63) 11(46) 8 (33)
45-54 74 52(70) 46(62) 38(51)
55-64 14 12(86) 13(93) 11(79)
65+ 12 8 (67) 9 (75) 6 (50)
n=l94
a g e (y rs .) Ch.+(%) HSV+CMV+Ch.+(%)
<35 76 11(14) 3 (4)
35-44 23 3 (12) 1 (4)
45-54 72 4 (6) 3 (4)
55-64 13 2 (15) 2 (15)
65+ 10 1 (10) 1 (10)
TABLES FROM CHAPTER 5
TABLE 20
Prevalence of antibody at d i f fe re n t  ages 
a) STUDY GROUP -  AGE AT DIAGNOSIS OF CARCINOMA 
1 n=100
a g e (y rs .) n HSV+(%) CMV+(%) HSV+CMV+(%)
<35 8 6 (75) 6 (75) 5 (62)
35-44 14 13(93) 9 (64) 8 (57)
45-54 24 20(83) 17(71) 15(62)
55-64 34 26(76) 30(82) 24(71)
65+ 20 15(75) 15(75) 11(55)
n=95
ag e (y rs .) n Ch.+(%) HSV+CMV+Ch .+(%)
<35 7 3 (43) 1 (14)
35-44 14 3 (21) 2 (14)
45-54 23 3 (13) 3 (13)
55-64 32 5 (16) 3 (9 )
65+ 19 3 (16) 2 (11)
STUDY GROUP -  AGE AT SAMPLING
n=100
a g e (y rs .) n HSV+(%) CMV+(%) HSV+CMV+(%)
<35 4 2 (50) 2 (50) 1 (25)
35-44 13 13(100) 8 (62) 8 (62)
45-54 10 9 (90) 7 (70) 6 (60)
55-64 39 29(74) 35(90) 28(72)
65+ 34 27(79) 25(74) 16(47)
n=95
a g e (y rs .) n Ch.+(%) HSV+CMV+Ch.+(%)
<35 3 2 (50) 0 (0)
35-44 13 3 (23) 2 (15)
45-54 10 3 (30) 3 (30)
55-64 37 3 (8) 2 (5)
65+ 32 6 (19) 4 (12)
CHAPTER 6
AGE RELATED ISOLATION AND ANTIBODY STATUS TO CHLAMYDIA
TRACHOMATIS
INTRODUCTION
Chlamydia trachomatis, is an extremely prevalent pathogen in 
the 20th. century. I t  is the cause of trachoma, the commonest 
preventable blindness, with around 500 m ill ion  cases worldwide 
(177). Some serotypes cause lymphogranuloma venereum, and 
genital carriage of the organism can lead to inclusion  
co n ju n c tiv it is  and non gonococcal u r e th r i t is .  Asymptomatic 
carriage, however, can a ffe c t  the greatest number of women, with 
rates of iso lation  of the organism of up to 16% of pregnant 
women (178). Most studies, however, indicate an iso la tion  rate  
of around 7% of sexually active females (59 ,179 ,180).
The role of C. trachomatis, in cervical carcinogenesis has 
already been discussed, and th is  at present, is unproven. I t  is 
however, an agent, that is isolated in the woman who is also at 
r isk of developing CIN. As HPV is being increasingly recognised 
as a fa c to r ,  associated w ith , and possibly causal to CIN, so too 
may C. trachomatis be important. The data shown in these present 
studies, indicate that th is  organism is prevalent in the 
population studied, and th is  concurs with the work of others 
(59 ,64 ,65 ,66 ,67 ,178 ,179 ,180 ) .  I t  has been shown by G r i f f i th s  and 
Baboonian that the prevalence of s e ro p o s it iv ity  to CMV, was a 
fac to r  of age (55 ) .  S im ilar work on C. trachomatis is not 
ava ilab le , and although the infection is known to be prevalent 
in the younger more sexually active woman, the rate  in older and 
postmenopausal women is not c le a r ly  established (64 ,181).
The two previous studies, have supplied data on both 
iso lation  and serology to C. trachomatis, on a large body of
normal women. By pooling these data, i t  is possible to observe 
the female population, fo r  rates of iso la tion  and 
seroconversion, at d i f fe re n t  ages. I t  may be that there is a 
change in the prevalence of the organism, and thus a possible  
co-variable for cervical neoplasia.
PATIENTS AND METHODS
The study population consisted of 214 women, with no evidence 
of pathological vaginal discharge, cervical in fec tion , pelvic  
inflammatory disease or CIN. One hundred patients had both 
iso lation  and serology for C. trachomatis, 20 additional
patients had iso la tion  only, and 94 patients had serology alone. 
There were 120 patients who had iso lation  performed (age range 
was 16-56 years), and 194 serological patients (age range of
16-89 years).
The iso la tion  techniques, and antibody t i t r a t io n s  have been 
described in the previous chapters.
RESULTS
Twenty of the 194 patients (10.3%), were seropositive with 
t itres>=16 and 10 of 120 (8.3%), were iso lation  pos it ive .
Patients were grouped into 5 year age bands, ranging from under 
20 to over 80. There were few patients over the age of 60 years. 
The prevalence of sero p o s it iv ity  was ra re ly  below 10% for any 
age group up to 60 years, but there was a peak of 26% (6 /23 )  at
age 30-34 years. Only one subject was seropositive over the age
of 60 years. Data are displayed in table 21, and 10 year age 
bands are shown in f ig .  1.
Iso lation  was confined to younger more sexually active women, 
with no positive cases over the age of 39 years. The peak age
range of is o la t io n ,  was 20-24 years with 28% (5 /1 8 ) .  Data are
shown in table 22, and 10 year age bands in f ig .  2. Iso lation
and serology rates are re lated  to age in f i g . 3.
There was no predilection  for any socio-economic group. The 
mean p ar ity  of the iso lation  positive patients was 1.22 (S.D.
1 .0 9 ) ,  considerably lower than the mean p a r ity  of the 
sero-positive patients; 2.62 (S.D. 1 .7 4 ) .  This e ffe c t  is l ik e ly  
to be due to the difference in the ages of the two groups, 
rather than any e ffe c t  on f e r t i l i t y .
DISCUSSION
There is wide d is p a r i ty ,  in the iso lation  rates of C.
trachomatis in the l i t e r a tu r e ,  and overall th is f igure  of 8% is
in accord with many studies (59 ,64 ,179 ,180 ,181). I t  is 
surprising however, that the age range is so narrow, with such 
high percentages of young women affected; More than one in four  
women between 20 and 24 years affected. These women were a l l
asymptomatic and as the organism is predominately sexually
transmitted, the chance of exposure to the organism must be very 
high, among sexually promiscuous women. The prevalence at 
d if fe re n t  ages in th is  study, is in accord with the findings of
Khurana and co-workers (181), who found 18% of women up to 30
years, and 13% of women up to 40 years, iso la tion  pos it ive . No
patient over 40 years was iso lation  pos it ive . Chlamydia 
iso lation  from the g e n ita l ia  has, however, also been found in
the postmenopausal p a t ien t ,  who has had hysterectomy (182).  
Schachter and co-workers showed that antibodies to C. 
trachomatis are less prevalent with increasing age (64 ) .  
Complement f ix a t in g  antibody was found in 25.9% of women under
35 years of age, but in only 5.3% of women over 35 years of age. 
This difference was not seen in women tested with the 
microimmunoflorescent te s t ,  and the p o s s ib i l i ty  of change in 
sexual behaviour of the population, was raised as an explanation 
for th is observation.
We are probably witnessing a prevalence of C. trachomatis 
in fec tion , not previously seen in less sexually relaxed times. 
Sim ilar seropositive rates to the iso la tion  rates were seen, but 
these occurred a decade la te r .  Those patients who had both tests  
done, did not always have positive  serology when iso lation  was 
posit ive . Iso la tion  is l ik e ly  to be the more sensitive te s t .  One 
explanation fo r th is  observation, was suggested by Kalimo et a l . 
(6 6 ) ,  who f e l t  that asymptomatic carriage only stimulated local 
antibody in the cerv ix . I t  may take a decade of asymptomatic 
carriage, fo r antibody to be detected in serum by th is  
p art ic u la r  microimmunoflorescent te s t .  Other workers have found 
a s im ilar  lack of detectib le  antibody in iso lation  pos itive  
patients (179).
The finding in th is  study, of such high colonisation rates in 
control women, who are healthy, suggests that th is  organism may 
e ith er  be commensal in a number of cases, or i t  has possibly a 
long la ten t phase as suggested by Kalimo e t.  a l . (66 ) .  These
figures are very much higher, than those studies which indicated  
higher iso lation  rates in CIN patients , than controls. In two 
such papers, the prevalence rate  of C. trachomatis in control 
patients by iso lation techniques, was .8% and 1% respective ly  
(57 ,64 ) .  Such low prevalence rates may be a feature of matching 
of controls, especially  fo r sexual behaviour. In another paper,
Hare and colleagues showed th a t  Chlamydia was highly sexually  
transmissible with 18% of partners of men with NGU, harbouring 
Chlamydia on the cervix (183). The strongest evidence 
implicating C. trachomatis in aetiology of CIN, s t i l l  l ies  with 
the observation of high rates of CIN, in C. trachomatis
iso la tion  positive patients (184). This, of course, may be 
association and not aetiology.
Such infection rates as have been found here, would add
support to e ither pre-operative cervical culture fo r  C. 
trachomatis, or prophylactic an t ib io t ics  fo r  procedures such as 
termination of pregnancy, or laparoscopic hydrotubation. This 
would reduce the chance of a chlamydial pelvic infection
following the procedure. There is l i t t l e  doubt, that Chlamydia 
causes tubal damage, and that th is  is a cause of i n f e r t i l i t y  
(185). Patients with tubal i n f e r t i l i t y ,  have the highest rates  
of positive  chlamydial t i t r e s  (186).
There appears to be a high ' in fe c t io n 1 rate with C. 
trachomatis, on the cervix of young healthy women. There is a 
lag time to the development of systemic antibodies. These high 
rates in young women, and low rates fo r iso la tion  and serology 
in the older woman, may suggest one of two things; E ither the 
immunological memory for C. trachomatis, f a l l s  below the
s e n s it iv i ty  of th is  te s t ,  with the passage of time, or indeed of 
much greater importance, C. trachomatis is a much more prevalent 
cervical organism than in the past. I f  th is  is so, an increase 
in Chlamydia related problems such as s a lp in g i t is ,  c e r v ic i t is ,  
and possibly CIN, may be inev itab le . I f  C. trachomatis is an
important co-factor in aetio logy of cervical neoplasia, then i t  
is l ik e ly  to be considerably less important in the older 
patien t ,  where i t  is more ra re ly  detected.
TABLES FROM CHAPTER 6
TABLE 21
S ero pos itiv ity  to C. trachomatis re lated to age
AGE GROUP NUMBER SEROPOSITIVE %
<20 years 10 0 0
20-24 years 18 2 11
25-29 years 25 3 12
30-34 years 23 6 26
35-39 years 14 2 14
40-44 years 9 1 11
45-49 years 24 0 0
50-54 years 48 4 8
55-59 years 8 1 12
>60 years 15 1 7
TOTAL 194 20 10.3
TABLE 22
Iso lation  of C. trachomatis re lated to age
AGE GROUP NUMBER CULTURE POSITIVE %
<20 years 10 0 0
20-24 years 18 5 28
25-29 years 25 2 8
30-34 years 22 2 9
35-39 years 14 1 7
40-44 years 6 0 0
45-49 years 10 0 0
50-54 years 13 0 0
55-59 years 2 0 0
>60 years 0 0 0
TOTAL 120 10 8.3
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SUMMARY TO SECTION 2
The purpose of the investigations in th is  section, has been 
to re la te  agents, which are associated with cervical neoplasia, 
to age of the pa t ien t .  The microbiological in su lts ,  to the lower 
genital t r a c t ,  are d i f fe re n t  as age progresses; Sexual 
intercourse, a f te r  the menopause, is less frequent. Cessation of 
menstruation, removes both the curettage e f fe c t ,  and the need 
fo r tampons which are an ideal culture medium ( c . f .  toxic  shock 
syndrome). The barriers  to in fection are less e f fe c t iv e ,  as
hormone deficiency becomes established, a f te r  the menopause.
In comparison to the childbearing years, the cervix is in a 
d if fe re n t  microbiological environment a f te r  the menopause. An
environment in which carcinoma more frequently  develops. The
fac to rs , however, that are strongly associated with cervical
neoplasia, namely HPV, HSV type 2 and possibly C. trachomatis, 
are ra re ly  found in the older woman. The postulate, is of 
a lte ra tio n  in genetic composition, many years before 
manifestation as carcinoma.
The e f fe c t  of age on is o la t io n , or evidence, of these agents, 
has been addressed by these studies in th is  section. HPV gives 
evidence of i ts  presence by, h isto log ica l or cytological 
techniques, only in pre-invasive disease. To determine that HPV 
is associated with a cervical carcinoma, requires DNA-DNA 
hybrid isation . This indicates the presence of DNA homologous to 
the DNA found in certain types of HPV. Investigation of HPV, by 
techniques other than in situ  hybrid isation , necessitates use of 
patients with CIN, rather than carcinoma. Relating the presence 
of HPV changes, to age at detection of CIN, gives some
indication of the influence of HPV, on rate at which
carcinogenesis develops. This agent may hasten the development 
of carcinoma, by i ts  action as a co-factor (49 ).  S im ila r ly  the 
carcinoma may develop la te r  in l i f e ,  with age as a co -fac tor .  A 
small, and in s ig n if ican t decrease in age at diagnosis of CIN, 
was seen in CIN 1 and 3. The population samples are probably not 
large enough for th is  point to be c le a r ly  made.
I t  is important that HPV was not found in any control
pat ien t ,  cy to lo g ica l ly ,  c l in ic a l ly ,  (or colposcopically in 24%), 
and th is  confirms HPV as a r isk  factor fo r  CIN. No HPV was found 
in the menopausal patients , who a l l  underwent colposcopy and 
cytology (chapter 4 ) ,  neither was i t  found in the control
patients to chapter 5 who had cytology.
HPV is an infrequent finding in older women.
There is ind irec t evidence of the protective e f fe c t  of the 
sheath, with very low rates of usage in the groups with HPV 
(chapter 4 ) .  Other workers have found that b a rr ie r  contraception 
prevents an anaerobic s h i f t  in cervical f lo r a  (187), and a 
protective e f fe c t  to cervical carcinoma is known.
There was confirmation that cervical inflammation may give 
r ise  to abnormal cytology, and the value of pre-colposcopic 
cervical culture and treatment was shown.
A more pronounced e ffe c t  of age, on rates of iso la t io n , than 
that due to HPV, was seen with C. trachomatis. The ages of 
iso lation  positive patients was younger than iso lation negative 
women, fo r a l l  groups (chapter 4, table 10). As th is  observation 
was equally evident in the control group, as the study groups, 
i t  appears l ik e ly  that both C. trachomatis, and sexual a c t iv i t y ,
are more closely re lated to youth, than any e f fe c t  due to C. 
trachomatis hastening the development of CIN.
The work of chapter 5, indicates th a t ,  although o v e ra ll ,  C. 
trachomatis previous in fe c tio n , is no more prevalent in the 
study than control group, there may be a difference in a small 
subset of women. A small cohort of women who are under 50 years 
and had poorly d if fe re n t ia te d  tumours, had a greater prevalence 
of antibodies to C. trachomatis.
The compiled data in chapter 6, do ind icate , th is  is an 
infection of the younger woman. Iso la tion  was not found in women 
over 40 years, and antibodies were ra re ly  detected in 
postmenopausal women. The s e n s it iv i ty  of the te s t ,  in detecting  
very low levels of antibody, in women who may have had in fection  
many years previously, may be low. The a lte rn a tive  explanation  
is that C. trachomatis is more prevalent in the population, due 
to a change in sexual practices, and fu rth e r  population e f fe c ts ,  
on f e r t i l i t y ,  and possibly CIN may yet be manifest.
The data available  for the postmenopausal women, although 
l im ited  in numbers, prove in te res tin g . There is no evidence, 
that postmenopausal women, are less prone to develop common 
vaginal in fections , than younger women. HRT s im ila r ly ,  did not 
improve the s itu a tio n , and indeed, more potential pathogens were 
isolated a f te r  HRT, than in the hormone d e fic ie n t  s ta te .
CHAPTER 7
VARIATION IN CERVICAL WATER AND CERVICAL HYDROXYPROLINE WITH AGE
INTRODUCTION
The success of cervical screening programmes in the U.K., has 
reduced the numbers of women, dying from cervical cancer, in the 
f i f t h  and sixth decades ( 1 ,4 ) .  There has been less benefit to 
women older than th is .  They are less l ik e ly  to avail themselves 
of cervical screening, and the screening process i t s e l f  may be 
less e f fe c t iv e .  I f  a cytological abnormality is found in the 
postmenopausal woman, often the f i r s t  diagnostic procedure is a 
cone biopsy. I t  is f e l t  that colposcopy has lim ited  value in 
these older pa tien ts , as often there is a fa i lu r e  to v isua lise  
the en tire  transformation zone. This raises the question of why 
the squamo-columnar junction (SCJ), recedes into the
endocervical canal as a woman ages.
The cervix of the postmenopausal woman, is smaller than that  
of the premenopausal woman, and the reduction in the cervical  
bulk tends to make the SCJ recede into the canal (135).  
Eversion, due to opening of the bivalve speculum, is less in the 
t ig h t  postmenopausal vagina, and may cause more distress or even 
trauma (188). Ostergard found the SCO in the canal of 100% of 
patients over 60 years (103), and Paterson e t . a l .  could only 
v isualise  the SCJ in half  th e ir  postmenopausal patients (125).  
This study and the following study, investigate the cervical  
stromal structure in women of various ages, for factors relevant  
to the re -location  of the SCJ with age. The f i r s t  study 
investigates the water and collagen content near the SCJ, and 
deeper in the cervical stroma. I t  also assesses the influence of 
exogenous oestrogens on both these cervical components. The
second study, searches fo r differences in collagen d is tr ibu tio n  
in the cerv ix , throughout adult l i f e .
Each study u t i l is e s  a d i f fe re n t  approach to collagen 
quantita tion . The f i r s t  study, investigates the hydroxyproline 
content both per unit weight, and as a proportion of to ta l  
protein in the sample. Hydroxyproline is an amino acid, that is 
v i r tu a l ly  specific  to collagen, and as such is a re l ia b le  
indicator of collagen content. I t  has been variously reported as 
10% (111) and 12% (112) of collagen. Collagen represents 82% of 
the to ta l protein in the non-pregnant cervix (118), and 85% of 
dry weight in the non-pregnant cervix (112). Acid soluble  
hydroxyproline, on the other hand, accounts fo r only 28% of the 
non-pregnant cervix (111), and thus the m ajority  of collagen in 
the non-pregnant s ta te ,  is old, with acid stable cross-links  
(112). Measurement of the hydroxyproline content, is an 
established investigation of collagen content (110,111,112,  
118,119). The second study, quantitates collagen, by re ly ing on 
i ts  property of b irefr ingency, and quantitating  the transmitted  
l ig h t  of h isto log ical preparations.
PATIENTS AND METHODS
Cervical biopsies, were obtained from 76 women (age range 
22-85 years), who attended the menopausal, gynaecological and 
colposcopic c l in ic s  at the Western In firm ary , Glasgow. Written  
informed consent fo r cervical biopsy was obtained, and approval 
was granted by the Western Infirm ary Ethical Committee. All 
biopsies, were obtained from healthy tissue; In 64 p atien ts ,  
punch biopsy by Leech-Wiliiamson forceps was obtained, and the 
sample included a small piece of cervical epithelium. The biopsy
was taken on the ectocervix , several m il l im itre s  from the 
external os. In the remaining 12 p a t ien ts , biopsy was obtained 
at hysterectomy from the cervical stroma, .5 cm. deep to the 
epithelium at the SCJ. No epithelium was present in these 
samples.
Biopsies were immediately frozen, stored at -2 0 °  C un ti l  
analysed, (maximum storage period 3 weeks). The tissue was dried 
at 37°C fo r  one week, and weighed to determine dry weight. Ten 
m i l l i l i t r e s  of 6N HC1 was added, and incubated at 3 7°C  fo r  one 
week, to break down the t issue. One ml. of th is  solution in 6N 
HC1 is hydrolysed, by heating at 105°C in an o i l  f i l l e d  heating 
block fo r  16 hours, and the hydroxyproline in the hydrolysate, 
assayed by the method of Blumenkranz e t.  a l . (189). The protein  
content of the t issue, was estimated by the method of Lowry 
et. a l . (190).
The f i r s t  analysis was performed on punch biopsies, from 30 
patients of age range 25-85 years. In these patients , the 
hydroxyproline protein r a t io ,  was correlated to age and 
menopause.
In the second analysis, performed on punch biopsy specimens 
from 27 fu rthe r  patients , water content was evaluated from wet 
and dry weights. Hydroxyproline was compared to dry weight, to 
exclude varia tion  in cervical water with age. Hydroxyproline/dry  
weight r a t io ,  and percentage water, were correlated to age and 
menopause. The biopsies in the second analysis, were more 
t ig h t ly  controlled fo r  weight, with an attempt to obtain larger  
biopsies. I f  the dry weight of biopsy was <8mg. in e ith er  
analysis group, then results were excluded, as the e p i th e l ia l
mass (with no hydroxyproline) was considered to be too great,  
re la t iv e  to the stromal mass. The e f fe c t  of too great an 
e p ith e l ia l  mass, would be to fa ls e ly  lower the 
hydroxyproline/dry weight r a t io ,  but by exclusion of small 
biopsies, th is  e ffe c t  was minimal.
The same percentage water and hydroxyproline/dry weight ra t io  
measurements, were made on 7 punch biopsies, from women taking  
hormone replacement therapy. They were also made on 12 deep
biopsies of cervical stroma, obtained at hysterectomy fo r  benign 
conditions, other than prolapse. Pre and postmenopausal samples 
were compared.
RESULTS
In the f i r s t  group of 30 specimens, the dry weight range was 
from 3-31 mg.; Ten were excluded, as they had a dry weight less 
than 8 mg. The results on the remaining 20, are shown in table  
23. The mean hydroxyproline to ta l protein r a t io ,  fo r  the
premenopausal women, was lower than the same ra t io  fo r  
postmenopausal women. The corre lation  of ra t io  to age, was not 
s ig n if ic a n t .  As biopsies of comparable size were obtained from 
both pre and postmenopausal women, and the difference was s t i l l  
apparent, the e f fe c t  of the s l ig h t ly  th icker epithelium in the 
premenopausal pa t ien t ,  was considered minimal.
The second group analysed, were more closely matched fo r  
size, but s t i l l  the range was 5.4-29 mg. Three were excluded; 2 
fo r being under 8 mg., and one because c l in ic a l  data could not 
be traced. Twentyfour samples were thus included in the
analysis. Comparison of cervical water, between the pre and
postmenopausal samples, revealed a d ifference (premenopausal
mean 79.3% postmenopausal mean 75.9%, p<0.05; table 24). This 
d iffe rence , however, became apparent at the menopause, and was 
not a gradual decrease in cervical water with age. The 
hydroxyproline dry weight r a t io ,  is not dependent on cervical 
water, so th is  ra t io  is not affected by these d ifferences. This 
ra t io  is also shown in table 24, and i t  is not dependent on the 
other proteins present in the tissue. This ra t io  is simply a 
measurement of hydroxyproline in a given piece of t issue , and as 
such is perhaps a c learer re f le c t io n  of collagen content, than
the ra t io  comparing hydroxyproline to to ta l  protein .
In the second group, there were 13 premenopausal pa t ien ts ,  
and 11 postmenopausal patients . By summating the ra tios  fo r  both 
groups, there were s ig n if ic a n t  differences between mean 
hydroxyproline dry weight ra t io s ;  (pre .055, post .080; t=4 .12 ,
p<0.001). The correlation  c o -e f f ic ie n t  of age to hydroxyproline
content, was s ig n if ican t  (r= .742 ,t=5 .20 ,p < 0 .00 1 ).  As the age
increased, so also did the hydroxyproline content, ind icating  
greater collagen density with advancing age.
The f in a l  group of samples analysed, included 12 biopsies
taken from the deep cervical stroma, and 7 punch biopsies from
women taking HRT. Seven of the deep biopsies were measured wet
and dry, and the cervical water was found to be considerably
lower in the deep biopsies, when compared to sup erfic ia l  
biopsies. There was no decrease in water content with age. 
S im ila r ly ,  there was l i t t l e  varia t ion  in the hydroxyproline 
content with age, in the deeper biopsies ( tab le  25). In general, 
these biopsies had a hydroxyproline content, s im ilar  to that  
found in superfic ia l biopsies, in postmenopausal women. Cervical
water near the epithelium there fo re , appears var iab le , and is 
dependent on age. Deeper in the cerv ix , there is a collagenous 
core, with a water content that is not variab le  with age.
The samples from patients taking HRT, included three small 
biopsies ( tab le  26). However, despite th is ,  the hydroxyproline 
dry weight ratios remained high, and were in the range of the 
postmenopausal pa t ien t ,  and above the values found in 
premenopausal women ( c f .  table  24). The water content however, 
had risen almost to the levels seen in the premenopausal 
patients .
DISCUSSION
The aim of th is  study, is to account for the change in
appearance of the cervix with age. From the c l in ic a l  viewpoint,
the most important change, is the in a b i l i t y  to v isualise
colposcopically, the squamo-columnar junction in the older woman 
(103,125,135). Biopsies taken from th is  area, have shown 
differences between pre- and postmenopausal women. There is a 
change in the proportion of cervical water between these women, 
but th is  change appears to occur at the time of the menopause, 
and is not gradual. The diminution of ovarian stero ids, with 
th e ir  water reta in ing  e f fe c t ,  may be responsible for th is .  The 
e f fe c t  of such a change, w i l l  be to make the cervix more dense, 
and less amenable to manipulation, during colposcopic
examination of the endocervix.
The percentage cervical water content, found in this study, 
are s l ig h t ly  higher than the findings of other authors. K le iss l  
and colleagues, found 73% water in cervical biopsies, taken at 
hysterectomy in 5 women aged 29-41 years (111). Danforth et a l .
found 74.4% cervical water in non-pregnant subjects (118), but 
both these studies used f u l l  thickness blocks, obtained at 
hysterectomy. Such figures are in agreement with the data 
obtained in the deep biopsy group, in th is study. One study
obtained cervical t issue, by a rotating  needle biopsy of cerv ix ,  
a technique y ie ld ing  s im ilar  tissue to the present punch biopsy 
study. This found an 80.8% cervical water in premenopausal women 
(112). These f igu res , are closely in accord with the data in
this study for the premenopausal woman. Comparison of the values 
fo r postmenopausal women, is not ava ilab le , however animal 
models ind icate , that there is an increased water loss from
connective tissue with age (191).
These observations on cervical water, explain some of the
c l in ic a l  find ings. The cervix in the premenopausal woman, is
more oedematous (104), and in the subepithelia l layer has an 
abundant blood supply. Both of these w il l  reduce a f te r  the
menopause. These changes, appear confined to the stroma near the 
surface epithelium, as the cervical stroma core appears s im ila r  
irrespective  of age.
As the.water content, of the cervical stroma at the SCJ
decreases with age, the hydroxyproline concentration r ises . This 
is independent of the water content, as the ra t io  to dry weight 
confirms. This change is more a gradual one, and not as
dependant on the event of the menopause. The young patient  
has a th icker epithelium which, with age, gradually th in s ,  
especially  a f te r  the menopause (192,193). The biopsies included 
the epithelium, and th is  must have some e f fe c t .  By considering 
only biopsies of a reasonable s ize , th is  e f fe c t  is minimised.
The change in the hydroxyproline content is re a l ,  not merely 
apparent, but i t  only affects the stroma adjacent to the
epithelium. Deeper biopsies ( ta b le  24), show no d ifference with 
ageing, and the hydroxyproline values are s im ilar to those 
biopsies taken from the postmenopausal patients by punch biopsy.
Study of the data ava ilab le  on the anatomy of the cerv ix , do 
not read ily  explain these findings. Hughesdon, in a monograph, 
compiled from h isto log ica l study, f irm ly  believed in a 
peripheral layer of smooth muscle which was continuous with the 
myometrium, and the smooth muscle of the vagina (114). He 
believed th is  to be a functional layer, and relevant to the
process of cervical d i la ta t io n .  Danforth, although accepting the 
existance of a peripheral layer of smooth muscle (115), took a
d if fe re n t  view. He believed that d i la ta t io n  was due to the
breakdown of cervical collagen, with resu lting  urinary excretion  
of hydroxyproline (110,115,118,119).
The findings reported here, are compatible with both views. 
Collagen content per weight, is a re f le c t io n  of collagen 
density. This w il l  be increased, i f  there is a greater amount of 
collagen, or i f  there is a decrease in the other constituents of 
cervical stroma. The presence of smooth muscle w il l  decrease 
collagen density. I f  th is  is found round the periphery of the
cerv ix , i t  w i l l  have the e f fe c t  of producing lower 
hydroxyproline values, in the superfic ia l samples of young 
women. A fter the menopause, there are fewer nerves found in the 
cervix (100), and i t  seems reasonable to presume there w i l l  be 
reduced smooth muscle. This would increase the collagen density, 
without an increase in to ta l collagen. S im ila r ly ,  the
subepithelia l vessels regress a f te r  the menopause, and th is  may 
fu rthe r  increase collagen density. The cervix could atrophy by 
loss of smooth muscle f ib res  and tissue f lu id ,  without e ith er  an 
increase or loss in to ta l collagen. This would account fo r the 
impression found by others, that the cervix becomes more fibrous  
a fte r  the menopause (104).
Danforth's views of hormonal control of destruction of 
collagen, also explain these find ings. Oestrogen w il l  soften the 
'pregnant' cerv ix , resu lting  in the breakdown of collagen (121)
and collagenolysis c e r ta in ly  occurs in labour (111,194). I t  is
thus l ik e ly ,  that in the childbearing years, the cervical
collagen is being created and broken down continuously. Outwith 
labour, collagen f i b r i l s  are much more regular and not
disordered. However, with labour, the structure becomes
disrupted, and amorphous material is deposited (195). I t  is the 
f ib ro b la s t  which controls collagen and ground substance
synthesis, and i t  is able to control collagen content, by
decreasing collagen synthesis, and increasing ground substance, 
in addition to the reverse. Prostaglandins are able to influence  
th is  balance and so too may ovarian steroids (196).
After the menopause, when the oestrogen stimulus is 
considerably reduced, collagen is l ik e ly  to be more stable, with 
more cross linkages, and consequently a greater proportion of 
insoluble collagen (193,197).
The collagen content in the deep cervical stroma, appears 
l i t t l e  influenced by advancing age. The percentage cervical  
water at th is  depth, is in accord with the findings of others on 
biopsies from s im ilar  sites (111,118). From th is  study, at the
depth of 0.5 cm. from the epithelium, the more dense collagen 
matrix does not a ffec t  the m a l le a b i l i ty  of the cervix at 
colposcopic examination.
The findings on the patients receiving HRT, suggest the water 
content is s im ilar  to the premenopausal woman, probably 
indicating the f lu id  re ta in ing  properties of the ovarian 
steroids. The collagen content, is unaffected by HRT. The 
findings of chapter 2, indicate that HRT improves the v i s i b i l i t y  
of the SCJ in menopausal women. I t  may be that tissue oedema, 
induced by ovarian stero ids, aids manoeuverability and 
m a lle a b i l i ty  of the cerv ix , without a s ig n if ican t  contribution  
from a decrease in the collagen content. I f  collagen, in the 
cervix of the older woman, is stable with many cross linkages, 
i t  may not be amenable to degradation and resynthesis, as 
happens in the younger woman.
This hypothesis, is somewhat at variance with other data on 
skin collagen. Collagen is known to be responsible fo r skin 
e la s t ic i t y ,  and is thought to decrease with age, both per dry 
weight and per skin area (198,199). Oestrogen has effects on the 
dermis of the skin, and in primates, w i l l  cause increase in 
water and glycosaminoglycans (200). This is s im ilar  to the 
findings in HRT treated women in th is  study. Further evidence 
suggests, that oestrogen may speed up the process of 
polymerisation of soluble to insoluble collagen (201), and 
oestrogen treatment, may increase dermal thickness (202). Recent 
work, has suggested that HRT w il l  increase to ta l skin thickness 
collagen content (124,203). This suggests, that oestrogen is 
responsible fo r synthesis of collagen, and possibly also the
decrease in collagenolysis in the skin. Indeed th is  is its  
e ffe c t  in increasing m ineralisation of the skeleton (122). The 
current study, has not investigated the to ta l collagen content 
of the cerv ix , and c e r ta in ly  the postmenopausal p a t ien t ,  usually  
has a considerably smaller cervix than the premenopausal woman. 
The to ta l collagen content of the cerv ix , may be lower in the 
postmenopausal pa t ien t ,  and consequently HRT may indeed increase 
the to ta l collagen content in the cerv ix . This study has shown 
that i t  does not increase collagen density.
In addition to tissue water, the important point as regards 
v isualisation  of the SCJ, is not to ta l collagen of the cerv ix ,  
but collagen density near the epithelium.
One last factor which should be mentioned, is the p o s s ib i l i ty  
that biopsies may contain glandular t issue. Such a f in d in g ,  
would be more l ik e ly  in the younger woman, and th is  would 
increase the water content, and reduce the hydroxyproline dry 
weight ra t io .  The following study, w i l l  refute  th is  as a cause 
of reduced collagen ra tios  in the younger pa t ien t .
TABLE 23
TABLES FROM CHAPTER 7
Hydroxyproline protein ra t io  from cervical biopsies
PREMENOPAUSAL POSTMENOPAUSAL
AGE WEIGHT OHP/PROTEIN AGE WEIGHT OHP/PROTEIN
MG. mg.
25 11.3 .0216 47 10.0 .0937
26 20.0 . 0343 49 13.5 .0710
30 17.0 .0560 50 10.3 .1560
31 18.0 .0739 52 10.4 .0402
31 10.4 .0270 52 11.6 .0759
32 12.5 .0342 53 10.0 .0413
38 29.0 .0271 60 20.4 .0689
41 24.6 .0560 66 26.6 .0579
74 21.0 .1291
76 14.2 .0795
77 31.5 .0752
MEAN OHP/PROTEIN RATIO 
,0468(S.D..0277)  
t = 2 .35 ;p<0.05
85 .075021.2
MEAN OHP/PROTEIN RATIO 
.0803(S. D..0333)
TABLES FROM CHAPTER 7
TABLE 24
Hydroxyproline dry weight ra t io  in cervical biopsies
PREMENOPAUSAL POSTMENOPAUSAL
AGE WET DRY %H20 OHP/ AGE WET DRY %H20 OHP/
WT.mg. WT.mg• DRYWT. WT.mg.. WT.mg• DRYWT
22 49.0 9.8 80 .031 43 50.8 10.5 79.3 .048
23 70.0 14.6 79.2 .034 49 85.8 18.9 78 .069
24 88.0 19.5 77.9 .056 50 90.6 21.2 76.6 .099
25 141.0 29.0 79.2 .068 53 108.2 27.6 74.5 .080
27 116.0 12.7 89 .039 56 98.6 25.1 74.5 .100
30 60.5 20.0 67 .055 60 73.1 17.8 75.6 .079
31 125.0 24.2 80.6 .050 61 64.1 15.6 76.6 .087
31 41.8 8.8 79 .068 62 89.5 22.5 74.9 .084
32 109.2 18.2 83.3 .055 67 100.0 24.2 75.8 .066
37 96.4 19.4 79.9 .067 69 62.8 16.1 74.4 .087
37 135.0 27.6 78.1 .058 79 47.5 11.8 75.2 .085
44 74.8 16.4 78.1 .049
45 114.0 23.4 79.5 .085
MEAN OHP/DRY WT. RATIO MEAN OHP/DRY WT. RATIO
.055 (S.D .. 015) .080 (S. D. . 015)
t=4. 12;p<0 .001
CORRELATION COEFFICIENT AGE Vs. OHP/WT. r= .742;t=5.20;p<0.001  
MEAN %H20 7 9 .3 (SD 4 .7 )  MEAN %H20 75.9 (SD 2 .2 )
t = 2 .2: p<0.05
TABLES FROM CHAPTER 7
TABLE 25
Hydroxyproline dry weight ra t io  and cervical water in deep 
biopsies
AGE WET WT. DRY WT. %H20 OHP/D
mg. mg.
26 23.7 7.6 67.9 .092
27 14.4 - .083
32 17.5 6.5 62.9 .092
40 19.5 - .052
43 60.5 16.0 73.6 .075
46 37.8 - .083
47 14.7 - .097
59 64.0 18.3 71.7 .066
60 21.3 - .076
64 94.7 27.6 70.9 .065
72 25.3 8.1 68.0 .086
76 46.1 10.3 77.7 .068
mean %H20 70.4 (SD 4 .7 )
mean OHP/DRY WT. .078(S .D ..013)
TABLES FROM CHAPTER 7
TABLE 2 6
Hydroxyproline dry weight ra t ios  and cervical water 
taking HRT
AGE WET WT. DRY WT. %H20 OHP/D
mg. mg.
45 20.1* 4.4 78.1 .091
50 122.0 26.6 78.2 .083
51 66.1 15.2 77.0 .066
51 30.3* 6.2 79.5 . 065
52 118.2 25.9 78.1 .069
53 19.6* 4.2 78.6 .071
63 42.5 11.8 72.2 .085
*-sman biopsies 
MEAN %H2077.4 (SD 2 .4 )
MEAN OHP/DRY WT. 0.076 (SD 0.010)
women
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CHAPTER 8
VARIATION IN THE COLLAGEN CONTENT OF THE CERVIX AT THE 
SQUAMOCQLUMNAR JUNCTION
INTRODUCTION
The previous study, inferred collagen presence by detection  
of hydroxyproline. D irect microscopic examination of sections of 
cervical stroma, does not c le a r ly  show collagen when viewed
under scattered l ig h t .  I f ,  however, the section is illumuminated 
by polarised l ig h t ,  collagen is eas ily  recognisable ( f i g . 4 ) .  Due 
to being a coiled structure , collagen has the property of 
birefringency, and re fracts  l ig h t  in three dimensions. As such, 
i t  is eas ily  v is ib le  when illuminated by polarised l ig h t .  The 
in te n s ity  of the l ig h t ,  refracted by collagen, is much greater  
than l ig h t  transmitted by other structures. An image analyser 
can be used to measure the area of l ig h t  of a certain density, 
seen under the microscope. As collagen appears much brighter  
than other structures, the image analyser can eas ily  quantitate  
collagen. A quantita tive  analysis, comparable to quantity of
collagen present, is obtained. This method may be used, to 
compare h isto log ica l sections for collagen content, but i t  w i l l  
not y ie ld  results of absolute collagen content. Provided 
histo log ical sections are comparable, and examined under 
identical circumstances, then comparative estimations of 
collagen content, may be made. These estimations may be made on 
sim ilar cervical sections, at a range of ages, and the varia t ion  
in collagen, per area of microscopic f i e l d ,  can be ascertained. 
Such data w i l l  augment that found in the previous study.
METHODS
Histological sections of complete cerv ix , from women at a
range of ages, were examined. In order to obtain a f u l l  spectrum 
of ages, sections were chosen from routine surgical
histopathology, obtained over the period 1972-83, at the Western 
In firm ary , Glasgow. The ICD ( In ternationa l C lass if ica tion  of
Diseases) coded records, were searched for patients who
underwent hysterectomy, or removal of en t ire  cerv ix , such as at 
Manchester rep a ir .  The period of search was so large, in order 
to obtain a large enough population of older pa tien ts .
Indications for hysterectomy, are generally l im ited to
malignancy or prolapse in the e ld e r ly ,  and many of such
specimens were unsuitable.
From the 12 years searched, 182 patients were selected as 
l ik e ly  to y ie ld  sections, taken from an in tact and healthy
cerv ix , in which cervical collagen could be comparatively
assessed. Cervical sections from these 182 patients , were
examined microscopically, and c r i t e r ia  of a c c e p t ib i l i ty  were 
applied. These c r i t e r ia  for a c c e p t ib i l i ty  were as follows; 1) 
The tissue must be well prepared, and of equitable thickness. 2) 
The overlying epithelium must be healthy, and the SCJ must be
v is ib le  h is to lo g ic a l ly .  3) There must be no stromal disease or 
malignancy in the cerv ix , and there must be no large glands or 
Nabothian f o l l i c l e s ,  which obscure the cervical stroma.
The application of these c r i t e r i a ,  excluded 84 p a t ien ts ,  
leaving 98, suitable fo r  fu rther  analysis. The great m ajo r ity ,  
were from patients undergoing hysterectomy, although 18 patients  
had a procidentia.
The indications fo r  surgery, were usually menstrual problems 
in the pre-menopausal patients , postmenopausal bleeding or 
benign ovarian enlargement in the immediately postmenopausal 
patients , and prolapse in the old patien t.  As the cervix u te r i
was the area examined fo r  collagen, no patient had any cervical 
disease, six patients had neoplasia of the endometrium; In s itu  
in one, and invasive in f iv e .  There was no neoplasia at any 
other s i te .
The h isto log ica l sections, were id e n t if ie d  only by th e ir  
histopathology number, and were examined without knowledge of 
data from the p a t ie n t ,  from whom the section was obtained. Two 
areas in each slide  were examined by an image analyser (Optomax 
Image Analyser, Micro Measurements Ltd. f i g s . 5 and 6) The f i r s t  
f i e ld ,  known as the superfic ia l f i e ld ,  was selected immediately 
deep to the basement membrane of the cervical epithelium, at the 
squamocolumnar junction . A f ie ld  was selected which did not 
contain Nabothian f o l l i c l e s ,  or cervical glands, and which was 
representative of the collagen content of the cerv ix , beneath 
the epithelium. A second f i e l d ,  known as the deep f i e l d ,  was 
also examined. This was 3 mm. deep to the basement membrane in 
the cervical stroma. This also was representative of the 
collagen content in the cerv ix , at th is  depth from the 
epithelium. Both selected f ie ld s  from each s l id e ,  were examined 
under polarised l ig h t ,  th is  rendered collagen d is t in c t  from 
other t issue.
The image of each f ie ld  was recorded by a video camera, and 
relayed to an image analyser, which had the f a c i l i t y  to record 
transmitted l ig h t  as a d ig ita l  readout. The analyser could be 
programmed to respond to a large range of l ig h t  in te n s it ie s .  
Several sections were examined to obtain the l ik e ly  range of 
transmitted l ig h t ,  from highly collagenous tissue, to almost 
collagen free  t issue. When the analyser was programmed to
respond to th is  range of refracted l ig h t ,  the s e n s it iv i ty
settings were not changed for the examinations of study 
sections. A ll the sections, both superfic ia l and deep, were
examined at one session, and a l l  observations were made without
a lte r ing  video camera or image analyser.
The size of both f ie ld s  was 1.3 x 1.5 mm., and each was 
examined at x 32 magnification by the analyser camera. To reveal 
error due to a r te fa c t , such as dust in the lenses, three  
background counts with no h isto log ica l section were taken. These 
counts were 28, and the range of values for collagen in the 
sections examined in the study, was from 245 to 15467.
From each section, three recordings of the in te n s ity  of the 
refracted l ig h t  were taken from each f ie ld .  Although results fo r  
the recordings at superfic ia l or deep f i e l d ,  showed l i t t l e  
inter-observational v a r ia t io n , the mean was taken as the value 
fo r  the f i e l d .  The standard deviation of the three recordings 
from each f ie ld ,  was less than 1% of the value. The comparison 
of the sup erfic ia l and the deep resu lts ,  gives an indication of
the homogeneity of the collagen in the cerv ix , and allows an
impression of e ith er  increasing, decreasing, or s im ilar  collagen  
presence, with increasing depth below the epithelium.
Age, histology of the endometrium, and presence of 
procidentia, were correlated to these recordings. Only three  
patients received exogenous hormones; One receiving oestrogens, 
one norethisterone and one danazol. The e f fe c t  of these was
thought to be minimal. Data on p a r i ty ,  where ava ilab le , was
correlated.
RESULTS
The age range of the 98 patients from whom the sections were 
obtained, was 28 to 79 years. A mean count was obtained from 3 
analyses, in each f i e l d ,  fo r each section. There was a very 
large var ia t ion  in the quantity of collagen present, between 
d if fe re n t  sections, and the d is tr ibu tio n  of the counts was not 
normal, being skewed to the r ig h t .  Logarithmic transformation, 
rendered the d is tr ib u tio n  normal. Each count is transformed to 
the logarithm, to base e, and mean values to age ranges, 
histo log ical groups,etc. are compared.
AGE
The values obtained for each f i e l d ,  were grouped according to 
age, into decades from under 30 years to over 70 years. Table 
27, f ig .  7) i l lu s t ra te s  the varia tion  according to age. There 
was l i t t l e  varia t ion  in the deeper value with advancing age. 
However, the sup erfic ia l value increased until  the menopause, 
and then f e l l  somewhat. A paired students t  test comparing 
collagen in the deep f i e l d ,  to collagen in the superfic ia l  
f i e l d ,  showed s ig n if ic a n t ly  more collagen in the deeper f i e ld  
for each decade, but the level of confidence decreased with age. 
The collagen content, appeared to become more homogeneous with 
age. The mean superfic ia l value fo r the 30-39 year olds, was 
s ig n if ic a n t ly  lower than the mean sup erfic ia l value fo r  the 
50-59 year olds. A correlation c o e ff ic ie n t ,  of age to 
superfic ia l value was s ig n i f ia n t ,  p<0.05.
The same data can be viewed as a ra t io  of deep to superfic ia l  
readings. The ra t io  was taken as deep value-28, fo r background 
count/ sup erfic ia l value-28, and th is  was computed for each
p a t ie n t .  The mean r a t io ,  fo r  each 5 year age band, to age 
greater than 70 years, was evaluated and correlated to age 
( tab le  28, f ig .  8 ) .  A high ra t io  indicated a cerv ix , which 
became more dense in collagen, with increasing distance below
the basement membrane. A low r a t io ,  implied a more homogeneous 
d is tr ib u tio n  of collagen. This ra t io  was derived, from numbers 
which were not normally d is tr ib u ted , so a non parametric tes t  
was used. Correlation of age to th is  r a t io ,  using Kendalls
co e ff ic ien t  of rank co rre la t io n , was s i g n i f i c a n t ^ .  216 p<.0027. 
A corre lation  of ra t io  to age, in patients without procidentia ,  
was also s ig n if ic a n t .
These data, indicate that fo r  women aged 30 to 54 years, 
there is a progressive decrease in th is  ra t io  with advancing
age. This is not due to decreasing collagen in the deeper f i e l d ,  
but due to increasing collagen, in the superfic ia l f i e l d .  I t  
would appear, that collagen in the superfic ia l f ie ld  area, 
increases per unit area ( in  two dimensional sections), with 
advancing age un ti l  the menopause. The ra t io  remains f a i r l y  
constant a fte r  the menopause.
HISTOLOGY
Endometrial histology was available  fo r 83 of the 98 
patients. Three premenopausal and twelve postmonopausal 
patien ts , had unknown histology, usually as a resu lt  of no 
curettings being ava ilab le , at amputation of the cerv ix , during 
vaginal re p a ir .  Table 29 shows the ages, mean log values and 
comparisons between the groups. The premenopausal subjects were 
divided, by histo logy, into p ro l i fe ra t iv e  and secretory  
endometrium. The mean ages of the two groups, was s im ilar  as was
the sup erfic ia l value. The deep value, however, was 
s ig n if ic a n t ly  d i f fe r e n t ,  with more collagen in the luteal phase. 
The t h i r t y  patients with atrophic histology, had s im ilar  values 
to the patients with hyperplastic histology, suggesting l i t t l e  
e ffe c t  on collagen of the endogenous oestrogen. Numbers were,
however, small. Seven patients had endometritis, or neoplastic
histology but meaningful conclusions cannot be drawn from th is  
number.
PROCIDENTIA
There were 19 patients who had a c l in ic a l  diagnosis of 
procidentia, and 18 of these were postmenopausal, (mean age 69 
years). These p a tien ts , had s ig n if ic a n t ly  lower values fo r both 
the s u p e r f ic ia l ,  and deep f ie ld s ,  than the patients over 50 
years, who did not have procidentia. They were, however, 
considerably older ( tab le  30). Those postmenopausal patients  
with procidentia , had reduced collagen per unit area, and by
inference, lower collagen density, than postmenopausal patients  
without procidentia . This is l ik e ly  to be a re f le c t io n  of tissue  
oedema that accompanies procidentia.
PARITY
Data on p a r ity  was only available  fo r  26 pa t ien ts , due to the 
long accumulation period, during which patients records were no 
longer obtainable. The only feature which was thought to 
possibly a ffe c t  collagen content, was n u l l ip a r i ty .  There were 
very few nulliparous patien ts , and th e ir  values were not 
d if fe re n t  from the mean for th e ir  age group.
DISCUSSION
This method, fo r the h isto log ical estimation of collagen, by
examination under polarised l ig h t ,  was described by Danforth in 
1960 (110), and the use of spectrophotometric methods has been 
validated by other authors to quantitate  collagen (195,204). I t  
has not been used to quantitate the collagen content, at 
d if fe re n t  ages, nor have conclusions, about the var ia t ion  in 
collagen with age, been drawn from th is  investigative  l ine  
before.
Image analysers, are used to measure area of a given density, 
from electron photomicrographs (205,206). They are less su itab le  
fo r examining h isto log ica l sections, as the density of the 
structures is often too s im ila r ,  to allow quantitation of any 
one s tructure . This, however, is not the case with collagen, 
which is very much brighter than other structures, when
illuminated with polarised l ig h t .
I t  is c ru c ia l ,  to confidence in the study, that a l l
recordings were made at one session, and taken without 
a lte ra tio n  of the image analyser, microscope, or camera. This
avoids the p i t f a l l s  in the use of the image analyser, reported
by Bradbury (207). Pre-selection of these slides was essen tia l,  
but slides were examined without the knowledge of the age or 
other data.
These data have shown, that the values fo r collagen taken 
deeper in the cervical stroma, are very constant throughout a 
spectrum of ages (tab le  27). The main difference is in the
sup erfic ia l value, which varies considerably with age. The
values in the younger women, are lower and show a greater  
difference to the respective deep values, than those of the
older women. The ra t io  of deep to superfic ia l value, is a
re f le c t io n  of th is  change in sup erfic ia l value with age. This 
ra t io  becomes lower with age, indicating that collagen presence, 
is d is tr ibu ted  equally throughout the cerv ix . This has relevance 
to consideration of the v i s i b i l i t y  of the squamo-columnar 
junction . High superfic ia l values, such as those found in the 
older p a t ie n t ,  w il l  represent a cervix which is not amenable to 
manipulation. This renders examination of the en tire  
transformation zone d i f f i c u l t ,  or impossible. Lower sup erfic ia l  
values, as found in the younger women, whether due to decreased 
collagen, increased water, or more smooth muscle, w i l l  allow
greater cervical manoeuverability.
This information is in accord with that found in the previous 
study, and i t  affords numerical evidence, that the cervix has
greater collagen density deeper in the stroma than 
s u p e r f ic ia l ly ,  irrespective  of age.
Consideration only of the younger p a t ie n t ,  reveals an 
in teresting  phenomenon. A s ig n if ican t  d ifference, in collagen 
presence, in the deep f ie ld  is apparent between those with
p ro l i fe r a t iv e ,  and those with secretory histology, despite no
age difference between the groups. The increased collagen 
density in the lu tea l phase group, is in accord with c l in ic a l  
evidence suggesting a more r ig id  cervix in the lu teal phase of 
the cycle (108,208). The continual synthesis, and breakdown of 
collagen, induced by oestrogen, is l ik e ly  to be responsible fo r  
th is observation (201).
Lower sup erfic ia l and deep values, over the age of seventy, 
can possibly be explained by the group with procidentia , having 
more oedema, in the prolapsed cerv ix . With age, the collagen in
the cervix would become more s tab le , with more cross linkages, 
and would give higher values at both f ie ld s .  This was found up 
to age 60 years. Above th is  age, collagen presence decreases, 
and th is  is the influence of the large proportion of women with 
procidentia, in th is  age group. By v ir tue  of tissue oedema and 
cervical hypertrophy,the collagen f ib res  are dispersed, and th is  
results in a decreased density of collagen, and lower values.
In the c l in ic a l  context, i t  is the woman aged 50 to 60 years 
who presents the colposcopist and cytologist with the greatest 
problems. In th is  age range, cytological and colposcopic 
abnormalities are not uncommon, but complete examination of the 
transformation zone, by e ith er  diagnostic method, is ra re ly  
assured, due to the re traction  of the SCJ into the endocervix. 
This study, indicates that at th is  age range, the collagen 
presence immediately below the SCJ is greatest. This renders the 
cervix less compliant, and mitigates against the success of 
colposcopic examination.
These data, and those from the previous chapter, w i l l  be 
discussed in the l ig h t  of other findings of th is  work, in the 
summary.
TABLES FROM CHAPTER 8
TABLE 2 7
Comparison of sup erfic ia l and deep values by age
AGE(yrs) n log sup log deep paired t  confidence
mean(SD) mean(SD) tes t P
20-29 3 7.95C.62) 8 .62 ( .1 2 ) n.s
30-39 24 *7 .4 4 (1 .0 4 ) 8 .4 2 ( .5 6 ) 5.63 .001
40-49 16 7.81 (1 .03 )
00<x>LOCO 5 .47 .001
50-59 25 * 8 . 1 8 ( .74) 8 .5 8 ( .52) 4.52 .001
60-69 12 8 .0 2 ( .7 4 ) 8 . 46 ( .67) 2.87 .05
70+ 18 7 .6 9 ( .95) 8 .0 9 ( .66) 2.62 .05
*30-39 vs 50-59 mean superfic ia l value t=2 .82 , p<0.01
TABLES FROM CHAPTER 8
TABLE 2 8
Deep, sup erfic ia l ra t io  by age
age(yrs) n (deep value -28 )
(su p erf ic ia l  value-28)mean (S .D .)
25-29 3 2 . 1 2 ( . 73)
30-34 15 3.86 (3 .31 )
35-39 9 3 .64 (2 .08 )
40-44 6 2 .46 (1 .25 )
45-49 10 2 .49 (1 .41 )
50-54 18 1 .5 7 ( .87)
55-59 7 1 .9 4 ( .7 2 )
60-69 12 1 .80 (1 .06 )
70+ 18 1 .86 (1 .36 )
Kendal Is coeffic ient of rank
TABLES FROM CHAPTER 8
TABLE 29
Comparison of values by histology
HISTOLOGY n log sup log deep mean age
mean(SD) mean(SD) yr s.
p r o ! i f . 26 7 .64 (1 .19 )
*3"tO.CO•CO 40.7 ) t = 2 .14
secret. 11 7 .8 3 ( .9 2 ) 8 .7 9 ( .6 9 ) 39.6 ) p<0.05
atrophic 30 7. 75 (.93) 8 . 28 ( .78) 60.8
hyperplas. 9 7 .8 4 ( .4 3 ) 8 .3 8 ( .25) 50.1
TABLE 30
Collagen and procidentia
log sup log deep mean age
n mean(SD) mean(SD) yrs •
PROCIDENTIA >50 18 7 .79 ( .8 2 ) 8 .0 8 ( .6 2 ) * 69.0 ) t = 2 . 72
NO PR0CIDENTIA>50 37 00 • o 00 • 00 ro 8 .5 5 ( .5 8 ) * 59.7 )p<0.01
FIGURE 4 -COLLAGEN UNDER POLARISED LIGHT 
photomicrograph
m W C  6 - , ,M E  mOMSCWE „  CABEBJ
FIGURE 6 -IMAGE ANALYSER
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Collagen content ratio by age
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ELECTRON MICROSCOPY OF CERVICAL STROMA
Three punch biopsies were obtained, one from a premenopausal 
woman,one from a postmenopausal woman, and one from a 
postmenopausal woman taking HRT. The fresh specimens were 
transported to the pathology laboratory where Dr. Rod Denholm 
performed electron microscopy on the specimens. The intention  
was to scan the collagen in the stroma,to see i f  there was any 
appreciable d ifference in the appearance of the collagen, 
especia lly  with reference to cross linkages. When the electron  
photomicrographs were compared,there was no obvious difference  
in the q u a lity  of the collagen,in  the three biopsies. As th is  
was a time consuming and expensive task, i t  was f e l t  that there  
was l i t t l e  point in pursuing th is  investigative  l in e .
SUMMARY TO SECTION 3 
The aim of the work reported in th is  thes is , has been to 
i l lu s t r a te  the differences in the cervix u teri of the older 
woman,to that of the younger woman.
The work in chapters two and three, has shown that colposcopy 
is of less value in the older woman, than younger women, but HRT 
w il l  increase th is  value. Doubts as to the effectiveness of 
cervical cytology in the older woman were raised. Other authors, 
have also had doubts, as to the effectiveness of screening the 
older woman (209), but these doubts are mainly founded on the 
reluctance of the postmenopausal pa t ien t ,  to attend for  
screening. Other worries on the ease of obtaining and 
in te rp re ting  a smear, have also been expressed (151). The 
f ind ing , that there is a fa i lu r e  of ex fo l ia t io n  in the older 
woman with CIN, has not had wide exposure or analysis.
I t  is ,  however, f e l t  that fa i lu r e  of cervical cytology to 
detect lesions in the older pa tien t,  is due to lesions being 
endocervical and not available  to cytological sampling. Special 
spatulae have been designed to sample the endocervix, and these 
are undergoing evaluation at present (23 ) .  There is no doubt, 
that the SCJ re tracts  into the endocervix with age. Two studies, 
in chapters 7 and 8, have endeavoured to f ind  changes, in the 
cervical stroma, which occur with age, which may account, at 
least in p a rt ,  fo r  th is  c l in ic a l  observation.
In addition to the re location , of the SCJ within the cervical  
canal with ageing, there is a change in the consistency of the 
cerv ix , which renders manipulation painful and d i f f i c u l t .  This
is p a r t ly  responsible fo r l im ita t ions  in screening. In extreme
cases, shrinkage of the stromal elements, can render the
cervical os stenosed and even occluded. The firmness of the 
cervix in the postmenopausal woman, rendered a suspicion that  
there was e ither a decrease in tissue water, or an increase in 
collagen density, or both. Changes in cervical water occur both 
within the menstrual cycle, and during pregnancy and labour. A 
change in cervical water seemed l ik e ly ,  as the hormonal milieu  
changed at the menopause. This was confirmed by measurement of 
dry and wet biopsies, and the c r i t i c a l  event to th is  change, was 
the menopause i t s e l f ,  and not age as such. Administration of HRT 
quickly reverted the water content to that of the premenopausal
woman, while having l i t t l e  e f fe c t  on the collagen content. The
cervical water, deeper in the cervical stroma, was s im ilar  in
pre- and postmenopausal women, and the cervical core i t s e l f ,
appears less influenced by c ircu la tin g  hormones.
This observation, in part explains, why the cervix is so fte r  
and more maleable in the younger woman, and also why the SCJ is 
more frequently  visualised in women taking HRT.
Observations on the collagen content, were made using two 
d if fe re n t  approaches, one biochemical, and the other 
h is to lo g ic a l.  The measurement of hydroxyproline as an indicator  
of the collagen content, is standard practice . I t  is generally
held that hydroxyproline, accounts fo r about 10% of the amino 
acid content of collagen. I ts  other advantage, is that i t  is 
present almost exclusively in collagen, and only as a trace in 
other proteins. I t  therefore correlates closely with collagen 
content. Hence many authors have used th is  measurement in
cervical studies (111,112,119). A corre lation  was observed 
between advancing age, and increasing hydroxyproline dry weight 
ra t io .  This indicates that the collagen density is increasing  
with age, at th is  s i te ,  ju s t  below the epithelium. There was the 
theoretica l p o s s ib i l i ty ,  that the th icker epithelium, in the 
younger p a t ie n t ,  would decrease the collagen content in punch 
biopsies. I t  was f e l t ,  that by including only biopsies of a 
reasonable s ize ,  this e f fe c t  would be minimised. The findings of 
increasing collagen with age, were confirmed by the h isto log ica l  
study.
This study used a d if fe re n t  approach, and th is  had not been 
used for th is  purpose before. Collagen, being b ire fr in g e n t , 
re fracts  l ig h t  in three dimensions, when viewed under polarised  
l ig h t .  This can eas ily  be detected by an image analyser. This 
technique has previously been described (204), but to use th is  
as a quantita tive  te s t ,  for comparing collagen contents, 
necessitated a l l  measurements, being performed under the same 
conditions, at the same time. Results were obtained which bore 
out the findings of the biochemical study. From both studies,  
there appears to be a l inear  re la tionsh ip , between the increase 
in collagen density, in the area immediately beneath the 
basement membrane of the epithelium, and advancing age. Both 
studies found very s im ilar collagen presence, deeper in the 
cervical stroma. There was, however, a s ig n if ic a n t  d ifference in 
the values obtained from the women with secretory endometrial 
histology, to those with p ro l i fe ra t iv e  histology, despite having 
the same mean age. This confers an explanation, on the c l in ic a l  
observation of increased firmness of the cerv ix , in the lu te a l
phase.
The r a t io ,  of the sup erfic ia l to deeper f i e l d ,  was valuable 
in showing that the cervix became more heterogeneous for  
collagen, with age. In the younger woman, the cervix became more 
collagen dense, with penetration into the stroma. In the older 
patient th is  was less pronounced.
Indubitab ly , endogenous hormones are a ffec ting  the cervical 
stroma at times outwith pregnancy, and observations on the 
presence of oestrogen receptors in the non pregnant patient  
would affirm  th is  (113).
This work, has attempted to explain the c l in ic a l  observation, 
of d i f f i c u l t y  in v isua lisa tion  of the SCJ in the older woman. 
That the SCJ recedes into the canal is not in doubt, and the 
c l in ic a l  e ffects  of th is ,  on the effectiveness of the screening 
programme for cervical cancer, have been suspected. I t  has been 
shown th a t ,  at the SCJ there is a structural change in the 
cerv ix , with age. There is a decrease in cervical water, and an 
increase in collagen density, both rendering the cervix less 
amenable to the manipulation that adequate cytology and 
colposcopy demands.
APPENDICES
A P P E N D IX  1
A P P E N D IX  TO CHAPTER 2
n=50 42 returned a f te r  2 months therapy/ 8 no return
KEY
COLUMN 1 age(years)
2 postmenopausal time(months) 1= s t i l l  menstruating
3 treatment a conjugated equine oestrogens/norgestrel-29
b oestradiol va lera te /levonorges tre l-4  
c oestrone/norethisterone-6  
d o es trad io l /o e s tr io l /n o re th is te ro n e-1  
e conjugated equine oestrogens-2
4 E2 value pmol/L -  not available
5 smear maturation value l ,2 o r  3 before/during
6 SCJ, + seen,++ eas ily  seen, -  not seen before/during
7 haemorrhages 0,1 or2 before/during
8 epithelium 0 ,1 ,2  or3 before/during
9 Lugols iodine 0 ,1 ,2  or 3 before/during
10 mucus 0 , l ,2 o r 3 before/during
11 i n i t i a l  score
12 score on therapy
13 change in score
13
8
4
9
9
12
8
12
4
2
6
8
0
0
0
14
5
6
12
5
9
14
10
11
2
4
4
2
8
7
8
4
2
4
1
9
4
8
4
10
6
15
9
3 4 5 6 7 8 9 10 11 12
a 150 2/2 - / - 0/0 2/3 1/1 0/3 6 14
a 150 1/3 - / - 2/2 2/3 1/1 2/3 16 20
a 150 2/2 - / - 1/2 2/3 2/2 0/2 11 20
a - 2/2 - /+ 0/1 3/3 0/1 0/2 6 15
a 150 2/3 - / - 2/2 2/3 1/3 0/3 12 24
a 150 2/2 +/+ 2/2 2/3 1/3 2/3 16 24
a 150 2/2 - / - 0/2 1/3 1/2 1/1 6 18
a 150 2/2 - / - 2/2 3/3 0/1 0/1 12 16
a 237 2/3 -/++ 2/2 3/3 2/2 2/3 20 22
a - 1/2 - /+ 2/2 3/3 0/2 0/1 12 18
a 150 1/3 - /+ 2/2 2/3 0/1 0/2 10 18
a 150 2/2 - /+ 2/2 3/3 2/2 2/2 20 20
a 793 2/3 - /+ 2/2 3/3 2/2 1/1 18 18
a 540 2/3 +/+ 2/2 2/2 3/3 3/3 22 22
a 150 2/3 - /+ 0/2 2/3 2/3 0/2 8 22
a 150 1/2 +/++ 1/2 3/3 1/2 1/1 13 18
a 150 2/2 - / - 2/2 0/1 2/2 1/3 12 18
a 150 1/3 - / - 0/2 2/3 0/1 1/2 6 18
a 409 2/2 - /+ 1/2 3/3 2/2 2/3 17 22
a 150 2/3 +/+ 1/2 3/3 2/3 1/3 15 24
a 150 1/3 - /++ 0/2 1/3 1/2 2/3 8 22
a 150 1/2 - / - 2/2 1/2 0/2 0/2 8 18
a 150 3/3 - /++ 1/2 2/3 1/2 0/2 9 20
a 150 2/2 +/+ 2/2 3/3 2/2 1/2 18 20
a 150 2/3 +/+ 2/2 2/3 2/2 2/3 18 22
a - 2/2 - / - 2/2 2/3 2/2 0/1 14 18
a 542 3/2 ++ /  ++ 2/2 2/2 1/2 3/3 18 20
a 150 3/3 - /+ 2/2 2/3 1/1 0/3 12 20
a 150 2/2 - /+ 1/2 3/3 1/2 0/1 11 18
b 150 2/3 - / - 2/2 1/3 1/1 1/3 12 20
b 456 3/2 - / - 2/2 2/2 0/2 0/0 10 14
b 150 3/3 - / - 2/2 3/3 2/2 1/2 18 20
b 150 2/2 +/+ 2/2 3/3 1/2 2/3 18 22
c 150 1/3 +/+ 2/1 3/3 0/1 1/2 14 15
c 150 1/2 +/+ 1/2 0/2 1/2 2/2 9 18
c 150 2/2 - / - 2/2 3/3 2/2 0/2 16 20
c - 2/3 - /+ 2/2 1/2 1/2 0/2 10 18
c 1060 2/3 - /+ + 2/2 2/3 2/2 1/2 16 20
c 171 2/2 - /+ 2/2 1/3 0/2 0/1 8 18
d 150 2/2 +/++ 2/2 2/3 1/1 1/3 14 20
e 150 1/3 - /+ 1/2 2/3 0/2 0/3 7 22
e 542 3/3 - / - 0/1 2/3 1/2 1/2 8 17
- 150 2 _ 2 0 2 0 10
- - 2 - 2 1 2 0 12 —
- 150 1 - 0 3 1 0 8
- 150 2 - 0 2 1 1 8
- - 2 - 1 1 1 0 7 pi
- 150 3 - 2 1 0 0 8
- 179 1 - 2 3 0 0 12
- 150 2 + 2 1 2 1 14 -
A P P E N D IX  2
C0LP0PH0T06RAPHS FROM PATIENTS IN CHAPTER 2 
As mentioned e a r l ie r  the q u a lity  of these colpophotographs 
was not always ideal but they are shown to i l lu s t r a te  the
findings of th is  chapter.
Patients receiving HRT 
Slides 20-21 50 year old occasional menstruation
Slide 20 before HRT, thinned epithelium, v is ib le  Squamo-
columnar junction (SCJ), mucus present 
Slide 21 on HRT Good uptake iodine 
Slides 22-23 50 year old LMP 5 years before
Slide 22 before HRT Mucus, haemorrhages, SCO not v is ib le  
Slide 23 before HRT poor uptake Lugols iodine 
Slides 24-25 52 year old LMP 18 months before
Slide 24 before HRT thin epithelium, SCJ not v is ib le  
Slide 25 before HRT v i r tu a l ly  no uptake iodine 
Slides 26-27 51 year old LMP 6 months before
Slide 26 before HRT thin epithelium, haemorrhages 
Slide 27 before HRT patchy uptake iodine 
Slides 28-29 45 year old irreg u la r  menstruation
Slide 28 on HRT metaplasia, mucus, thick epithelium  
Slide 29 moderate uptake iodine 
Slide 30 50 year old LMP 6 years before
Slide 30 on HRT SCJ v is ib le  with forceps, previously not
visible
Slides 31-32 48 year old LMP 3 months before
Slide 31 before HRT thinned epithelium, SCJ not v is ib le
Slide 32 SCJ on HRT SCJ v is ib le  with forceps
Slides 33-34 52 year old LMP 18 months before
Slide 33 before HRT thin epithelium, SCJ not seen 
Slide 34 on HRT th icker epithelium  
Slides 35-36 49 year old LMP 2years before 
Slide 35 on HRT squamous metaplasia, mucus 
Slide 36 on HRT SCJ seen with forceps 
Slide 37 57 year old LMP 3 years before
Slide 37 before HRT thin epithelium, mucus, SCJ not seen
Slides 38-40 54 year old LMP 3 years before
Slide 38 before HRT cervical polyps, no mucus, SCJ not seen 
Slide 39 before HRT poor uptake iodine 
Slide 40 on HRT better uptake iodine 
Slides 41-42 52 year old LMP 5 years before
Slide 41 before HRT thin epithelium, haemorrhages, SCJ seen 
without endocervical forceps
Slide 42 during HRT endocervical prolapse, SCJ eas ily  seen,
th icker epithelium, mucus
Slide 43 during HRT good uptake iodine
A P P E N D IX  3
This appendix supplies evidence of CIN in the four women from 
the study in Chapter 3.
The re fe rra l  le t t e r  to Dr. Malcolm Anderson is shown. This 
id e n t if ie s  the four patients by name. Dr. Anderson's reply is 
shown, indicating that he agrees with the diagnosis in a ll  
patients , and he goes fu rth e r  to suggest, that in Patient Martin  
the abnormality may even be CIN 3.
A fter these le t te r s ,  there is a short section devoted to each
pa tien t .  This takes the form of identify ing  the patient from
table 6, giving a colposcopic diagram, followed by photocopies 
of orig ina l cytology, which is negative, and histology which 
shows CIN. At the end of each patients ' section there follows  
photomicrographs of h isto logy, and in some cases 
colpophotographs or cytology photographs.
PATIENT 1- TABLE 6- MARTIN 
54 YEARS OLD- LMP 4 YEARS BEFORE
A) COLPOSCOPIC DIAGRAM
B) FIRST SMEAR REPORT- NEGATIVE
C) SECOND SMEAR REPORT- NEGATIVE
D) PUNCH BIOPSY REPORT- CIN 1-2
E) FIGURE 9 C0LP0PH0T0GRAPH SHOWING ATZ WITH AWE
F) FIGURE 10 NEGATIVE CERVICAL CYTOLOGY FROM PATIENT 1.
G) FIGURE 11 PHOTOMICROGRAPH SHOWING CIN 2 FROM PATIENT 1.
H) FIGURE 12 PHOTOMICROGRAPH SHOWING CIN 2 FROM PATIENT 1.
PATIENT 4- .TABLE 6- CRAWFORD 
51 YEAR OLD- LMP 5 YEARS BEFORE
A) COLPOSCOPIC DIAGRAM
B) FIRST SMEAR REPORT- NEGATIVE
C) PUNCH BIOPSY REPORT- CIN 1
0) FIGURE 13 COLPOPHOTOGRAPH (RATHER POOR) SHOWING TINY RIM OF
AWE.
E) FIGURE 14 PHOTOMICROGRAPH SHOWING CIN 1/ EPITHELIAL ATYPIA
FROM PATIENT 4.
PATIENT 5- TABLE 6- WALLACE 
50 YEAR OLD- LMP 9 YEARS BEFORE
A) COLPOSCOPIC DIAGRAM
B) FIRST SMEAR REPORT- NEGATIVE
C) COLPOSCOPIC DIAGRAM AFTER SUTURE REMOVED SHOWING AWE AND
MOSAIC
D) SECOND SMEAR -  NEGATIVE
E) PUNCH BIOPSY REPORT- CIN 1
F) FIGURE 15 COLPOPHOTOGRAPH SHOWING MCDONALD SUTURE BUT NO AWE
G) FIGURE 16 PHOTOMICROGRAPH SHOWING CIN 1 FROM PATIENT 5.
PATIENT 11- TABLE 6- KEENAN 
37 YEAR OLD- LMP 6 YEARS BEFORE
A) COLPOSCOPIC DIAGRAM
B) FIRST SMEAR REPORT- NEGATIVE
C) PUNCH BIOPSY REPORT- CIN 1
D) FIGURE 17 PHOTOMICROGRAPH SHOWING CIN 1 FROM PATIENT 11.
»ef. ADGR/EM 
Ref.
4th July, 1984
| Dr. M.C. Anderson, 
jSenior Lecturer, 
Histopathology Department, 
Samaritan Hospital for Women, 
Marylebone Road,
LONDON,
NW1 5YE.
Dear Dr. Anderson,
These are the slides I spoke to you about in Bristol. These few patients 
lere among 50 patients about to receive hormone replacement therapy. Cytology 
ad never previously been abnormal and there was no indication to colposcope 
ther than as a screening tool.
We thought all four smears were negative. Martin was thought to have 
IN 2, Keenan and Wallace CIN I and Crawford we were not convinced had CIN. 
bur opinion is very much appreciated.
Could you please return these slides when you have finished with them.
Thank you again.
Yours sincerely
Anthony D.G. Roberts 
Registrar to Dr. J.W. Cordiner
Yorkhill, Glasgow G3 8SH 
Telephone: 041-339 8888
THE SAMARITAN HOSPITAL FOR WOMEN
MARYLEBONE ROAD 
LONDON NW1 5YE
DEPARTMENT OF HISTOPATHOLOGY AND COLPOSCOPY
Senior Lecturer and Honorary Consultant 
M. C. Anderson F.R.C. Path.
Telephone 01 -402 4211 
Ext. 138
MCA/ce
20 August 1984
Dr A D G Roberts
Reistrar in Gynaecology
Queen Mother’s Hospital
Yorkhill
Glasgow
G3 8SH
Dear Dr Roberts
Thank you for sending me the slides on these four postmenopausal 
patients about whom we spoke in Bristol.
As we discussed on the telephone, I agree with your diagnoses 
on all of them. In fact, I would suggest that the abnormality 
in Martin is at the upper end of the CIN 2 range and, in the 
crypts, may be CIN 3. I have not reviewed the cytology as I am
not a cytologist. *
I am returning the slides. 
With kind regards 
Yours sincerely
C Anderson
PADDINGTON AND NORTH KENSINGTON HEALTH AUTHORITY
PATIENT 1 MARTIN
PATIENT 1- TABLE 6 - MARTIN 
54 YEAR OLD - LMP 4 YEARS BEFORE 
Negative cytology 
Histology CIN 2(3)
WELL DEFINED AWE LESION
AND SATELLITE
SCJ NOT VISIBLE
SMEAR
BIOPSY
TAKEN
HRT PRESCRIBED
FIRST SMEAR REPORT
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•PATHOLOGY REPORT - CIN 1-2 
WESTERN 1N F1R M A RY/G AR TNA VEL G ENERAL HOSPITAL •
Lab. No.: 
Initialled as seen:
Name: HARTIM,
Phys./Surg.: Dr- Roberts
54
PAT
Hosp. No.:
Ward: G1° WIG
Punch biopsy of cervix_
These are scrappy fragments.
Microscopy shows extensive squamous metaplasia of 
endocervical glands, with focal mild dysplasia 
(CIN I-II).
Robin Reid
7600SNOP
0 * 1 1  O f  _ _
O P f R A T IO N  7.7.83 11.7Punch biopsy of cervix
FIGURE 9 -COLPOPHOTOGRAPH FROM PATIENT MARTIN SHOWING AN ATZ 
WITH AWE
FIGURE 10-NEGATIVE CERVICAL CYTOLOGY FROM PATIENT MARTIN
PATIENT MARTIN C I N  x S O O
n
FIGURE 11-PHOTOMICROGRAPH FROM PATIENT MARTIN SHOWING CIN in GLAND x 20 0
FIGURE 12-PHOTOMICROGRAPH FROM PATIENT MARTIN SHOWING CIN 2 * 2 0 0
PATIENT 4 CRAWFORD
PATIENT 4- TABLE 6 - CRAWFORD 
51 YEAR OLD - LMP 5 YEARS BEFORE 
Negative cytology 
Histology CIN 1/ATYPIA
RIM OF AWE
SCJ NOT VISIBLE
SMEAR TAKEN 
BIOPSY TAKEN
HRT COULD NOT BE TOLERATED
SMEAR AND BIOPSY REPORTS OVER
FIRST SMEAR REPORT
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D a ta  <i o f  L M .P .
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tissue with mild dysplasia of squamous epithelium (CIN I). 
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A P P E N D IX  4
NOTES ON THE COMPLETION OF THIS THESIS 
During the co llection of data for th is  thesis , i t  was decided 
that su itab le  information would be stored, and analysed, by a 
microcomputer. I f e l t  that i f  the computer was situated at home, 
then greater access to the data would be ava ilab le , and 
consequently more time for analysis. For th is purpose, I 
purchased a microcomputer and learned BASIC.
Patient information from the studies in chapters four, f iv e ,
and e igh t,  was held in a simple database, and these data were
examined by a programme that I devised. The pr inc ip le  behind 
th is method of data analysis is very simple; Information was 
held in an alphanumeric s tr in g , th is  is a sequence of d ig its  or 
numbers, which are held in an array such as th is ;
13287362 patient 1
15387221 patient 2
12376233 patient 3
Any piece of information can be coded a number, fo r example 
the f i r s t  number of the string may be p a r i ty ,  the second and 
th ir d ,  age, and the fourth , the organism iso la ted , or the 
specific  measurement. Patient 1 therefore, was para 1, age 32, 
and had organism 8, say C.trachomatis iso la ted . Analysis of the 
data, can be carried out by 'questioning' the s tr ing . By asking 
the string  from patient 1 what is the fourth character, and 
counting i f  i t  is 8, and then passing on to string  2 and 
continuing the count, the number with 8 as the fourth character
i . e .  with C. trachomatis, is quickly summated. Quick answers to
f a i r l y  complex questions could be obtained.
Any number of conditions could be made to make the questions 
very specific  such as; i f  the fourth character is 3, and the
f i f t h  character is 6, and the eighth character is 4, and the
tw elfth  character is 5, then count the second and th ird  
character, i . e .  age. By such specific  application of the database 
to the data, i t  was uncomplicated to obtain prevalence of 
specific  conditions, and mean ages, p a r i t ie s  etc .
To work in conjunction with th is  database, some colleagues
and I wrote programmes to perform s ta t is t ic s  d ire c t ly  on the
data held in the arrays. S ta t is t ic a l  programmes fo r standard 
deviations, standard errors , t  te s ts ,  chi square te s ts ,  
fa c to r ia ls ,  logarithmic transformation, and nonparametric tests  
such as Mann Whitney U tes t  and Kendals co e ff ic ie n t  of rank 
corre la t ion , were a l l  devised and applied d ire c t ly  to the data.
These methods,enabled the data to be analysed much quicker, 
than by manual methods. Furthermore, in teresting  correlations  
could be quickly checked, and s ta t is t ic a l  analysis applied.
The nature of a thesis , makes i t  very suitable for being
w ritten on a word processor. A le t t e r  q u a li ty  daisywheel
p r in te r ,  fas t  data storage and re tr ie v a l  system, and a word 
processing programme were added to the microcomputer. The main 
benefit of th is  system,was that I could w rite ,  and re w r i te ,a t
home in the evening, and a hard copy could be obtained a f te r
each d ra f t .  Not only did th is  teach me to type, i t  avoided the 
repeated use of secretaria l time. The whole system including a l l  
software cost less than £500, and did not require a special 
video display u n it ,  a humble te lev is ion  proving adequate.
There is ,  however, a balance in a l l  things, and th is  is no 
exception. Once the system was operational i t  ran smoothly, but 
the teething problems with hardware, and especia lly  programming, 
were considerable. There were problems with f i l e  handling and 
error trapping which, in the absence of specialised help, took a 
considerable time to correct. In terms of time saved over manual 
methods, by using a computer to such a large extent, the issue 
is f a i r l y  marginal. However, the experience of becoming even a 
l i t t l e  'computer l i t e r a t e '  is an investment fo r the fu tu re .
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